background	NN	ROOT
:	:	punct

owner	NN	nsubj
of	IN	prep
patent	NN	pobj
for	IN	prep
name	NN	compound
-	HYPH	punct
brand	NN	compound
hypertension	NN	compound
drug	NN	pobj
sue	VBD	ROOT
propose	VBN	amod
manufacturer	NN	dobj
of	IN	prep
generic	JJ	amod
version	NN	pobj
for	IN	prep
infringement	NN	pobj
.	.	punct

follow	VBG	prep
a	DT	det
bench	NN	compound
trial	NN	pobj
,	,	punct
the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	nsubj
for	IN	prep
the	DT	det
Northern	NNP	compound
District	NNP	pobj
of	IN	prep
Illinois	NNP	pobj
,	,	punct
James	NNP	compound
M.	NNP	compound
Rosenbaum	NNP	conj
,	,	punct
Chief	NNP	compound
Judge	NNP	appos
,	,	punct
enter	VBD	ROOT
a	DT	det
final	JJ	amod
judgment	NN	dobj
for	IN	prep
patent	NN	compound
owner	NN	pobj
.	.	punct

manufacturer	NN	nsubj
appeal	VBD	ROOT
.	.	punct

 	_SP	

holding	NNS	ROOT
:	:	punct

the	DT	det
Court	NNP	nsubj
of	IN	prep
Appeals	NNPS	pobj
,	,	punct
Michel	NNP	conj
,	,	punct
Chief	NNP	compound
Judge	NNP	appos
,	,	punct
hold	VBD	ROOT
that	IN	dobj
:	:	punct

 	_SP	

clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	nsubj
show	VBD	ccomp
that	IN	mark
a	DT	det
skilled	JJ	amod
artisan	NN	nsubjpass
would	MD	aux
have	VB	aux
be	VBN	auxpass
motivate	VBN	ccomp
to	TO	aux
combine	VB	xcomp
prior	JJ	amod
art	NN	compound
reference	NNS	dobj
to	TO	aux
achieve	VB	advcl
the	DT	det
claim	VBN	amod
invention	NN	dobj
;	:	punct

 	_SP	
manufacturer	NN	nsubj
show	VBN	ROOT
by	IN	agent
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
that	IN	mark
a	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
have	VB	aux
have	VBN	acl
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
;	:	punct
and	CC	cc

 	_SP	
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	nsubj
show	VBD	conj
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
to	TO	aux
optimize	VB	xcomp
acid	JJ	compound
addition	NN	compound
salt	NN	compound
formulation	NN	dobj
for	IN	prep
an	DT	det
active	JJ	amod
pharmaceutical	NN	amod
ingredient	NN	pobj
in	IN	prep
hypertension	NN	compound
drug	NN	pobj
.	.	punct

 	_SP	

Pfizer	NNP	compound
Inc.	NNP	nsubj
file	VBD	ROOT
suit	NN	dobj
against	IN	prep
Apotex	NNP	pobj
,	,	punct
Inc.	NNP	appos
(	-LRB-	punct
formerly	RB	advmod
know	VBN	acl
as	IN	prep
Tor	NNP	compound
Pharm	NNP	pobj
,	,	punct
Inc.	NNP	appos
)	-RRB-	punct
in	IN	prep
the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	pobj
for	IN	prep
the	DT	det
Northern	NNP	compound
District	NNP	pobj
of	IN	prep
Illinois	NNP	pobj
on	IN	prep
July	NNP	pobj
30	CD	nummod
,	,	punct
2003	CD	nummod
,	,	punct
allege	VBG	advcl
that	IN	dobj
,	,	punct
pursuant	JJ	ccomp
to	IN	prep
21	CD	pobj
u.s.c.	NN	npadvmod
¡±	NNP	advmod
355(j)(5)(b)(iii	CD	dep
)	-RRB-	punct
,	,	punct
Apotex	NNP	poss
's	POS	case
filing	NN	nsubj
with	IN	prep
the	DT	det
United	NNP	nmod
States	NNP	nmod
Food	NNP	nmod
and	CC	cc
Drug	NNP	conj
Administration	NNP	pobj
(	-LRB-	punct
"	``	punct
FDA	NNP	appos
"	''	punct
)	-RRB-	punct
of	IN	prep
-PRON-	PRP$	poss
Abbreviated	NNP	compound
New	NNP	compound
Drug	NNP	compound
Application	NNP	pobj
(	-LRB-	punct
"	``	punct
ANDA	NNP	nmod
"	''	punct
)	-RRB-	punct
No.	SYM	appos
76	CD	nummod
-	SYM	punct
719	CD	nummod
seek	VBG	acl
approval	NN	dobj
to	TO	aux
commercially	RB	advmod
sell	VB	acl
amlodipine	JJ	compound
besylate	NN	compound
tablet	NNS	dobj
(	-LRB-	punct
2.5	CD	nummod
mg	NN	appos
,	,	punct
5	CD	nummod
mg	NN	conj
,	,	punct
and	CC	cc
10	CD	nummod
mg	NN	compound
strength	NNS	conj
)	-RRB-	punct
before	IN	prep
the	DT	det
expiration	NN	pobj
of	IN	prep
the	DT	det
term	NN	pobj
of	IN	prep
U.S.	NNP	compound
patent	NN	compound
No.	SYM	pobj
4,879,303	CD	nummod
(	-LRB-	punct
"	``	punct
the	DT	det
¡¬303	JJ	compound
patent	NN	appos
"	''	punct
)	-RRB-	punct
to	IN	prep
Pfizer	NNP	pobj
,	,	punct
infringe	VBD	conj
claim	NNS	dobj
1	CD	npadvmod
-	SYM	punct
3	CD	prep
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
.	.	punct

the	DT	det
ANDA	NNP	compound
product	NN	nsubj
seek	VBD	ROOT
to	TO	aux
be	VB	auxpass
approve	VBN	xcomp
by	IN	agent
Apotex	NNP	pobj
be	VBZ	conj
a	DT	det
generic	JJ	amod
version	NN	attr
of	IN	prep
Pfizer	NNP	poss
's	POS	case
amlodipine	JJ	compound
besylate	NN	compound
drug	NN	compound
product	NN	pobj
,	,	punct
which	WDT	nsubjpass
be	VBZ	auxpass
commercially	RB	advmod
sell	VBN	relcl
in	IN	prep
tablet	NN	compound
form	NN	pobj
in	IN	prep
the	DT	det
United	NNP	compound
States	NNP	pobj
under	IN	prep
the	DT	det
trademark	NN	pobj
Norvasc	NNP	compound
(r)	SYM	appos
.	.	punct
Norvasc	NNP	dobj
(r)	SYM	nsubjpass
be	VBZ	auxpass
approve	VBN	conj
by	IN	agent
the	DT	det
FDA	NNP	pobj
for	IN	prep
treat	VBG	pcomp
hypertension	NN	dobj
and	CC	cc
chronic	VB	amod
stable	JJ	amod
and	CC	cc
vasospastic	JJ	conj
angina	NN	conj
.	.	punct

the	DT	det
¡¬303	JJ	compound
patent	NN	nsubjpass
,	,	punct
entitle	VBN	acl
"	``	punct
Pharmaceutically	NNP	advmod
Acceptable	NNP	compound
Salts	NNPS	oprd
,	,	punct
"	''	punct
be	VBZ	auxpass
list	VBN	ROOT
in	IN	prep
the	DT	det
FDA	NNP	poss
's	POS	case
Approved	NNP	compound
Drug	NNP	compound
Products	NNPS	pobj
with	IN	prep
Therapeutic	NNP	compound
Equivalence	NNP	compound
evaluation	NNS	pobj
(	-LRB-	punct
"	``	punct
Orange	NNP	compound
Book	NNP	appos
"	''	punct
)	-RRB-	punct
with	IN	prep
respect	NN	pobj
to	IN	prep
the	DT	det
Norvasc	NNP	compound
(r)	SYM	compound
drug	NN	compound
product	NN	pobj
in	IN	prep
accordance	NN	pobj
with	IN	prep
21	CD	nummod
U.S.C.	NNP	nmod
¡±	CD	advmod
355(b)(1	CD	pobj
)	-RRB-	punct
.	.	punct

Apotex	NNP	nsubj
certify	VBN	ROOT
in	IN	prep
ANDA	NNP	compound
No.	SYM	pobj
76	CD	nummod
-	SYM	punct
719	CD	nummod
that	IN	mark
-PRON-	PRP	nsubj
believe	VBD	ccomp
the	DT	det
¡¬303	JJ	nummod
patent	NN	nsubj
be	VBD	ccomp
invalid	JJ	acomp
and	CC	cc
unenforceable	JJ	conj
,	,	punct
and	CC	cc
seek	VBD	conj
approval	NN	dobj
to	IN	prep
market	NN	pobj
and	CC	cc
sell	VB	conj
-PRON-	PRP$	poss
amlodipine	JJ	compound
besylate	NN	compound
tablet	NNS	dobj
before	IN	prep
September	NNP	pobj
25	CD	nummod
,	,	punct
2007	CD	nummod
(	-LRB-	punct
i.e.	FW	advmod
,	,	punct
the	DT	det
expiration	NN	compound
date	NN	appos
of	IN	prep
the	DT	det
¡¬303	JJ	nummod
patent	NN	pobj
plus	CC	cc
an	DT	det
additional	JJ	amod
six	CD	nummod
month	NNS	conj
of	IN	prep
pediatric	JJ	amod
exclusivity	NN	pobj
)	-RRB-	punct
pursuant	JJ	advcl
to	IN	prep
21	CD	nummod
C.F.R.	NNP	nmod
¡±	NNP	advmod
314.94(a)(12)(i)(a)(4	CD	pobj
)	-RRB-	punct
.	.	punct

 	_SP	

In	IN	prep
-PRON-	PRP$	poss
answer	NN	pobj
to	IN	prep
Pfizer	NNP	poss
's	POS	case
complaint	NN	pobj
,	,	punct
Apotex	NNP	nsubj
deny	VBD	ROOT
infringement	NN	dobj
and	CC	cc
counterclaim	VBN	conj
for	IN	prep
declaratory	JJ	amod
judgment	NNS	pobj
that	IN	mark
the	DT	det
claim	NNS	nsubj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
be	VBP	relcl
invalid	JJ	acomp
for	IN	prep
anticipation	NN	pobj
and	CC	cc
obviousness	JJ	conj
,	,	punct
and	CC	cc
that	IN	mark
the	DT	det
¡¬303	JJ	compound
patent	NN	nsubj
be	VBZ	conj
unenforceable	JJ	acomp
due	IN	prep
to	IN	prep
Pfizer	NNP	poss
's	POS	case
allege	VBN	amod
inequitable	JJ	amod
conduct	NN	pobj
before	IN	prep
the	DT	det
United	NNP	compound
States	NNP	nmod
Patent	NNP	nmod
and	CC	cc
Trademark	NNP	conj
Office	NNP	pobj
(	-LRB-	punct
"	``	punct
USPTO	NNP	appos
"	''	punct
)	-RRB-	punct
.	.	punct

prior	RB	advmod
to	IN	prep
trial	NN	pobj
,	,	punct
however	RB	advmod
,	,	punct
Apotex	NNP	nsubj
stipulate	VBD	ROOT
that	IN	mark
-PRON-	PRP$	poss
ANDA	NNP	compound
product	NN	nsubj
contain	VBZ	ccomp
each	DT	det
limitation	NN	dobj
of	IN	prep
claim	NNS	pobj
1	CD	npadvmod
-	SYM	punct
3	CD	prep
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
,	,	punct
and	CC	cc
that	IN	mark
if	IN	mark
the	DT	det
¡¬303	JJ	compound
patent	NN	nsubjpass
be	VBD	auxpass
uphold	VBN	advcl
as	IN	prep
valid	JJ	amod
and	CC	cc
enforceable	JJ	conj
,	,	punct
-PRON-	PRP$	poss
ANDA	NNP	compound
product	NN	nsubj
would	MD	aux
literally	RB	advmod
infringe	VB	conj
those	DT	det
claim	NNS	dobj
.	.	punct

 	_SP	

follow	VBG	prep
a	DT	det
bench	NN	compound
trial	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
enter	VBD	ROOT
a	DT	det
final	JJ	amod
judgment	NN	dobj
on	IN	prep
January	NNP	pobj
29	CD	nummod
,	,	punct
2006	CD	nummod
for	IN	dative
Pfizer	NNP	pobj
and	CC	cc
against	IN	conj
Apotex	NNP	pobj
on	IN	prep
Apotex	NNP	poss
's	POS	case
request	NN	pobj
for	IN	prep
declaratory	JJ	amod
judgment	NNS	pobj
that	IN	mark
the	DT	det
claim	NNS	nsubj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
be	VBP	acl
invalid	JJ	acomp
or	CC	cc
unenforceable	JJ	conj
.	.	punct

base	VBN	prep
on	IN	prep
the	DT	det
stipulation	NN	pobj
,	,	punct
the	DT	det
trial	NN	compound
court	NN	nsubj
find	VBD	ROOT
infringement	NN	dobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
then	RB	advmod
order	VBD	ROOT
that	IN	mark
the	DT	det
effective	JJ	amod
date	NN	nsubj
of	IN	prep
any	DT	det
approval	NN	pobj
of	IN	prep
Apotex	NNP	poss
's	POS	case
ANDA	NNP	nmod
No.	SYM	pobj
76	CD	nummod
-	SYM	punct
719	CD	conj
shall	MD	aux
not	RB	neg
be	VB	ccomp
early	JJR	acomp
than	IN	prep
September	NNP	pobj
25	CD	nummod
,	,	punct
2007	CD	appos
,	,	punct
and	CC	cc
enjoin	VBD	conj
Apotex	NNP	dobj
from	IN	prep
make	VBG	pcomp
,	,	punct
use	VBG	advcl
,	,	punct
offer	VBG	conj
to	TO	aux
sell	VB	xcomp
,	,	punct
sell	VBG	conj
,	,	punct
or	CC	cc
import	VBG	conj
into	IN	prep
the	DT	det
United	NNP	compound
States	NNP	pobj
any	DT	det
product	NN	dobj
comprise	VBG	acl
amlodipine	NN	compound
besylate	NN	dobj
cover	VBN	acl
by	IN	agent
(	-LRB-	punct
or	CC	cc
the	DT	det
use	NN	nsubjpass
of	IN	prep
which	WDT	pobj
be	VBZ	auxpass
cover	VBN	conj
by	IN	agent
)	-RRB-	punct
the	DT	det
claim	NNS	dobj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
until	IN	prep
September	NNP	pobj
25	CD	nummod
,	,	punct
2007	CD	appos
.	.	punct

Pfizer	NNP	compound
Inc.	NNP	ROOT
v.	CC	prep
Apotex	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
No.	SYM	conj
03c	CD	nummod
5289	CD	npadvmod
(	-LRB-	punct
N.D.Ill	NNP	subtok
.	.	punct
January	NNP	npadvmod
29	CD	nummod
,	,	punct
2006	CD	nummod
)	-RRB-	punct
.	.	punct

 	_SP	

Pfizer	NNP	nsubj
dismiss	VBD	ROOT
-PRON-	PRP$	poss
claim	NN	dobj
of	IN	prep
willful	JJ	amod
infringement	NN	pobj
against	IN	prep
Apotex	NNP	pobj
by	IN	prep
a	DT	det
Stipulation	NNP	pobj
and	CC	cc
order	NN	conj
date	VBD	acl
January	NNP	npadvmod
23	CD	nummod
,	,	punct
2006	CD	appos
.	.	punct

Apotex	NNP	nsubj
now	RB	advmod
appeal	VBZ	ROOT
from	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
final	JJ	amod
judgment	NN	pobj
,	,	punct
challenge	VBG	advcl
the	DT	det
ruling	NNS	dobj
as	IN	prep
to	IN	prep
validity	NN	pobj
and	CC	cc
enforceability	NN	conj
.	.	punct

Because	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
err	VBD	advcl
in	IN	prep
hold	VBG	pcomp
that	IN	mark
the	DT	det
subject	JJ	amod
matter	NN	nsubj
of	IN	prep
claim	NNS	pobj
1	CD	npadvmod
-	SYM	punct
3	CD	prep
of	IN	prep
the	DT	det
¡¬	NNP	nmod
303	CD	nummod
patent	NN	pobj
would	MD	aux
not	RB	neg
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
,	,	punct
-PRON-	PRP	nsubj
reverse	VBP	ROOT
.	.	punct

-PRON-	PRP	nsubj
therefore	RB	advmod
do	VBP	aux
not	RB	neg
address	VB	ROOT
Apotex	NNP	poss
's	POS	case
assertion	NN	dobj
that	IN	mark
-PRON-	PRP	nsubj
have	VBD	aux
prove	VBN	acl
that	IN	mark
Pfizer	NNP	nsubj
engage	VBD	ccomp
in	IN	prep
inequitable	JJ	amod
conduct	NN	pobj
before	IN	prep
the	DT	det
USPTO	NNP	pobj
during	IN	prep
prosecution	NN	pobj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
.	.	punct

 	_SP	

i.	NN	compound
BACKGROUND	NNP	nsubj

 	_SP	
Norvasc	NNP	compound
(r)	SYM	nsubj
contain	VBZ	ROOT
amlodipine	JJ	compound
besylate	NN	dobj
.	.	punct

the	DT	det
active	JJ	amod
ingredient	NN	nsubj
find	VBN	acl
in	IN	prep
Norvasc	NNP	pobj
(r)	SYM	appos
be	VBZ	ROOT

2-	XX	subtok
[	-LRB-	punct
(	-LRB-	punct
2	CD	nummod
-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine	XX	npadvmod
,	,	punct
commonly	RB	advmod
refer	VBN	ccomp
to	IN	prep
as	IN	prep
amlodipine	NN	pobj
.	.	punct
Amlodipine	NNP	nsubj
be	VBZ	ccomp
a	DT	det
member	NN	attr
of	IN	prep
a	DT	det
class	NN	pobj
of	IN	prep
compound	NNS	pobj
refer	VBN	acl
to	IN	prep
as	IN	prep
dihydropyridine	NNS	pobj
.	.	punct
active	JJ	amod
drug	NN	compound
molecule	NNS	nsubjpass
,	,	punct
such	JJ	amod
as	IN	prep
amlodipine	NN	pobj
,	,	punct
be	VBP	auxpass
frequently	RB	advmod
make	VBN	conj
into	IN	prep
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NNS	pobj
to	TO	aux
improve	VB	advcl
-PRON-	PRP$	poss
bioavailability	NN	dobj
.	.	punct
amlodipine	JJ	compound
besylate1	NNP	nsubj
be	VBZ	conj
an	DT	det
acid	JJ	compound
addition	NN	compound
salt	NN	compound
form	NN	attr
of	IN	prep
amlodipine	NN	pobj
,	,	punct
form	VBN	acl
from	IN	prep
the	DT	det
reaction	NN	pobj
of	IN	prep
amlodipine	NN	pobj
,	,	punct
a	DT	det
weak	JJ	amod
base	NN	conj
,	,	punct
and	CC	cc
benzene	NN	amod
sulphonic	JJ	amod
acid	NN	conj
.	.	punct

 	_SP	
Pfizer	NNP	poss
's	POS	case
Discovery	NNP	compound
Chemistry	NNP	compound
group	NN	attr
,	,	punct
locate	VBN	amod
in	IN	prep
Sandwich	NNP	pobj
,	,	punct
England	NNP	appos
,	,	punct
invent	VBN	amod
amlodipine	NN	appos
and	CC	cc
discover	VBD	conj
-PRON-	PRP$	poss
anti	JJ	subtok
-	JJ	subtok
hypertensive	JJ	amod
and	CC	cc
anti	JJ	subtok
-	JJ	subtok
ischemic	JJ	amod
pharmacological	JJ	amod
property	NNS	dobj
prior	RB	advmod
to	IN	prep
1982	CD	pobj
.	.	punct
pfizer	NN	nsubj
file	VBD	conj
a	DT	det
patent	NN	compound
application	NN	dobj
in	IN	prep
the	DT	det
United	NNP	compound
Kingdom	NNP	pobj
on	IN	prep
March	NNP	pobj
11	CD	nummod
,	,	punct
1982	CD	nummod
specifically	RB	advmod
claim	VBG	advcl
amlodipine	NN	dobj
.	.	punct
a	DT	det
U.S.	NNP	compound
counterpart	NN	compound
application	NN	dobj
claim	VBG	acl
priority	NN	dobj
from	IN	prep
the	DT	det
U.K.	NNP	compound
application	NN	pobj
issue	VBN	acl
as	IN	prep
U.S.	NNP	compound
patent	NN	compound
No.	SYM	pobj
4,572,909	CD	nummod
(	-LRB-	punct
"	``	punct
the	DT	det
¡¬909	JJR	nummod
patent	NN	dobj
"	''	punct
)	-RRB-	punct
on	IN	prep
February	NNP	pobj
25	CD	nummod
,	,	punct
1986.2	CD	npadvmod
the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubj
claim	VBZ	conj
certain	JJ	amod
dihydropyridine	NN	compound
compound	NNS	dobj
and	CC	cc
-PRON-	PRP$	poss
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NNS	conj
.	.	punct
the	DT	quantmod
¡¬909	JJR	nummod
patent	NN	nsubj
disclose	VBZ	conj
that	IN	mark
the	DT	det
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NNS	nsubj
of	IN	prep
amlodipine	NN	pobj
"	''	punct
be	VBP	ccomp
those	DT	attr
form	VBN	acl
from	IN	prep
acid	NNS	pobj
which	WDT	nsubj
form	VBP	relcl
non	JJ	subtok
-	JJ	subtok
toxic	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NNS	dobj
contain	VBG	acl
pharmaceutically	RB	advmod
acceptable	JJ	amod
anion	NNS	dobj
,	,	punct
such	JJ	amod
as	IN	prep
hydrochloride	NN	pobj
,	,	punct
hydrobromide	NN	conj
,	,	punct
sulphate	NN	conj
,	,	punct
phosphate	NN	conj
or	CC	cc
acid	JJ	conj
phosphate	NN	nmod
,	,	punct
acetate	JJ	amod
,	,	punct
maleate	JJ	nmod
,	,	punct
fumarate	VB	conj
,	,	punct
lactate	VBP	conj
,	,	punct
tartrate	NN	conj
,	,	punct
citrate	JJ	conj
and	CC	cc
gluconate	JJ	conj
salt	NNS	conj
,	,	punct
"	''	punct
and	CC	cc
that	IN	mark
the	DT	det
preferred	JJ	amod
salt	NN	nsubj
be	VBZ	conj
maleate.3	ADD	punct
¡¬909	JJR	nummod
patent	NN	compound
col.2	NN	compound
ll.3	NNP	compound
-	SYM	punct
10	CD	attr
.	.	punct

 	_SP	
meanwhile	RB	advmod
,	,	punct
on	IN	prep
or	CC	cc
about	IN	conj
July	NNP	pobj
14	CD	nummod
,	,	punct
1982	CD	nummod
,	,	punct
the	DT	det
Discovery	NNP	compound
Chemistry	NNP	compound
group	NN	nsubj
recommend	VBD	ccomp
that	IN	mark
amlodipine	NN	nsubjpass
be	VB	auxpass
develop	VBN	ccomp
as	IN	prep
a	DT	det
commercial	JJ	amod
drug	NN	compound
product	NN	pobj
.	.	punct
By	IN	prep
this	DT	det
time	NN	pobj
,	,	punct
Pfizer	NNP	nsubj
have	VBD	aux
make	VBN	advmod
several	JJ	amod
acid	JJ	compound
addition	NN	compound
salt	NNS	dobj
of	IN	prep
amlodipine	NN	pobj
,	,	punct
include	VBG	prep
the	DT	det
maleate	JJ	pobj
,	,	punct
fumarate	VB	conj
,	,	punct
salicylate	VBP	conj
,	,	punct
hydrochloride	VB	conj
,	,	punct
and	CC	cc
methane	NN	compound
sulphonate	JJ	compound
form	NNS	conj
.	.	punct
the	DT	det
Discovery	NNP	compound
Chemistry	NNP	compound
group	NN	nsubj
designate	VBD	advcl
amlodipine	NN	compound
maleate	NN	dobj
as	IN	prep
the	DT	det
drug	NN	compound
substance	NN	pobj
for	IN	prep
development	NN	pobj
.	.	punct

 	_SP	
On	IN	prep
or	CC	cc
about	IN	conj
August	NNP	pobj
11	CD	nummod
,	,	punct
1982	CD	nummod
,	,	punct
the	DT	det
project	NN	nsubjpass
of	IN	prep
formulate	VBG	pcomp
a	DT	det
commercial	JJ	amod
drug	NN	compound
product	NN	dobj
be	VBD	auxpass
assign	VBN	advcl
to	IN	prep
Dr.	NNP	compound
James	NNP	compound
Wells	NNP	pobj
,	,	punct
a	DT	det
manager	NN	appos
in	IN	prep
Pfizer	NNP	poss
's	POS	case
Pharmaceutical	NNP	nmod
Research	NNP	nmod
and	CC	cc
Development	NNP	conj
Department	NNP	pobj
,	,	punct
who	WP	nsubjpass
be	VBD	auxpass
assist	VBN	relcl
by	IN	agent
Mr.	NNP	compound
Edward	NNP	compound
Davison	NNP	pobj
,	,	punct
a	DT	det
member	NN	appos
of	IN	prep
the	DT	det
same	JJ	amod
group	NN	pobj
.	.	punct
By	IN	prep
April	NNP	pobj
24	CD	nummod
,	,	punct
1984	CD	nummod
,	,	punct
Dr.	NNP	compound
Wells	NNP	nsubj
identify	VBD	ccomp
a	DT	det
formulation	NN	dobj
for	IN	prep
amlodipine	NN	compound
maleate	NN	pobj
that	WDT	nsubj
produce	VBD	relcl
"	``	punct
excellent	JJ	amod
capsule	NNS	dobj
"	''	punct
.	.	punct
In	IN	prep
attempt	VBG	pcomp
to	TO	aux
produce	VB	xcomp
a	DT	det
direct	JJ	amod
compression	NN	compound
tablet	NN	compound
product	NN	dobj
of	IN	prep
an	DT	det
amlodipine	JJ	amod
maleate	JJ	compound
formulation	NN	pobj
,	,	punct
however	RB	advmod
,	,	punct
Dr.	NNP	compound
Wells	NNP	nsubj
encounter	VBD	conj
two	CD	nummod
problem	NNS	dobj
:	:	punct
(	-LRB-	punct
1	LS	meta
)	-RRB-	punct
chemical	NN	compound
instability	NN	appos
of	IN	prep
the	DT	det
amlodipine	NN	compound
maleate	NN	pobj
,	,	punct
and	CC	cc
(	-LRB-	punct
2	LS	nummod
)	-RRB-	punct
stickiness	NN	conj
of	IN	prep
the	DT	det
tablet	NN	compound
blend	NN	pobj
of	IN	prep
amlodipine	JJ	compound
maleate	NN	pobj
.	.	punct
chemical	JJ	compound
stability	NN	nsubj
refer	VBZ	conj
to	IN	prep
the	DT	det
resistance	NN	pobj
of	IN	prep
a	DT	det
drug	NN	compound
compound	NN	pobj
to	IN	prep
chemical	NN	compound
breakdown	NN	pobj
,	,	punct
while	IN	mark
stickiness	NN	nsubj
refer	VBZ	advcl
to	IN	prep
the	DT	det
adherence	NN	pobj
of	IN	prep
the	DT	det
drug	NN	compound
substance	NN	pobj
,	,	punct
in	IN	prep
formulation	NN	pobj
,	,	punct
to	IN	conj
manufacturing	NN	amod
equipment	NN	pobj
,	,	punct
such	JJ	amod
as	IN	prep
the	DT	det
punch	NN	compound
face	VBZ	pobj
of	IN	prep
a	DT	det
tablet	NN	npadvmod
-	HYPH	punct
make	VBG	amod
press	NN	pobj
.	.	punct

 	_SP	
to	TO	aux
solve	VB	advcl
the	DT	det
problem	NNS	dobj
of	IN	prep
the	DT	det
tablet	NN	compound
form	NN	pobj
of	IN	prep
amlodipine	NN	compound
maleate	NN	pobj
,	,	punct
Dr.	NNP	compound
Wells	NNP	nsubj
suggest	VBD	advmod
that	IN	mark
other	JJ	amod
amlodipine	JJ	compound
salt	NNS	nsubjpass
be	VB	auxpass
make	VBN	ccomp
and	CC	cc
test	VBN	conj
.	.	punct
In	IN	prep
a	DT	det
memo	NN	pobj
date	VBN	acl
April	NNP	npadvmod
24	CD	nummod
,	,	punct
1984	CD	nummod
,	,	punct
Dr.	NNP	compound
Wells	NNP	nsubj
acknowledge	VBD	ccomp
the	DT	det
difficulty	NN	dobj
in	IN	prep
stickiness	NN	pobj
and	CC	cc
stability	NN	conj
-PRON-	PRP	nsubj
be	VBD	aux
experience	VBG	relcl
in	IN	prep
attempt	VBG	pcomp
to	TO	aux
make	VB	xcomp
a	DT	det
tablet	NN	compound
formulation	NN	dobj
of	IN	prep
amlodipine	JJ	compound
maleate	NN	pobj
and	CC	cc
state	VBD	advcl
that	IN	mark
,	,	punct
by	IN	prep
change	VBG	pcomp
from	IN	prep
the	DT	det
maleate	JJ	compound
salt	NN	pobj
to	IN	prep
the	DT	det
free	JJ	amod
base	NN	pobj
of	IN	prep
amlodipine	NN	pobj
or	CC	cc
another	DT	det
acid	JJ	compound
addition	NN	compound
salt	NN	conj
,	,	punct
"	''	punct
many	JJ	nsubj
of	IN	prep
the	DT	det
stability	NN	compound
problem	NNS	pobj
would	MD	aux
disappear	VB	ccomp
"	''	punct
.	.	punct
Dr.	NNP	compound
Wells	NNP	nsubj
identify	VBD	ccomp
six	CD	nummod
alternative	JJ	amod
anion	NNS	dobj
,	,	punct
i.e.	FW	advmod
,	,	punct
hydrochloride	NN	appos
,	,	punct
methane	NN	compound
sulphonate	NN	conj
,	,	punct
benzene	NN	compound
sulphonate	NN	conj
,	,	punct
lactate	VBP	conj
,	,	punct
succinate	JJ	conj
,	,	punct
and	CC	cc
acetate	VB	conj
,	,	punct
as	IN	prep
potential	JJ	amod
anion	NNS	pobj
with	IN	prep
which	WDT	pobj
to	TO	aux
create	VB	relcl
acid	JJ	compound
addition	NN	compound
salt	NN	compound
form	NNS	dobj
of	IN	prep
amlodipine	NN	pobj
.	.	punct
-PRON-	PRP	nsubj
also	RB	advmod
eventually	RB	advmod
add	VBD	ccomp
the	DT	det
tosylate	JJ	amod
anion	NN	dobj
to	IN	prep
this	DT	det
group	NN	pobj
.	.	punct
Dr.	NNP	compound
Wells	NNP	nsubj
testify	VBD	ccomp
at	IN	prep
trial	NN	pobj
that	IN	mark
-PRON-	PRP	nsubj
select	VBD	ccomp
these	DT	det
candidate	NNS	dobj
base	VBN	prep
on	IN	prep
-PRON-	PRP$	poss
differ	VBG	amod
structure	NNS	pobj
and	CC	cc
property	NNS	conj
,	,	punct
but	CC	cc
could	MD	aux
not	RB	neg
explain	VB	conj
why	WRB	advmod
three	CD	nsubj
of	IN	prep
the	DT	det
seven	CD	nummod
alternative	JJ	amod
anion	NNS	pobj
be	VBD	ccomp
member	NNS	attr
of	IN	prep
the	DT	det
same	JJ	amod
class	NN	pobj
of	IN	prep
sulphonic	JJ	amod
acid	NNS	pobj
.	.	punct

 	_SP	
Mr.	NNP	compound
Davison	NNP	nsubj
testify	VBD	ccomp
at	IN	prep
trial	NN	pobj
that	IN	mark
-PRON-	PRP	nsubj
test	VBD	ccomp
these	DT	det
amlodipine	JJ	compound
acid	NN	compound
addition	NN	compound
salt	NN	compound
form	NNS	dobj
as	RB	advmod
well	RB	advmod
as	IN	cc
amlodipine	JJ	compound
maleate	NN	conj
and	CC	cc
the	DT	det
free	JJ	amod
base	NN	conj
for	IN	prep
solubility	NN	pobj
,	,	punct
pH	NNS	intj
,	,	punct
hygroscopicity	NN	conj
,	,	punct
and	CC	cc
stickiness	NN	conj
.	.	punct
another	DT	det
researcher	NN	nsubjpass
,	,	punct
Dr.	NNP	compound
Robin	NNP	compound
Platt	NNP	appos
,	,	punct
an	DT	det
analytical	JJ	amod
chemist	NN	appos
at	IN	prep
Sandwich	NNP	pobj
,	,	punct
be	VBD	auxpass
bring	VBN	ccomp
in	RP	prt
to	TO	aux
test	VB	advcl
the	DT	det
stability	NN	dobj
of	IN	prep
the	DT	det
amlodipine	JJ	compound
acid	NN	compound
addition	NN	compound
salt	NNS	pobj
.	.	punct
Dr.	NNP	compound
Platt	NNP	nsubj
subject	VBD	ccomp
the	DT	det
maleate	NN	dobj
,	,	punct
acetate	VB	conj
,	,	punct
succinate	JJ	conj
,	,	punct
besylate	NN	conj
,	,	punct
mesylate	JJ	conj
,	,	punct
and	CC	cc
eventually	RB	advmod
the	DT	det
tosylate	NN	amod
,	,	punct
salicylate	VB	conj
,	,	punct
and	CC	cc
hydrochloride	VB	conj
salt	NN	amod
form	NNS	dobj
of	IN	prep
amlodipine	NN	pobj
to	IN	prep
thin	JJ	amod
-	HYPH	punct
layer	NN	compound
chromatography	NN	pobj
to	TO	aux
determine	VB	advcl
the	DT	det
number	NN	dobj
and	CC	cc
amount	NN	conj
of	IN	prep
degradant	NNS	pobj
find	VBN	acl
in	IN	prep
the	DT	det
various	JJ	amod
amlodipine	NN	compound
salt	NNS	pobj
,	,	punct
and	CC	cc
compile	VBD	conj
a	DT	det
ranking	NN	amod
thereof	NN	dobj
base	VBN	prep
upon	IN	prep
the	DT	det
stability	NN	pobj
of	IN	prep
each	DT	det
salt	NN	compound
formulation	NN	pobj
.	.	punct

 	_SP	
Dr.	NNP	compound
Platt	NNP	poss
's	POS	case
finding	NNS	nsubjpass
be	VBD	auxpass
communicate	VBN	ccomp
to	IN	prep
Dr.	NNP	compound
Wells	NNP	pobj
via	IN	prep
memorandum	NN	pobj
on	IN	prep
or	CC	cc
about	IN	conj
October	NNP	pobj
9	CD	nummod
,	,	punct
1984	CD	nummod
,	,	punct
wherein	WRB	advmod
Dr.	NNP	compound
Platt	NNP	nsubj
report	VBD	advcl
that	IN	mark
the	DT	det
besylate	NN	compound
salt	NN	nsubj
"	''	punct
show	VBD	ccomp
a	DT	det
much	RB	advmod
improved	JJ	amod
stability	NN	compound
profile	NN	dobj
over	IN	prep
the	DT	det
maleate	NN	pobj
in	IN	prep
all	DT	det
case	NNS	pobj
"	''	punct
.	.	punct
On	IN	prep
October	NNP	pobj
11	CD	nummod
,	,	punct
1984	CD	nummod
,	,	punct
Dr.	NNP	compound
Wells	NNP	nsubj
recommend	VBD	ccomp
via	IN	prep
memorandum	NN	pobj
to	IN	prep
Dr.	NNP	compound
J.R.	NNP	compound
Davidson	NNP	pobj
,	,	punct
a	DT	det
deputy	NN	appos
of	IN	prep
Pfizer	NNP	poss
's	POS	case
Pharmaceutical	NNP	nmod
Research	NNP	nmod
and	CC	cc
Development	NNP	conj
Department	NNP	pobj
,	,	punct
that	IN	mark
the	DT	det
amlodipine	NN	compound
maleate	JJ	compound
salt	NN	nsubjpass
be	VB	auxpass
replace	VBN	relcl
with	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
for	IN	prep
the	DT	det
commercial	JJ	amod
amlodipine	NN	compound
tablet	NN	compound
product	NN	pobj
base	VBN	acl
on	IN	prep
Dr.	NNP	compound
Platt	NNP	poss
's	POS	case
memo	NN	pobj
and	CC	cc
Mr.	NNP	compound
Davison	NNP	poss
's	POS	case
test	NN	compound
result	NNS	conj
.	.	punct

 	_SP	
By	IN	prep
April	NNP	pobj
30	CD	nummod
,	,	punct
1985	CD	nummod
,	,	punct
both	DT	nsubj
amlodipine	NN	amod
maleate	NN	nmod
and	CC	cc
amlodipine	JJ	conj
besylate	NN	nsubj
be	VBD	aux
undergo	VBG	ccomp
human	JJ	amod
testing	NN	dobj
in	IN	prep
clinical	JJ	amod
trial	NNS	pobj
.	.	punct
pfizer	NN	compound
scientist	NNS	nsubj
predict	VBD	ccomp
that	IN	mark
the	DT	det
capsule	NN	compound
form	NN	nsubj
of	IN	prep
amlodipine	JJ	compound
maleate	NN	pobj
would	MD	aux
have	VB	ccomp
a	DT	det
shelf	NN	compound
life	NN	dobj
of	IN	prep
three	CD	nummod
year	NNS	pobj
,	,	punct
but	CC	cc
that	IN	mark
"	``	punct
poor	JJ	amod
stability	NN	conj
of	IN	prep
amlodipine	JJ	amod
maleate	JJ	compound
tablet	NN	compound
formulation	NNS	pobj
"	''	punct
precluded	JJ	amod
commercialization	NN	appos
.	.	punct
On	IN	prep
the	DT	det
other	JJ	amod
hand	NN	pobj
,	,	punct
the	DT	det
scientist	NNS	nsubj
note	VBD	ccomp
that	IN	mark
amlodipine	JJ	nsubj
besylate	NN	ccomp
tablet	NN	compound
formulation	NNS	nsubj
exhibit	VBN	ccomp
"	``	punct
clear	JJ	amod
superiority	NN	dobj
"	''	punct
in	IN	prep
-PRON-	PRP$	poss
processing	NN	compound
characteristic	NNS	pobj
,	,	punct
particularly	RB	advmod
non	JJ	subtok
-	JJ	subtok
stickiness	JJ	appos
,	,	punct
and	CC	cc
in	IN	conj
stability	NN	pobj
.	.	punct
capsule	NN	compound
formulation	NNS	nsubjpass
of	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
have	VBD	aux
not	RB	neg
yet	RB	advmod
be	VBN	auxpass
produce	VBN	advcl
,	,	punct
but	CC	cc
work	VB	nsubjpass
on	IN	prep
this	DT	det
project	NN	pobj
be	VBD	auxpass
"	``	punct
expect	VBN	conj
to	TO	aux
be	VB	xcomp
straightforward	JJ	acomp
"	''	punct
.	.	punct

 	_SP	
On	IN	prep
April	NNP	pobj
4	CD	nummod
,	,	punct
1986	CD	nummod
,	,	punct
Pfizer	NNP	nsubj
file	VBD	ccomp
a	DT	det
patent	NN	compound
application	NN	dobj
to	TO	aux
amlodipine	VB	advcl
besylate	NN	dobj
in	IN	prep
the	DT	det
U.K.	NNP	pobj
,	,	punct
which	WDT	nsubj
eventually	RB	advmod
issue	VBD	relcl
as	IN	prep
U.K.	NNP	compound
Patent	NNP	compound
No.	SYM	pobj
160833	CD	nummod
.	.	punct
On	IN	prep
May	NNP	pobj
5	CD	nummod
,	,	punct
1986	CD	nummod
,	,	punct
Pfizer	NNP	nsubj
submit	VBD	ccomp
a	DT	det
supplement	NN	dobj
to	IN	dative
the	DT	det
FDA	NNP	pobj
state	VBG	advcl
that	IN	mark
the	DT	det
dosage	NN	compound
form	NN	nsubj
anticipate	VBN	acl
for	IN	prep
commercial	JJ	amod
use	NN	pobj
would	MD	aux
be	VB	ccomp
a	DT	det
tablet	NN	attr
of	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
and	CC	cc
that	IN	mark
all	DT	det
future	JJ	amod
clinical	JJ	amod
trial	NNS	nsubj
with	IN	prep
amlodipine	NN	pobj
would	MD	aux
use	VB	conj
this	DT	det
new	JJ	amod
formulation	NN	dobj
.	.	punct
In	IN	prep
the	DT	det
supplement	NN	pobj
,	,	punct
Pfizer	NNP	nsubj
state	VBD	pobj
,	,	punct
"	``	punct
-PRON-	PRP	nsubj
feel	VBP	ccomp
that	IN	mark
the	DT	det
change	NN	nsubjpass
in	IN	prep
salt	NN	compound
form	NN	pobj
be	VBZ	auxpass
justify	VBN	ccomp
since	IN	mark
benzenesulfonate	NN	nsubj
be	VBZ	advcl
a	DT	det
commercially	RB	advmod
acceptable	JJ	amod
salt	NN	attr
,	,	punct
as	IN	mark
exemplify	VBN	advcl
by	IN	agent
the	DT	det
tranquilizer	NN	amod
mesoridazine	NN	pobj
(	-LRB-	punct
Serentil	NNP	appos
)	-RRB-	punct
.	.	punct
"	''	punct
In	IN	prep
support	NN	pobj
of	IN	prep
the	DT	det
use	NN	pobj
of	IN	prep
the	DT	det
besylate	NN	compound
salt	NN	compound
form	NN	pobj
of	IN	prep
amlodipine	NN	pobj
,	,	punct
Pfizer	NNP	nsubj
submit	VBD	ccomp
a	DT	det
summary	NN	dobj
of	IN	prep
the	DT	det
acute	JJ	amod
oral	JJ	amod
toxicity	NN	pobj
of	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
and	CC	cc
amlodipine	NN	conj
maleate	NN	dobj
in	IN	prep
rat	NNS	pobj
and	CC	cc
a	DT	det
comparison	NN	conj
of	IN	prep
the	DT	det
effect	NNS	pobj
of	IN	prep
both	CC	preconj
the	DT	det
besylate	NN	nmod
and	CC	cc
maleate	JJ	conj
form	NNS	pobj
on	IN	prep
blood	NN	compound
pressure	NN	pobj
and	CC	cc
heart	NN	compound
rate	NN	conj
of	IN	prep
dog	NNS	pobj
.	.	punct
Pfizer	NNP	nsubj
state	VBD	ccomp
that	IN	mark
the	DT	det
result	NNS	nsubj
show	VBD	ccomp
that	IN	mark
there	EX	expl
be	VBD	ccomp
no	DT	det
quantitative	JJ	amod
difference	NN	attr
in	IN	prep
efficacy	NN	pobj
between	IN	prep
equivalent	JJ	amod
dos	NNS	pobj
of	IN	prep
amlodipine	JJ	compound
besylate	NN	compound
tablet	NNS	pobj
or	CC	cc
capsule	NNS	conj
and	CC	cc
amlodipine	VB	amod
maleate	JJ	compound
capsule	NNS	conj
.	.	punct
In	IN	prep
addition	NN	pobj
,	,	punct
Pfizer	NNP	nsubj
submit	VBD	ccomp
a	DT	det
pharmacokinetic	JJ	amod
report	NN	dobj
and	CC	cc
interim	VBP	amod
clinical	JJ	amod
summary	NN	conj
showing	NN	acl
that	DT	mark
amlodipine	JJ	compound
besylate	NN	compound
tablet	NNS	nmod
and	CC	cc
amlodipine	NN	conj
maleate	JJ	compound
capsule	NNS	nsubj
be	VBD	ccomp
bioequivalent	JJ	acomp
and	CC	cc
have	VBD	conj
comparable	JJ	amod
safety	NN	dobj
and	CC	cc
toleration	NN	conj
when	WRB	advmod
administer	VBN	relcl
to	IN	prep
healthy	JJ	amod
human	JJ	amod
volunteer	NNS	pobj
.	.	punct

 	_SP	
On	IN	prep
March	NNP	pobj
25	CD	nummod
,	,	punct
1987	CD	nummod
,	,	punct
Pfizer	NNP	nsubj
file	VBD	ccomp
a	DT	det
U.S.	NNP	compound
application	NN	dobj
(	-LRB-	punct
serial	NN	appos
no	UH	intj
.	.	punct
07/030,658	LS	punct
)	-RRB-	punct
to	TO	aux
amlodipine	VB	advcl
besylate	NN	dobj
claim	VBG	acl
priority	NN	dobj
from	IN	prep
the	DT	det
U.K.	NNP	compound
application	NN	pobj
.	.	punct
during	IN	prep
prosecution	NN	pobj
,	,	punct
the	DT	det
examiner	NN	nsubj
initially	RB	advmod
reject	VBD	ccomp
all	DT	det
claim	NNS	dobj
of	IN	prep
the	DT	det
application	NN	pobj
as	IN	prep
obvious	JJ	amod
over	IN	prep
the	DT	det
¡¬909	JJR	nummod
patent	NN	pobj
in	IN	prep
view	NN	pobj
of	IN	prep
U.S.	NNP	compound
Patent	NNP	compound
4,032,637	CD	pobj
to	IN	prep
Spiegel	NNP	pobj
(	-LRB-	punct
1977	CD	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
Spiegel	NNP	appos
"	''	punct
)	-RRB-	punct
and	CC	cc
U.S.	NNP	compound
patent	NN	conj
3,816,612	CD	nummod
to	IN	prep
Schmidt	NNP	pobj
(	-LRB-	punct
1974	CD	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
Schmidt	NNP	appos
"	''	punct
)	-RRB-	punct
.	.	punct
the	DT	det
examiner	NN	nsubj
note	VBD	conj
that	IN	mark
Schmidt	NNP	nsubj
disclose	VBZ	ccomp
that	IN	mark
aryl	NN	nmod
sulphonic	JJ	amod
acid	NN	compound
salt	NNS	nsubj
,	,	punct
which	WDT	nsubj
include	VBP	relcl
besylate	NN	dobj
,	,	punct
be	VBP	ccomp
superior	JJ	acomp
to	IN	prep
the	DT	det
prefer	VBN	amod
maleate	NN	pobj
of	IN	prep
the	DT	det
'	``	punct
909	CD	nummod
patent	NN	pobj
,	,	punct
while	IN	mark
Spiegel	NNP	nsubj
provide	VBZ	advcl
an	DT	det
example	NN	dobj
of	IN	prep
a	DT	det
pharmaceutical	NN	amod
compound	NN	pobj
wherein	WRB	mark
the	DT	det
besylate	NN	compound
form	NN	nsubjpass
be	VBZ	auxpass
specifically	RB	advmod
identify	VBN	conj
as	IN	prep
the	DT	det
preferred	JJ	amod
embodiment	NN	pobj
.	.	punct
In	IN	prep
response	NN	pobj
to	IN	prep
the	DT	det
rejection	NN	pobj
,	,	punct
Pfizer	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
the	DT	det
besylate	NN	compound
salt	NN	nsubj
,	,	punct

 	_SP	
while	IN	mark
not	RB	neg
the	DT	det
most	RBS	advmod
soluble	JJ	amod
salt	NN	advcl
,	,	punct
have	VBZ	ccomp
many	JJ	amod
other	JJ	amod
advantage	NNS	dobj
not	RB	neg
possess	VBN	acl
by	IN	agent
other	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NNS	pobj
....	.	punct
In	IN	prep
addition	NN	pobj
to	IN	prep
have	VBG	pcomp
good	JJ	amod
solubility	NN	dobj
,	,	punct
[	-LRB-	punct
the	DT	det
besylate	NN	compound
salt	NN	nsubj
]	-RRB-	punct
be	VBZ	ccomp
unique	JJ	acomp
in	IN	prep
impart	VBG	pcomp
to	IN	prep
the	DT	det
product	NN	nmod
good	JJ	amod
stability	NN	pobj
,	,	punct
nonhygroscopicity	NN	conj
and	CC	cc
good	JJ	amod
processability	NN	conj
.	.	punct

For	IN	prep
one	CD	nummod
salt	NN	pobj
to	TO	aux
have	VB	pobj
all	DT	nsubjpass
of	IN	prep
these	DT	det
outstanding	JJ	amod
feature	NNS	pobj
be	VBZ	auxpass
not	RB	neg
suggest	VBN	ROOT
or	CC	cc
teach	VBN	conj
in	IN	prep
the	DT	det
art	NN	pobj
,	,	punct
and	CC	cc
would	MD	aux
require	VB	conj
extensive	JJ	amod
experimentation	NN	dobj
to	TO	aux
find	VB	acl
.	.	punct

 	_SP	

the	DT	det
examiner	NN	nsubj
,	,	punct
however	RB	advmod
,	,	punct
maintain	VBD	ROOT
the	DT	det
rejection	NN	dobj
,	,	punct
state	VBG	advcl
that	IN	mark
"	``	punct
these	DT	det
quality	NNS	nsubj
be	VBP	ccomp
basic	JJ	amod
consideration	NNS	attr
by	IN	prep
a	DT	det
person	NN	pobj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
for	IN	prep
select	VBG	pcomp
a	DT	det
suitable	JJ	amod
pharmaceutical	JJ	amod
salt	NN	dobj
"	''	punct
as	IN	mark
evidence	VBN	advcl
by	IN	agent
Berge	NNP	pobj
,	,	punct
"	``	punct
Pharmaceutical	NNP	compound
Salts	NNPS	npadvmod
,	,	punct
"	``	punct
J.	NNP	compound
Pharm.	NNP	compound
Sci	NNP	appos
.	NNP	punct
,	,	punct
66(1):1	CD	nmod
-	SYM	punct
19	CD	prep
(	-LRB-	punct
Jan.1977	NNP	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
Berge	NNP	appos
"	''	punct
)	-RRB-	punct
.	.	punct

table	NN	nsubj
1	CD	nummod
of	IN	prep
Berge	NNP	pobj
show	VBZ	ROOT
53	CD	nsubj
FDA	NNP	npadvmod
-	HYPH	punct
approve	VBN	amod
,	,	punct
commercially	RB	advmod
market	VBN	amod
anion	NNS	dobj
,	,	punct
include	VBG	prep
benzene	NN	compound
sulphonate	NN	pobj
,	,	punct
that	WDT	nsubj
be	VBP	relcl
useful	JJ	acomp
for	IN	prep
make	VBG	pcomp
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
salt	NNS	dobj
,	,	punct
and	CC	cc
list	VBZ	conj
the	DT	det
relative	JJ	amod
frequency	NN	dobj
of	IN	prep
which	WDT	pobj
each	DT	nsubjpass
be	VBD	auxpass
use	VBN	relcl
as	IN	prep
a	DT	det
percentage	NN	pobj
base	VBN	acl
on	IN	prep
the	DT	det
total	JJ	amod
number	NN	pobj
of	IN	prep
anion	NNS	pobj
or	CC	cc
cation	NNS	conj
in	IN	prep
use	NN	pobj
through	IN	prep
1974	CD	pobj
.	.	punct

Berge	NNP	nsubj
disclose	VBZ	ROOT
that	WDT	mark
benzene	NN	compound
sulphonate	NN	nsubj
have	VBD	ccomp
a	DT	det
frequency	NN	dobj
of	IN	prep
use	NN	pobj
of	IN	prep
0.25	CD	nummod
%	NN	pobj
.	.	punct

 	_SP	

In	IN	prep
response	NN	pobj
to	IN	prep
a	DT	det
final	JJ	amod
obviousness	JJ	amod
rejection	NN	pobj
by	IN	prep
the	DT	det
Examiner	NNP	pobj
,	,	punct
Pfizer	NNP	nsubj
file	VBD	ROOT
a	DT	det
continuation	NN	compound
application	NN	dobj
(	-LRB-	punct
serial	NN	amod
no	UH	appos
.	.	punct
07/256,938	ADD	npadvmod
)	-RRB-	punct
and	CC	cc
abandon	VBD	conj
the	DT	det
original	JJ	amod
application	NN	dobj
.	.	punct

along	IN	prep
with	IN	prep
the	DT	det
continuation	NN	compound
application	NN	pobj
,	,	punct
Pfizer	NNP	nsubj
submit	VBD	ROOT
a	DT	det
preliminary	JJ	amod
amendment	NN	dobj
and	CC	cc
statement	NN	conj
,	,	punct
and	CC	cc
a	DT	det
declaration	NN	conj
under	IN	prep
37	CD	pobj
c.f.r.	NN	nmod
¡±	CD	punct
1.132	CD	appos
by	IN	prep
Dr.	NNP	compound
Wells	NNP	pobj
date	VBD	acl
October	NNP	npadvmod
3	CD	nummod
,	,	punct
1988	CD	nummod
(	-LRB-	punct
"	``	punct
Wells	NNP	compound
Declaration	NNP	dobj
"	''	punct
)	-RRB-	punct
.	.	punct

In	IN	prep
the	DT	det
statement	NN	pobj
,	,	punct
Pfizer	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
the	DT	det
Wells	NNP	compound
Declaration	NNP	nsubj
demonstrate	VBD	ccomp
that	IN	mark
the	DT	det
besylate	NN	compound
salt	NN	nsubj
of	IN	prep
amlodipine	NN	pobj
possess	VBN	ccomp
"	''	punct
all	PDT	predet
the	DT	det
desire	VBN	amod
characteristic	NNS	dobj
necessary	JJ	amod
for	IN	prep
a	DT	det
medicinal	JJ	amod
agent	NN	pobj
"	''	punct
and	CC	cc
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
not	RB	neg
have	VB	aux
be	VBN	conj
obvious	JJ	acomp
"	''	punct
that	IN	mark
only	RB	advmod
the	DT	det
besylate	NN	compound
salt	NN	nsubj
of	IN	prep
amlodipine	NN	pobj
would	MD	aux
have	VB	ccomp
all	PDT	predet
the	DT	det
necessary	JJ	amod
property	NNS	dobj
for	IN	prep
a	DT	det
commercial	JJ	amod
product	NN	pobj
"	''	punct
.	.	punct

Pfizer	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
choose	VBG	csubj
an	DT	det
appropriate	JJ	amod
salt	NN	dobj
be	VBZ	ccomp
a	DT	det
very	RB	advmod
difficult	JJ	amod
task	NN	attr
"	''	punct
since	IN	mark
each	DT	det
salt	NN	nsubj
impart	VBZ	advcl
unique	JJ	amod
property	NNS	dobj
to	IN	prep
the	DT	det
parent	NN	compound
compound	NN	pobj
"	''	punct
and	CC	cc
that	IN	mark
one	CD	nsubj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
"	``	punct
conclude	VB	conj
that	IN	mark
the	DT	det
besylate	NN	compound
salt	NN	nsubj
of	IN	prep
amlodipine	NN	pobj
be	VBZ	ccomp
a	DT	det
unique	JJ	amod
compound	NN	attr
and	CC	cc
not	RB	neg
an	DT	det
obvious	JJ	amod
one	NN	conj
"	''	punct
.	.	punct

the	DT	det
Wells	NNP	compound
Declaration	NNP	nsubj
state	VBD	ROOT
that	IN	mark
the	DT	det
besylate	NN	compound
salt	NN	nsubjpass
of	IN	prep
amlodipine	NN	pobj
be	VBD	auxpass
"	``	punct
find	VBN	ccomp
to	TO	aux
possess	VB	xcomp
a	DT	det
highly	RB	advmod
desirable	JJ	amod
combination	NN	dobj
of	IN	prep
physicochemical	JJ	amod
property	NNS	pobj
,	,	punct
"	''	punct
include	VBG	prep
good	JJ	amod
solubility	NN	pobj
,	,	punct
stability	NN	conj
,	,	punct
non	JJ	subtok
-	JJ	subtok
hygroscopicity	JJ	conj
,	,	punct
and	CC	cc
processability	NN	conj
,	,	punct
which	WDT	pobj
property	NNS	nsubj
be	VBP	relcl
"	``	punct
unpredictable	JJ	acomp
both	CC	preconj
individually	RB	advmod
and	CC	cc
collectively	RB	conj
"	''	punct
.	.	punct

 	_SP	

the	DT	det
continuation	NN	compound
application	NN	nsubjpass
be	VBD	auxpass
allow	VBN	ROOT
and	CC	cc
issue	VBN	conj
as	IN	prep
the	DT	det
¡¬303	JJ	nummod
patent	NN	pobj
on	IN	prep
November	NNP	pobj
7	CD	nummod
,	,	punct
1989	CD	nummod
.	.	punct

the	DT	det
first	JJ	amod
three	CD	nummod
claim	NNS	nsubjpass
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
be	VBP	auxpass
reproduce	VBN	ROOT
here	RB	advmod
:	:	punct

 	_SP	

1	CD	ROOT
.	.	punct

the	DT	det
besylate	NN	compound
salt	NN	ROOT
of	IN	prep
amlodipine	NN	pobj
.	.	punct

 	_SP	

2	CD	ROOT
.	.	punct

a	DT	det
pharmaceutical	JJ	amod
composition	NN	nsubj
comprise	VBG	ROOT
an	DT	det
anti	JJ	advmod
hypertensive	JJ	amod
,	,	punct
antiischaemic	JJ	conj
or	CC	cc
angina	NN	conj
-	HYPH	punct
alleviate	VBG	amod
effective	JJ	amod
amount	NN	dobj
of	IN	prep
the	DT	det
besylate	NN	compound
salt	NN	pobj
of	IN	prep
amlodipine	NN	pobj
as	IN	mark
claim	VBN	advcl
in	IN	prep
claim	NN	pobj
1	CD	dobj
together	RB	advmod
with	IN	prep
a	DT	det
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
diluent	NN	pobj
or	CC	cc
carrier	NN	conj
.	.	punct

 	_SP	

3	CD	ROOT
.	.	punct

a	DT	det
tablet	NN	compound
formulation	NN	nsubjpass
comprise	VBG	acl
an	DT	det
anti	JJ	subtok
-	JJ	subtok
hypertensive	JJ	amod
,	,	punct
antiischaemic	JJ	conj
or	CC	cc
angina	NN	conj
-	HYPH	punct
alleviate	VBG	amod
effective	JJ	amod
amount	NN	dobj
of	IN	prep
the	DT	det
besylate	NN	compound
salt	NN	pobj
of	IN	prep
amlodipine	NN	pobj
as	IN	mark
claim	VBN	advcl
in	IN	prep
claim	NN	pobj
1	CD	dobj
in	IN	prep
admixture	NN	pobj
with	IN	prep
excipient	NNS	pobj
.	.	punct

 	_SP	
Norvasc	NNP	punct
(r)	SYM	nsubjpass
be	VBD	auxpass
launch	VBN	ROOT
as	IN	prep
a	DT	det
commercial	JJ	amod
product	NN	pobj
by	IN	prep
Pfizer	NNP	pobj
in	IN	prep
the	DT	det
U.S.	NNP	pobj
in	IN	prep
November	NNP	pobj
1992	CD	nummod
.	.	punct

 	_SP	

From	IN	prep
January	NNP	pobj
11	CD	nummod
,	,	punct
2006	CD	appos
,	,	punct
to	IN	prep
January	NNP	pobj
18	CD	nummod
,	,	punct
2006	CD	appos
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
conduct	VBD	ROOT
a	DT	det
bench	JJ	compound
trial	NN	dobj
on	IN	prep
the	DT	det
issue	NNS	pobj
of	IN	prep
(	-LRB-	punct
1	CD	pobj
)	-RRB-	punct
whether	IN	mark
the	DT	det
claim	NNS	nsubjpass
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
be	VBD	auxpass
anticipate	VBN	acl
by	IN	agent
the	DT	det
disclosure	NN	pobj
of	IN	prep
the	DT	det
¡¬909	JJR	nummod
patent	NN	pobj
,	,	punct
(	-LRB-	punct
2	LS	appos
)	-RRB-	punct
whether	IN	mark
the	DT	det
¡¬303	JJ	compound
patent	NN	nsubj
be	VBD	advcl
invalid	JJ	acomp
for	IN	prep
obviousness	JJ	pobj
,	,	punct
and	CC	cc
(	-LRB-	punct
3	LS	meta
)	-RRB-	punct
whether	IN	mark
the	DT	det
claim	NNS	nsubj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
be	VBD	conj
unenforceable	JJ	acomp
due	IN	prep
to	IN	pcomp
inequitable	JJ	amod
conduct	NN	pobj
before	IN	prep
the	DT	det
USPTO	NNP	pobj
.	.	punct

On	IN	prep
January	NNP	pobj
18	CD	nummod
,	,	punct
2006	CD	appos
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ROOT
-PRON-	PRP$	poss
finding	NNS	nsubj
and	CC	cc
conclusion	NNS	conj
pursuant	JJ	ccomp
to	IN	prep
Fed	NNP	pobj
.	.	punct

R.Civ	NNP	ROOT
.	.	punct

P.	NNP	ROOT
52(a	NNP	nummod
)	-RRB-	punct
orally	RB	advmod
in	IN	prep
open	JJ	amod
court	NN	pobj
.	.	punct

bench	NN	compound
order	NN	compound
tr	UH	subtok
.	.	ROOT

1	CD	ROOT
-	SYM	punct
28	CD	prep
,	,	punct
January	NNP	npadvmod
18	CD	nummod
,	,	punct
2006	CD	nummod
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
Apotex	NNP	nsubj
fail	VBD	ccomp
to	TO	aux
meet	VB	xcomp
-PRON-	PRP$	poss
burden	NN	dobj
of	IN	prep
prove	VBG	pcomp
invalidity	NN	dobj
or	CC	cc
inequitable	JJ	amod
conduct	NN	conj
by	IN	prep
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
first	RB	advmod
address	VBD	ROOT
the	DT	det
issue	NN	dobj
of	IN	prep
invalidity	NN	pobj
by	IN	prep
anticipation	NN	pobj
,	,	punct
find	VBG	advcl
that	IN	mark
while	IN	mark
the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubj
claim	VBZ	advcl
a	DT	det
genus	NN	dobj
of	IN	prep
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
salt	NNS	pobj
of	IN	prep
amlodipine	NN	pobj
that	WDT	nsubj
encompass	VBZ	relcl
amlodipine	JJ	compound
besylate	NN	dobj
,	,	punct
the	DT	det
¡¬	NNP	nmod
909	CD	nummod
patent	NN	nsubj
do	VBZ	aux
not	RB	neg
as	IN	advmod
a	DT	det
matter	NN	appos
of	IN	prep
law	NN	pobj
disclose	VB	ccomp
-PRON-	PRP	dobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
hold	VBD	ROOT
that	IN	mark
since	IN	mark
the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubj
do	VBZ	aux
not	RB	neg
list	VB	advcl
the	DT	det
specie	NNS	dobj
of	IN	prep
a	DT	det
salt	NN	pobj
make	VBN	acl
from	IN	prep
benzene	NN	compound
sulphonate	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
do	VBZ	aux
not	RB	neg
anticipate	VB	ccomp
the	DT	det
claim	NNS	dobj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
.	.	punct

 	_SP	

With	IN	prep
regard	NN	pobj
to	IN	prep
obviousness	JJ	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
reject	VBD	ROOT
Apotex	NNP	poss
's	POS	case
argument	NN	dobj
that	IN	mark
the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubj
in	IN	prep
view	NN	pobj
of	IN	prep
the	DT	det
Berge	NNP	compound
article	NN	pobj
(	-LRB-	punct
and	CC	cc
other	JJ	amod
prior	JJ	amod
art	NN	conj
)	-RRB-	punct
render	VBD	acl
the	DT	det
invention	NN	nsubj
of	IN	prep
the	DT	det
claim	NNS	pobj
of	IN	prep
the	DT	det
¡¬303	JJ	nummod
patent	NN	pobj
obvious	JJ	ccomp
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
first	RB	advmod
find	VBD	ROOT
that	IN	mark
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	ccomp
a	DT	det
bachelor	NN	poss
's	POS	case
degree	NN	dobj
in	IN	prep
pharmaceutical	JJ	amod
science	NN	pobj
or	CC	cc
analytical	JJ	amod
chemistry	NN	conj
,	,	punct
and	CC	cc
some	DT	det
experience	NN	conj
in	IN	prep
drug	NNS	pobj
and	CC	cc
drug	NN	compound
preparation	NN	conj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
the	DT	det
Berge	NNP	compound
article	NN	nsubj
do	VBZ	aux
not	RB	neg
direct	VB	ccomp
the	DT	det
skilled	JJ	amod
artisan	NN	dobj
to	TO	aux
create	VB	advcl
the	DT	det
besylate	NN	compound
salt	NN	dobj
of	IN	prep
amlodipine	NN	pobj
because	IN	mark
Berge	NNP	nsubj
disclose	VBZ	advcl
that	WDT	mark
benzene	NN	compound
sulphonate	NN	nsubjpass
be	VBD	auxpass
use	VBN	ccomp
only	RB	advmod
at	IN	prep
a	DT	det
frequency	NN	pobj
of	IN	prep
0.25	CD	nummod
%	NN	pobj
,	,	punct
or	CC	cc
1	CD	dobj
out	IN	prep
of	IN	prep
every	DT	quantmod
400	CD	nummod
drug	NNS	pobj
,	,	punct
prior	RB	advmod
to	IN	prep
1974	CD	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
note	VBD	ROOT
that	IN	mark
the	DT	det
examiner	NN	nsubj
must	MD	aux
have	VB	aux
consider	VBN	ccomp
the	DT	det
Berge	NNP	compound
article	NN	oprd
since	IN	mark
-PRON-	PRP	nsubjpass
be	VBD	auxpass
cite	VBN	advcl
in	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
,	,	punct
yet	CC	cc
the	DT	det
examiner	NN	nsubj
ultimately	RB	advmod
determine	VBD	conj
that	IN	mark
the	DT	det
claim	NNS	nsubj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
be	VBD	ccomp
not	RB	neg
obvious	JJ	acomp
in	IN	prep
view	NN	pobj
of	IN	prep
this	DT	det
reference.4	NN	punct
further	RBR	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ccomp
that	IN	mark
there	EX	expl
would	MD	aux
be	VB	ccomp
no	DT	det
expectation	NN	attr
of	IN	prep
success	NN	pobj
in	IN	prep
make	VBG	pcomp
a	DT	det
besylate	NN	compound
salt	NN	dobj
of	IN	prep
amlodipine	NN	pobj
because	IN	mark
,	,	punct
as	IN	mark
Berge	NNP	nsubj
teach	VBZ	advcl
and	CC	cc
expert	NN	amod
testimony	NN	conj
on	IN	prep
both	DT	det
side	NNS	pobj
accept	VBN	advcl
,	,	punct
"	``	punct
there	EX	expl
be	VBZ	ccomp
no	DT	det
reliable	JJ	amod
way	NN	attr
of	IN	prep
predict	VBG	pcomp
the	DT	det
influence	NN	dobj
of	IN	prep
a	DT	det
particular	JJ	amod
salt	NN	compound
specie	NNS	pobj
on	IN	prep
the	DT	det
behavior	NN	pobj
of	IN	prep
a	DT	det
parent	NN	compound
compound	NN	pobj
"	''	punct
.	.	punct

bench	NN	compound
order	NN	compound
tr	UH	subtok
.	.	ROOT
23:3	CD	nummod
-	SYM	punct
6	CD	prep
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
also	RB	advmod
state	VBD	ROOT
that	IN	mark
the	DT	det
besylate	NN	compound
salt	NN	nsubj
of	IN	prep
amlodipine	NN	pobj
be	VBD	ccomp
unexpectedly	RB	advmod
superior	JJ	acomp
to	IN	prep
the	DT	det
amlodipine	JJ	compound
salt	NNS	pobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

specifically	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ROOT
that	IN	mark
,	,	punct
while	IN	mark
amlodipine	JJ	compound
besylate	NN	nsubj
be	VBD	advcl
not	RB	neg
superior	JJ	acomp
to	TO	aux
amlodipine	VB	xcomp
maleate	NN	dobj
"	''	punct
in	IN	prep
every	DT	det
category	NN	pobj
,	,	punct
"	''	punct
-PRON-	PRP	nsubj
nonetheless	RB	advmod
"	``	punct
clearly	RB	advmod
and	CC	cc
unexpectedly	RB	conj
illustrate	VBZ	ccomp
a	DT	det
superior	JJ	amod
combination	NN	dobj
of	IN	prep
property	NNS	pobj
when	WRB	advmod
compare	VBN	advcl
to	IN	prep
what	WP	nsubjpass
be	VBD	auxpass
suggest	VBN	pcomp
in	IN	prep
the	DT	det
prefer	VBN	amod
preparation"-ostensibly	RB	advmod
the	DT	det
amlodipine	NN	compound
maleate	NN	pobj
disclose	VBN	acl
as	IN	prep
the	DT	det
preferred	JJ	amod
embodiment	NN	pobj
of	IN	prep
the	DT	det
¡¬909	JJR	nummod
patent	NN	pobj
.	.	punct

These	DT	det
property	NNS	nsubj
include	VBD	ROOT
good	JJ	amod
solubility	NN	dobj
,	,	punct
stability	NN	conj
,	,	punct
non	JJ	subtok
-	JJ	subtok
hygroscopicity	JJ	npadvmod
,	,	punct
and	CC	cc
processability	NN	conj
(	-LRB-	punct
non	JJ	subtok
-	JJ	subtok
stickiness	JJ	conj
)	-RRB-	punct
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	det
amlodipine	JJ	compound
besylate	NN	ccomp
exhibit	VBN	acl
at	IN	advmod
least	JJS	advmod
a	DT	nummod
solubility	NN	dobj
exceed	VBG	acl
1.0	CD	nummod
mg	NN	nmod
/	SYM	punct
ml	NN	dobj
,	,	punct
which	WDT	nsubj
the	DT	det
court	NN	nsubj
state	VBD	relcl
be	VBZ	ccomp
the	DT	det
desirable	JJ	amod
solubility	NN	compound
factor	NN	attr
for	IN	prep
a	DT	det
commercial	JJ	amod
product	NN	pobj
,	,	punct
and	CC	cc
that	IN	mark
the	DT	det
¡¬303	JJ	compound
patent	NN	nsubj
list	VBD	ccomp
the	DT	det
besylate	NN	compound
salt	NN	compound
form	NN	dobj
of	IN	prep
amlodipine	NN	pobj
as	IN	prep
the	DT	det
most	RBS	advmod
stable	JJ	amod
salt	NN	compound
form	NN	pobj
out	IN	prep
of	IN	prep
eight	CD	nummod
salt	NNS	pobj
test	VBN	acl
,	,	punct
with	IN	prep
the	DT	det
maleate	JJ	amod
salt	NN	compound
form	NN	nsubj
be	VBG	pcomp
sixth	JJ	acomp
on	IN	prep
the	DT	det
list	NN	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
also	RB	advmod
reject	VBD	ROOT
Apotex	NNP	poss
's	POS	case
argument	NN	dobj
that	IN	mark
amlodipine	JJ	compound
besylate	NN	nsubjpass
be	VBZ	auxpass
actually	RB	advmod
hygroscopic	JJ	acl
rather	RB	advmod
than	IN	cc
non	JJ	subtok
-	JJ	subtok
hygroscopic	JJ	conj
as	IN	mark
disclose	VBN	advcl
in	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
.	.	punct

Apotex	NNP	nsubj
assert	VBD	ROOT
that	IN	mark
amlodipine	JJ	compound
besylate	NN	nsubj
attract	VBZ	ccomp
water	NN	dobj
because	IN	mark
-PRON-	PRP	nsubj
(	-LRB-	punct
1	CD	appos
)	-RRB-	punct
can	MD	aux
exist	VB	advcl
as	IN	prep
a	DT	det
hydrate	NN	pobj
,	,	punct
(	-LRB-	punct
2	LS	meta
)	-RRB-	punct
may	MD	aux
have	VB	ccomp
water	NN	dobj
within	IN	prep
-PRON-	PRP$	poss
crystalline	NN	amod
structure	NN	pobj
,	,	punct
and	CC	cc
(	-LRB-	punct
3	LS	nsubj
)	-RRB-	punct
can	MD	aux
have	VB	conj
water	NN	dobj
on	IN	prep
-PRON-	PRP$	poss
surface	NN	pobj
at	IN	prep
extended	JJ	amod
temperature	NNS	pobj
and	CC	cc
humidity	NN	conj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ROOT
that	IN	mark
while	IN	mark
each	DT	nsubj
of	IN	prep
these	DT	det
fact	NNS	pobj
be	VBZ	advcl
true	JJ	acomp
,	,	punct
each	DT	nsubj
be	VBD	aux
entirely	RB	advmod
unenlightening	JJ	ccomp
because	IN	mark
hygroscopicity	NN	nsubj
per	FW	prep
se	FW	pobj
be	VBD	advcl
not	RB	neg
a	DT	det
critical	JJ	amod
factor	NN	attr
.	.	punct

instead	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
emphasize	VBD	ROOT
that	IN	mark
the	DT	det
maleate	JJ	compound
salt	NN	nsubj
of	IN	prep
amlodipine	NN	pobj
undergo	VBD	ccomp
a	DT	det
Michael	NNP	compound
addition	NN	compound
reaction	NN	dobj
when	WRB	advmod
expose	VBN	advcl
to	IN	prep
water	NN	pobj
,	,	punct
create	VBG	advcl
at	IN	advmod
least	RBS	advmod
ten	CD	nummod
degradation	NN	compound
product	NNS	dobj
make	VBG	acl
amlodipine	NN	amod
maleate	NN	dobj
unsuitable	JJ	amod
at	IN	advmod
least	JJS	advmod
in	IN	prep
tablet	NN	compound
form	NN	pobj
for	IN	prep
medicinal	JJ	amod
purpose	NNS	pobj
,	,	punct
whereas	IN	mark
the	DT	det
amlodipine	JJ	compound
besylate	NN	nsubj
do	VBD	aux
not	RB	neg
undergo	VB	advcl
the	DT	det
same	JJ	amod
reaction	NN	dobj
.	.	punct

lastly	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
Pfizer	NNP	nsubj
conduct	VBD	ccomp
extensive	JJ	amod
test	NNS	dobj
for	IN	prep
processability	NN	pobj
of	IN	prep
the	DT	det
amlodipine	JJ	compound
besylate	NN	pobj
by	IN	prep
manufacture	VBG	amod
tablet	NNS	pobj
on	IN	prep
conventional	JJ	amod
tablet	NN	npadvmod
-	HYPH	punct
make	VBG	amod
machinery	NN	pobj
and	CC	cc
measure	VBG	conj
the	DT	det
amount	NN	dobj
of	IN	prep
product	NN	pobj
sticking	NN	acl
to	IN	prep
the	DT	det
punch	NN	compound
face	NN	pobj
after	IN	prep
each	DT	det
manufacturing	NN	compound
run	NN	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	ROOT
that	IN	mark
the	DT	det
test	NNS	nsubj
show	VBD	ccomp
that	IN	mark
amlodipine	JJ	compound
besylate	NN	nsubj
be	VBD	ccomp
sufficiently	RB	advmod
non	JJ	subtok
-	JJ	subtok
sticky	JJ	acomp
so	IN	mark
as	IN	mark
to	TO	aux
be	VB	advcl
commercially	RB	advmod
processable	JJ	acomp
and	CC	cc
less	RBR	advmod
sticky	JJ	conj
than	IN	prep
the	DT	det
maleate	JJ	compound
form	NN	pobj
.	.	punct

 	_SP	

Besides	IN	prep
evidence	NN	pobj
of	IN	prep
superiority	NN	pobj
provide	VBN	acl
in	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
-PRON-	PRP	appos
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
point	VBD	ROOT
to	IN	prep
another	DT	det
"	``	punct
objective	JJ	amod
consideration	NN	pobj
"	''	punct
in	IN	prep
determine	VBG	pcomp
that	DT	det
amlodipine	JJ	compound
besylate	NN	nsubj
be	VBD	ccomp
not	RB	neg
obvious	JJ	acomp
over	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
:	:	punct
"	``	punct
pfizer	NN	nsubj
would	MD	aux
not	RB	neg
have	VB	aux
change	VBN	ccomp
from	IN	prep
the	DT	det
maleate	NN	pobj
,	,	punct
into	IN	prep
which	WDT	pobj
-PRON-	PRP	nsubj
have	VBD	aux
invest	VBN	relcl
both	DT	det
time	NN	dobj
and	CC	cc
research	NN	compound
dollar	NNS	conj
,	,	punct
to	TO	aux
seek	VB	advcl
out	RP	prt
a	DT	det
very	RB	advmod
strange	JJ	amod
and	CC	cc
rare	JJ	conj
besylate	NN	compound
salt	NN	dobj
,	,	punct
absent	JJ	amod
an	DT	det
extremely	RB	advmod
good	JJ	amod
reason	NN	dobj
"	''	punct
.	.	punct

bench	JJ	compound
order	NN	compound
tr	UH	ROOT
.	.	punct
23:16	CD	npadvmod
-	SYM	punct
21	CD	prep
.	.	punct

For	IN	prep
all	PDT	predet
these	DT	det
reason	NNS	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
hold	VBD	ROOT
that	IN	mark
the	DT	det
claim	NNS	nsubjpass
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
be	VBD	auxpass
not	RB	neg
prove	VBN	ccomp
invalid	JJ	oprd
for	IN	prep
obviousness	JJ	pobj
.	.	punct

 	_SP	

next	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
reject	VBD	ROOT
Apotex	NNP	poss
's	POS	case
claim	NN	dobj
that	IN	mark
Pfizer	NNP	nsubj
engage	VBD	acl
in	IN	prep
inequitable	JJ	amod
conduct	NN	pobj
before	IN	prep
the	DT	det
USPTO	NNP	pobj
in	IN	prep
violation	NN	pobj
of	IN	prep
-PRON-	PRP$	poss
duty	NN	pobj
of	IN	prep
candor	NN	pobj
and	CC	cc
37	CD	nummod
C.F.R	NNS	npadvmod
¡±	CD	compound
1.56	CD	appos
.	.	punct

Apotex	NNP	nsubj
argue	VBD	ROOT
that	IN	mark
Pfizer	NNP	nsubj
make	VBD	ccomp
several	JJ	amod
material	JJ	compound
misrepresentation	NNS	dobj
to	IN	prep
the	DT	det
USPTO	NNP	pobj
during	IN	prep
prosecution	NN	pobj
of	IN	prep
the	DT	det
application	NN	pobj
lead	VBG	acl
to	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
,	,	punct
include	VBG	prep
misrepresent	VBG	pcomp
the	DT	det
solubility	NN	dobj
,	,	punct
stability	NN	conj
,	,	punct
and	CC	cc
hygroscopicity	NN	conj
of	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
and	CC	cc
misrepresent	VBG	conj
the	DT	det
number	NN	dobj
of	IN	prep
tablet	NNS	pobj
test	VBN	acl
for	IN	prep
processability	NN	pobj
both	DT	advmod
in	IN	prep
the	DT	det
patent	NN	compound
application	NN	pobj
and	CC	cc
in	IN	conj
the	DT	det
Wells	NNP	compound
Declaration	NNP	pobj
.	.	punct

specifically	RB	advmod
,	,	punct
Apotex	NNP	nsubj
assert	VBD	ROOT
that	IN	mark
Pfizer	NNP	nsubj
(	-LRB-	punct
1	LS	appos
)	-RRB-	punct
fraudulently	RB	advmod
identify	VBD	ccomp
the	DT	det
solubility	NN	dobj
of	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
in	IN	prep
-PRON-	PRP$	poss
application	NN	pobj
for	IN	prep
patent	NN	pobj
as	IN	prep
4.6	CD	nummod
mg	NN	nmod
/	SYM	punct
ml	NN	pobj
where	WRB	advmod
internal	JJ	amod
Pfizer	NNP	compound
document	NNS	nsubj
show	VBP	relcl
the	DT	det
solubility	NN	nsubj
to	TO	aux
actually	RB	advmod
be	VB	ccomp
3.5	CD	nummod
mg	NN	nmod
/	SYM	punct
ml	NN	attr
;	,	punct
(	-LRB-	punct
2	LS	meta
)	-RRB-	punct
fraudulently	RB	advmod
claim	VBD	ccomp
in	IN	prep
the	DT	det
application	NN	pobj
to	TO	aux
have	VB	aux
test	VBN	xcomp
over	IN	quantmod
a	DT	quantmod
thousand	CD	nummod
tablet	NNS	dobj
for	IN	prep
stickiness	NN	pobj
where	WRB	advmod
internal	JJ	amod
Pfizer	NNP	compound
document	NNS	nsubj
show	VBP	relcl
vary	VBG	amod
number	NNS	dobj
up	IN	prep
to	IN	prep
only	RB	advmod
150	CD	nummod
tablet	NNS	nsubjpass
be	VBD	auxpass
actually	RB	advmod
test	VBN	acl
;	:	punct
and	CC	cc
(	-LRB-	punct
3	LS	meta
)	-RRB-	punct
fraudulently	RB	advmod
rank	VBD	conj
the	DT	det
respective	JJ	amod
stability	NNS	dobj
of	IN	prep
the	DT	det
various	JJ	amod
salt	NN	compound
form	NNS	pobj
of	IN	prep
amlodipine	NN	pobj
in	IN	prep
an	DT	det
ordinal	JJ	pobj
-	:	punct
rather	RB	advmod
than	IN	cc
quantitative	JJ	compound
-	HYPH	punct
fashion	NN	conj
so	IN	mark
as	IN	mark
to	TO	aux
conceal	VB	advcl
from	IN	prep
the	DT	det
USPTO	NNP	pobj
that	IN	mark
the	DT	det
stability	NN	compound
difference	NNS	nsubj
between	IN	prep
the	DT	det
besylate	NN	pobj
,	,	punct
tosylate	VBP	conj
,	,	punct
and	CC	cc
mesylate	JJ	conj
salt	NN	amod
form	NNS	dobj
of	IN	prep
amlodipine	NN	pobj
be	VBD	ccomp
actually	RB	advmod
very	RB	advmod
minor	JJ	acomp
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
first	RB	advmod
determine	VBD	ROOT
that	IN	mark
none	NN	nsubj
of	IN	prep
these	DT	det
allege	VBN	amod
misrepresentation	NNS	pobj
be	VBD	ccomp
either	CC	preconj
material	NN	attr
or	CC	cc
false	JJ	conj
.	.	punct

In	IN	prep
this	DT	det
regard	NN	pobj
,	,	punct
the	DT	det
court	NN	nsubj
state	VBD	ROOT
that	IN	mark
whether	IN	mark
the	DT	det
solubility	NN	nsubj
of	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
be	VBZ	csubj
4.6	CD	nummod
mg	NN	nmod
/	SYM	punct
ml	NN	nsubj
as	IN	mark
identify	VBN	advcl
in	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
or	CC	cc
3.5	CD	nummod
mg	NN	nmod
/	SYM	punct
ml	NN	conj
as	IN	mark
identify	VBN	advcl
in	IN	prep
internal	JJ	amod
Pfizer	NNP	compound
document	NNS	pobj
be	VBD	ccomp
at	IN	advmod
most	JJS	advmod
a	DT	det
minor	JJ	amod
discrepancy	NN	attr
give	VBN	acl
that	IN	mark
any	DT	det
solubility	NN	nsubj
over	IN	prep
the	DT	det
critical	JJ	amod
1.0	CD	nummod
mg	NN	nmod
/	SYM	punct
ml	NN	compound
level	NN	pobj
be	VBD	pcomp
sufficient	JJ	amod
solubility	NN	attr
to	TO	aux
meet	VB	relcl
the	DT	det
standard	NNS	dobj
of	IN	prep
a	DT	det
drug	NN	compound
company	NN	pobj
seek	VBG	acl
to	TO	aux
produce	VB	xcomp
a	DT	det
commercial	JJ	amod
drug	NN	dobj
.	.	punct

As	IN	prep
for	IN	prep
stability	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
amlodipine	JJ	compound
besylate	NN	nsubj
be	VBD	ccomp
far	RB	advmod
more	RBR	advmod
stable	JJ	acomp
than	IN	prep
amlodipine	JJ	amod
maleate	NN	pobj
,	,	punct
which	WDT	nsubj
as	IN	mark
describe	VBN	relcl
above	IN	prep
undergoe	NNS	pobj
the	DT	det
undesirable	JJ	amod
Michael	NNP	compound
addition	NN	compound
reaction	NN	dobj
.	.	punct

second	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
hold	VBD	ROOT
that	IN	mark
Apotex	NNP	nsubj
fail	VBD	ccomp
to	TO	aux
show	VB	xcomp
intent	JJ	dobj
to	TO	aux
deceive	VB	acl
by	IN	prep
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
.	.	punct

indeed	RB	advmod
,	,	punct
the	DT	det
court	NN	nsubj
find	VBD	ROOT
"	``	punct
precious	JJ	amod
little	JJ	amod
evidence	NN	dobj
at	RB	advmod
all	RB	advmod
"	``	punct
show	VBG	acl
an	DT	det
intent	NN	dobj
to	TO	aux
deceive	VB	acl
,	,	punct
state	VBG	advcl
that	IN	mark
"	``	punct
while	IN	mark
-PRON-	PRP	nsubj
be	VBZ	advcl
clear	JJ	acomp
that	IN	mark
Pfizer	NNP	nsubj
be	VBD	ccomp
eager	JJ	acomp
to	TO	aux
extend	VB	xcomp
the	DT	det
patent	NN	compound
life	NN	dobj
of	IN	prep
-PRON-	PRP$	poss
amlodipine	NN	compound
compound	NN	pobj
,	,	punct
such	PDT	predet
a	DT	det
desire	NN	nsubj
do	VBZ	aux
not	RB	neg
rise	VB	ccomp
to	IN	prep
the	DT	det
level	NN	pobj
of	IN	prep
fraudulent	JJ	amod
conduct	NN	pobj
"	''	punct
.	.	punct

bench	JJ	compound
order	NN	compound
tr	UH	ROOT
.	.	punct

25:24	CD	ROOT
-	SYM	punct
26:1	CD	prep
.	.	punct

 	_SP	

On	IN	prep
January	NNP	pobj
29	CD	nummod
,	,	punct
2006	CD	appos
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
enter	VBD	ROOT
a	DT	det
final	JJ	amod
judgment	NN	dobj
in	IN	prep
favor	NN	pobj
of	IN	prep
Pfizer	NNP	pobj
and	CC	cc
against	IN	conj
Apotex	NNP	pobj
on	IN	prep
Pfizer	NNP	poss
's	POS	case
claim	NN	pobj
of	IN	prep
infringement	NN	pobj
as	RB	advmod
well	RB	advmod
as	IN	cc
on	IN	prep
Apotex	NNP	poss
's	POS	case
counterclaim	NNS	nsubj
allege	VBG	pcomp
and	CC	cc
seek	VBG	conj
declaration	NNS	dobj
of	IN	prep
invalidity	NN	pobj
and	CC	cc
unenforceability	NN	conj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
also	RB	advmod
order	VBD	ROOT
that	IN	mark
,	,	punct
pursuant	JJ	prep
to	IN	prep
35	CD	nummod
U.S.C.	NNP	nmod
¡±	CD	advmod
271(e)(4)(a	CD	pobj
)	-RRB-	punct
,	,	punct
the	DT	det
effective	JJ	amod
date	NN	nsubj
of	IN	prep
any	DT	det
approval	NN	pobj
of	IN	prep
Apotex	NNP	poss
's	POS	case
ANDA	NNP	nmod
No.	SYM	pobj
76	CD	nummod
-	SYM	punct
719	CD	conj
shall	MD	aux
not	RB	neg
be	VB	ccomp
early	JJR	acomp
than	IN	prep
September	NNP	pobj
25	CD	nummod
,	,	punct
2007	CD	appos
,	,	punct
and	CC	cc
pursuant	JJ	conj
to	IN	prep
35	CD	nummod
u.s.c.	NN	nmod
¡±	CD	advmod
271(e)(4)(b	CD	pobj
)	-RRB-	punct
,	,	punct
enjoin	VBD	conj
Apotex	NNP	dobj
,	,	punct
-PRON-	PRP$	poss
officer	NNS	conj
,	,	punct
agent	NNS	conj
,	,	punct
servant	NNS	conj
,	,	punct
employee	NNS	conj
and	CC	cc
attorney	NNS	conj
,	,	punct
and	CC	cc
those	DT	det
person	NNS	conj
in	IN	prep
active	JJ	amod
concert	NN	pobj
or	CC	cc
participation	NN	conj
with	IN	prep
-PRON-	PRP	pobj
,	,	punct
from	IN	prep
engage	VBG	pcomp
in	IN	prep
the	DT	det
manufacture	NN	pobj
,	,	punct
use	VBP	conj
,	,	punct
offer	VBP	conj
for	IN	prep
sale	NN	pobj
,	,	punct
or	CC	cc
sale	NN	conj
within	IN	prep
the	DT	det
U.S.	NNP	pobj
,	,	punct
or	CC	cc
importation	NN	conj
into	IN	prep
the	DT	det
U.S.	NNP	pobj
of	IN	prep
any	DT	det
product	NN	pobj
comprise	VBG	acl
amlodipine	NN	compound
besylate	NN	dobj
cover	VBN	acl
by	IN	agent
,	,	punct
or	CC	cc
the	DT	det
use	NN	nsubjpass
of	IN	prep
which	WDT	pobj
be	VBZ	auxpass
cover	VBN	acl
by	IN	agent
,	,	punct
the	DT	det
claim	NNS	appos
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
until	IN	prep
September	NNP	pobj
25	CD	nummod
,	,	punct
2007	CD	appos
.	.	punct

Pfizer	NNP	compound
Inc.	NNP	ROOT
v.	CC	prep
Apotex	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
No.	SYM	conj
03c	CD	nummod
5289	CD	npadvmod
(	-LRB-	punct
N.D.Ill	NNP	subtok
.	.	punct
January	NNP	npadvmod
29	CD	nummod
,	,	punct
2006	CD	nummod
)	-RRB-	punct
.	.	punct

On	IN	prep
February	NNP	pobj
17	CD	nummod
,	,	punct
2006	CD	appos
,	,	punct
Apotex	NNP	nsubj
file	VBD	ROOT
a	DT	det
timely	JJ	amod
notice	NN	dobj
of	IN	prep
appeal	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
have	VBP	ROOT
jurisdiction	NN	dobj
pursuant	JJ	advmod
to	IN	prep
28	CD	nummod
U.S.C.	NNP	nmod
¡±	CD	nummod
1295(a)(1	CD	pobj
)	-RRB-	punct
.	.	punct

 	_SP	

II	NNP	ROOT
.	.	punct

DISCUSSION	NNP	ROOT

 	_SP	

Apotex	NNP	nsubj
appeal	VBZ	ROOT
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
final	JJ	amod
judgment	NN	dobj
that	WDT	mark
-PRON-	PRP	nsubj
fail	VBD	relcl
to	TO	aux
prove	VB	xcomp
by	IN	prep
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
that	IN	mark
the	DT	det
invention	NN	nsubj
of	IN	prep
claim	NNS	pobj
1	CD	npadvmod
-	SYM	punct
3	CD	prep
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	acl
obvious	JJ	acomp
and	CC	cc
be	VBP	conj
therefore	RB	advmod
invalid	JJ	acomp
,	,	punct
and	CC	cc
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
finding	NN	conj
that	IN	mark
Apotex	NNP	nsubj
fail	VBD	acl
to	TO	aux
prove	VB	xcomp
Pfizer	NNP	nsubj
commit	VBD	ccomp
inequitable	JJ	amod
conduct	NN	dobj
before	IN	prep
the	DT	det
USPTO	NNP	pobj
.	.	punct

Because	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
err	VBD	advcl
in	IN	prep
hold	VBG	pcomp
non-	NNS	dobj
obvious	JJ	amod
the	DT	det
invention	NN	dobj
of	IN	prep
claim	NNS	pobj
1	CD	npadvmod
-	SYM	punct
3	CD	prep
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
reverse	VBP	ROOT
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
judgment	NN	dobj
.	.	punct

Since	IN	mark
-PRON-	PRP	nsubj
hold	VBP	advcl
that	IN	nsubj
claim	VBZ	ccomp
1	CD	npadvmod
-	SYM	punct
3	CD	prep
be	VBP	ccomp
invalid	JJ	acomp
for	IN	prep
obviousness	JJ	pobj
,	,	punct
-PRON-	PRP	nsubj
need	VBP	ROOT
not	RB	neg
and	CC	cc
do	VB	aux
not	RB	neg
address	VB	conj
Apotex	NNP	poss
's	POS	case
assertion	NN	dobj
that	IN	mark
Pfizer	NNP	nsubj
engage	VBD	acl
in	IN	prep
inequitable	JJ	amod
conduct	NN	pobj
before	IN	prep
the	DT	det
USPTO	NNP	pobj
during	IN	prep
prosecution	NN	pobj
of	IN	prep
the	DT	det
¡¬	NNP	nmod
303	CD	nummod
patent	NN	pobj
.	.	punct

  	_SP	

On	IN	prep
appeal	NN	pobj
from	IN	prep
a	DT	det
bench	JJ	compound
trial	NN	pobj
,	,	punct
this	DT	det
court	NN	nsubj
review	VBZ	ROOT
the	DT	det
trial	NN	compound
court	NN	poss
's	POS	case
conclusion	NNS	dobj
of	IN	prep
law	NN	nmod
de	FW	nmod
novo	NN	pobj
and	CC	cc
finding	NNS	conj
of	IN	prep
fact	NN	pobj
for	IN	prep
clear	JJ	amod
error	NN	pobj
.	.	punct

Golden	NNP	compound
Blount	NNP	ROOT
,	,	punct
Inc.	NNP	appos
v.	CC	prep
Robert	NNP	compound
H.	NNP	compound
Peterson	NNP	compound
Co.	NNP	conj
,	,	punct
365	CD	nummod
f.3d	CD	appos
1054	CD	nummod
,	,	punct
1058	CD	appos
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.2004	LS	appos
)	-RRB-	punct
.	.	punct

the	DT	det
ultimate	JJ	amod
conclusion	NN	nsubj
of	IN	prep
whether	IN	mark
a	DT	det
claim	VBN	amod
invention	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	pcomp
obvious	JJ	acomp
be	VBZ	ROOT
a	DT	det
question	NN	attr
of	IN	prep
law	NN	pobj
review	VBN	acl
de	FW	nmod
novo	NN	dobj
base	VBN	prep
on	IN	prep
underlie	VBG	amod
finding	NNS	pobj
of	IN	prep
fact	NN	pobj
review	VBN	acl
for	IN	prep
clear	JJ	amod
error	NN	pobj
.	.	punct

Richardson	NNP	compound
-	HYPH	punct
Vicks	NNP	compound
Inc.	NNP	ROOT
v.	CC	prep
Upjohn	NNP	compound
Co.	NNP	pobj
,	,	punct
122	CD	nummod
f.3d	CD	nummod
1476	CD	nummod
,	,	punct
1479	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1997	ADD	appos
)	-RRB-	punct
.	.	punct

a	DT	det
factual	JJ	amod
finding	NN	nsubj
be	VBZ	ROOT
clearly	RB	advmod
erroneous	JJ	acomp
if	IN	mark
,	,	punct
despite	IN	prep
some	DT	det
support	VBG	amod
evidence	NN	pobj
,	,	punct
"	''	punct
the	DT	det
review	VBG	amod
court	NN	nsubjpass
on	IN	prep
the	DT	det
entire	JJ	amod
evidence	NN	pobj
be	VBZ	auxpass
leave	VBN	advcl
with	IN	prep
the	DT	det
definite	JJ	amod
and	CC	cc
firm	JJ	conj
conviction	NN	pobj
that	IN	mark
a	DT	det
mistake	NN	nsubjpass
have	VBZ	aux
be	VBN	auxpass
commit	VBN	acl
"	''	punct
.	.	punct

United	NNP	compound
States	NNP	ROOT
v.	IN	prep
U.S.	NNP	compound
Gypsum	NNP	compound
Co.	NNP	pobj
,	,	punct
333	CD	nummod
U.S.	NNP	appos
364	CD	nummod
,	,	punct
395	CD	appos
,	,	punct

68	CD	nummod
s.ct	NN	subtok
.	.	ROOT

525	CD	ROOT
,	,	punct
92	CD	nummod
L.Ed	NNS	appos
.	.	punct

746	CD	ROOT
(	-LRB-	punct
1948	CD	appos
)	-RRB-	punct
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
hold	VBD	ROOT
that	IN	mark
Apotex	NNP	nsubj
have	VBD	aux
establish	VBN	ccomp
a	DT	det
prima	NN	amod
facie	NN	compound
case	NN	dobj
of	IN	prep
obviousness	JJ	pobj
because	IN	mark
the	DT	det
patent	NN	compound
examiner	NN	nsubj
initially	RB	advmod
reject	VBD	advcl
the	DT	det
claim	NNS	dobj
to	TO	aux
amlodipine	VB	acl
besylate	NN	dobj
for	IN	prep
obviousness	JJ	pobj
.	.	punct

specifically	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ROOT
,	,	punct
"	``	punct
the	DT	det
¡¬303	JJ	compound
patent	NN	poss
's	POS	case
file	NN	compound
wrapper	NN	nsubj
show	VBZ	ccomp
that	IN	mark
the	DT	det
examiner	NN	nsubj
originally	RB	advmod
reject	VBD	ccomp
the	DT	det
claim	VBN	amod
invention	NN	dobj
because	IN	prep
of	IN	pcomp
obviousness	JJ	pobj
.	.	punct

under	IN	prep
these	DT	det
circumstance	NNS	pobj
,	,	punct
of	IN	prep
course	NN	pobj
,	,	punct
the	DT	det
Court	NNP	nsubj
must	MD	aux
accept	VB	ROOT
that	IN	mark
the	DT	det
defendant	NN	nsubj
have	VBZ	aux
make	VBN	ccomp
a	DT	det
prima	NN	amod
facie	NN	dobj
show	VBG	acl
on	IN	prep
this	DT	det
question	NN	pobj
"	''	punct
.	.	punct

bench	NN	compound
order	NN	compound
tr	UH	subtok
.	.	ROOT
21:20	CD	npadvmod
-	SYM	punct
24	CD	prep
.	.	punct

the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
ruling	NN	nsubjpass
must	MD	aux
be	VB	auxpass
reject	VBN	ROOT
,	,	punct
not	RB	preconj
only	RB	advmod
because	IN	mark
-PRON-	PRP	nsubj
be	VBZ	advcl
legally	RB	advmod
incorrect	JJ	acomp
,	,	punct
but	CC	cc
also	RB	advmod
because	IN	mark
-PRON-	PRP	nsubj
may	MD	aux
reflect	VB	conj
a	DT	det
serious	JJ	amod
misconception	NN	dobj
regard	VBG	prep
the	DT	det
proper	JJ	amod
burden	NN	pobj
of	IN	prep
proof	NN	pobj
each	DT	det
party	NN	compound
bear	VBZ	dobj
in	IN	prep
a	DT	det
patent	NN	compound
litigation	NN	pobj
.	.	punct

  	_SP	

-PRON-	PRP$	poss
case	NN	compound
law	NN	nsubj
consistently	RB	advmod
provide	VBZ	ROOT
that	IN	mark
a	DT	det
court	NN	nsubjpass
be	VBZ	auxpass
never	RB	neg
bind	VBN	ccomp
by	IN	agent
an	DT	det
examiner	NN	poss
's	POS	case
finding	NN	pobj
in	IN	prep
an	DT	det
ex	FW	compound
parte	NN	compound
patent	NN	compound
application	NN	compound
proceeding	NN	pobj
.	.	punct

Fromson	NNP	ROOT
v.	IN	prep
Advance	NNP	compound
Offset	NNP	compound
Plate	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
755	CD	nummod
f.2d	CD	nummod
1549	CD	appos
,	,	punct
1555	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1985	LS	appos
)	-RRB-	punct
.	.	punct

thus	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
can	MD	aux
never	RB	neg
be	VB	ROOT
the	DT	det
case	NN	attr
that	IN	mark
an	DT	det
examiner	NN	poss
's	POS	case
interim	JJ	amod
finding	NN	nsubj
of	IN	prep
prima	NN	amod
facie	NN	compound
obviousness	JJ	pobj
render	NNS	acl
the	DT	det
claim	NNS	dobj
of	IN	prep
an	DT	det
issue	VBN	amod
patent	NN	compound
prima	NN	compound
facie	NN	pobj
obvious	JJ	amod
.	.	punct

instead	RB	advmod
,	,	punct
deference	NN	nsubj
to	IN	prep
the	DT	det
decision	NNS	pobj
of	IN	prep
the	DT	det
USPTO	NNP	pobj
take	VBZ	ROOT
the	DT	det
form	NN	dobj
of	IN	prep
the	DT	det
presumption	NN	pobj
of	IN	prep
validity	NN	pobj
under	IN	prep
35	CD	nummod
U.S.C.	NNP	pobj
¡±	NNP	nummod
282	CD	nummod
.	.	punct

Purdue	NNP	compound
Pharma	NNP	compound
L.P.	NNP	ROOT
v.	CC	prep
Faulding	NNP	compound
Inc.	NNP	pobj
,	,	punct
230	CD	nummod
f.3d	CD	appos
1320	CD	appos
,	,	punct
1329	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2000	LS	parataxis
)	-RRB-	punct
.	.	punct

that	RB	advmod
is	RB	advmod
,	,	punct
by	IN	prep
statute	NN	pcomp
a	DT	det
patent	NN	nsubj
be	VBZ	ROOT
valid	JJ	acomp
upon	IN	prep
issuance	NN	pobj
,	,	punct
35	CD	nummod
U.S.C.	NNP	nmod
¡±	NNP	nummod
282	CD	npadvmod
,	,	punct
and	CC	cc
include	VBN	conj
within	IN	prep
the	DT	det
presumption	NN	pobj
of	IN	prep
validity	NN	pobj
be	VBZ	conj
a	DT	det
presumption	NN	attr
of	IN	prep
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	pobj
.	.	punct

Structural	NNP	compound
Rubber	NNP	compound
Prods	NNP	pobj
.	.	punct
Co.	NNP	ROOT
v.	CC	prep
Park	NNP	compound
Rubber	NNP	compound
Co.	NNP	pobj
,	,	punct
749	CD	nummod
f.2d	CD	nummod
707	CD	appos
,	,	punct

714	CD	nummod
(	-LRB-	punct
Fed	NNP	ROOT
.	.	punct
cir.1984	ADD	acomp
)	-RRB-	punct
.	.	punct

Since	IN	mark
-PRON-	PRP	nsubj
must	MD	aux
presume	VB	advcl
a	DT	det
patent	NN	compound
valid	JJ	dobj
,	,	punct
the	DT	det
patent	NN	compound
challenger	NN	nsubj
bear	VBZ	ROOT
the	DT	det
burden	NN	dobj
of	IN	prep
prove	VBG	pcomp
the	DT	det
factual	JJ	amod
element	NNS	dobj
of	IN	prep
invalidity	NN	pobj
by	IN	prep
clear	JJ	pobj
and	CC	cc
convincing	JJ	conj

evidence.5	ADD	ROOT

that	DT	det
burden	NN	nsubj
of	IN	prep
proof	NN	pobj
never	RB	neg
shift	VBZ	ROOT
to	IN	prep
the	DT	det
patentee	NN	pobj
to	TO	aux
prove	VB	advcl
validity	NN	dobj
.	.	punct

Hybritech	NNP	compound
Inc.	NNP	ROOT
v.	CC	prep
Monoclonal	NNP	compound
Antibodies	NNPS	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
802	CD	nummod
f.2d	CD	conj
1367	CD	nummod
,	,	punct
1375	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1986	NN	appos
)	-RRB-	punct
.	.	punct
"	''	punct

the	DT	det
presumption	NN	nsubj
[	-LRB-	punct
of	IN	prep
validity	NN	pobj
]	-RRB-	punct
remain	VBZ	ROOT
intact	JJ	acomp
and	CC	cc
[	-LRB-	punct
the	DT	det
burden	NN	nsubj
of	IN	prep
proof	NN	pobj
remain	VBZ	conj
]	-RRB-	punct
on	IN	prep
the	DT	det
challenger	NN	pobj
throughout	IN	prep
the	DT	det
litigation	NN	pobj
,	,	punct
and	CC	cc
the	DT	det
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
standard	NN	nsubj
do	VBZ	aux
not	RB	neg
change	VB	conj
"	''	punct
.	.	punct

Idaho	NNP	ROOT

  	_SP	

-PRON-	PRP	nsubj
be	VBZ	ccomp
true	JJ	acomp
that	IN	mark
once	RB	mark
a	DT	det
challenger	NN	nsubj
have	VBZ	aux
present	VBN	ccomp
a	DT	det
prima	NN	amod
facie	NN	compound
case	NN	dobj
of	IN	prep
invalidity	NN	pobj
,	,	punct
the	DT	det
patentee	NN	nsubj
have	VBZ	ROOT
the	DT	det
burden	NN	dobj
of	IN	prep
go	VBG	pcomp
forward	RB	advmod
with	IN	prep
rebuttal	JJ	amod
evidence	NN	pobj
.	.	punct

see	VB	ROOT
Mas	NNP	compound
-	HYPH	punct
Hamilton	NNP	compound
Group	NNP	dobj
v.	IN	prep
LaGard	NNP	nmod
,	,	punct
Inc.	NNP	pobj
,	,	punct
156	CD	nummod
F.3d	NNP	appos
1206	CD	nummod
,	,	punct
1216	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1998	LS	appos
)	-RRB-	punct
(	-LRB-	punct
cite	VBG	pobj
Hybritech	NNP	dobj
,	,	punct
802	CD	nummod
f.2d	CD	dobj
at	IN	prep
1376	CD	pobj
)	-RRB-	punct
;	:	punct
Cable	NNP	compound
Elec	NNP	conj
.	.	punct

Prods	NNP	compound
.	.	punct
Inc.	NNP	nsubj
v.	CC	prep
Genmark	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
770	CD	nummod
f.2d	CD	punct
1015	CD	nummod
,	,	punct
1022	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1985	LS	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
If	IN	mark
evidence	NN	nsubjpass
be	VBZ	auxpass
present	VBN	advcl
establish	VBG	xcomp
a	DT	det
prima	NN	amod
facie	NN	compound
case	NN	dobj
of	IN	prep
invalidity	NN	pobj
,	,	punct
the	DT	det
opponent	NN	nsubj
of	IN	prep
invalidity	NN	pobj
must	MD	aux
come	VB	ROOT
forward	RB	advmod
with	IN	prep
evidence	NN	pobj
to	TO	aux
counter	VB	acl
the	DT	det
prima	NN	amod
facie	NN	compound
challenge	NN	dobj
to	IN	prep
the	DT	det
presumption	NN	pobj
of	IN	prep
section	NN	pobj
282	CD	nummod
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

but	CC	cc
,	,	punct
all	DT	nsubj
that	DT	nsubj
mean	VBZ	relcl
be	VBZ	ROOT
that	IN	mark
even	RB	advmod
though	IN	mark
a	DT	det
patentee	NN	nsubj
never	RB	neg
must	MD	aux
submit	VB	advcl
evidence	NN	dobj
to	TO	aux
support	VB	relcl
a	DT	det
conclusion	NN	dobj
by	IN	prep
a	DT	det
judge	NN	pobj
or	CC	cc
jury	NN	conj
that	IN	mark
a	DT	det
patent	NN	nsubj
remain	VBZ	acl
valid	JJ	acomp
,	,	punct
once	RB	mark
a	DT	det
challenger	NN	nsubj
introduce	VBZ	advcl
evidence	NN	dobj
that	WDT	nsubj
may	MD	aux
lead	VB	relcl
to	IN	prep
a	DT	det
conclusion	NN	pobj
of	IN	prep
invalidity	NN	pobj
-	:	punct
what	WP	dobj
-PRON-	PRP	nsubj
call	VBP	relcl
a	DT	det
prima	NN	amod
facie	NN	compound
case	NN	oprd
-	:	punct
the	DT	det
patentee	NN	nsubj
"	''	punct
would	MD	aux
be	VB	auxpass
well	RB	advmod
advise	VBN	ccomp
to	TO	aux
introduce	VB	xcomp
evidence	NN	dobj
sufficient	JJ	amod
to	TO	aux
rebut	VB	xcomp
that	DT	dobj
of	IN	prep
the	DT	det
challenger	NN	pobj
"	''	punct
.	.	punct

Orthokinetics	NNP	ROOT
,	,	punct
Inc.	NNP	appos
v.	IN	prep

Safety	NNP	compound
Travel	NNP	compound
Chairs	NNPS	ROOT
,	,	punct
Inc.	NNP	appos
,	,	punct
806	CD	nummod
f.2d	CD	appos
1565	CD	nummod
,	,	punct
1570	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1986	NN	appos
)	-RRB-	punct
.	.	punct

  	_SP	

however	RB	advmod
,	,	punct
this	DT	det
requirement	NN	nsubj
do	VBZ	aux
not	RB	neg
"	``	punct
in	IN	prep
substance	NN	pobj
shift	VB	ROOT
the	DT	det
burden	NN	dobj
of	IN	prep
persuasion	NN	pobj
,	,	punct
"	``	punct
Cable	NNP	compound
Elec	NNP	npadvmod
.	.	punct
,	,	punct
770	CD	nummod
f.2d	CD	appos
at	IN	prep
1022	CD	pobj
,	,	punct
because	IN	mark
"	``	punct
the	DT	det
presumption	NN	nsubj
of	IN	prep
validity	NN	pobj
remain	VBZ	advcl
intact	JJ	acomp
and	CC	cc
the	DT	det
ultimate	JJ	amod
burden	NN	nsubj
of	IN	prep
prove	VBG	pcomp
invalidity	NN	nsubj
remain	VBZ	conj
with	IN	prep
the	DT	det
challenger	NN	pobj
throughout	IN	prep
the	DT	det
litigation	NN	pobj
"	''	punct
.	.	punct

Mas	NNP	compound
-	HYPH	punct
Hamilton	NNP	compound
Group	NNP	nsubj
,	,	punct
156	CD	nummod
f.3d	CD	appos
at	IN	prep
1216	CD	pobj
;	:	punct
see	VB	ROOT
also	RB	advmod
Innovative	NNP	compound
Scuba	NNP	compound
Concepts	NNPS	dobj
,	,	punct
Inc.	NNP	appos
v.	IN	prep
Feder	NNP	compound
Indus	NNP	pobj
.	.	punct
,	,	punct
Inc.	NNP	npadvmod
,	,	punct
26	CD	nummod
f.3d	CD	appos
1112	CD	nummod
,	,	punct
1115	CD	npadvmod
(	-LRB-	punct
Fed	NNP	ccomp
.	.	punct
Cir.1994	NNP	dobj
)	-RRB-	punct
;	:	punct
Ashland	NNP	compound
Oil	NNP	appos
,	,	punct
Inc.	NNP	appos
v.	CC	prep
Delta	NNP	compound
Resins	NNP	pobj
&	CC	cc
Refractories	NNP	conj
,	,	punct
Inc.	NNP	appos
,	,	punct
776	CD	nummod
f.2d	CD	nummod
281	CD	appos
,	,	punct
287	CD	nummod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1985	LS	appos
)	-RRB-	punct
.	.	punct

the	DT	det
trial	NN	compound
court	NN	nsubj
have	VBZ	ROOT
the	DT	det
responsibility	NN	dobj
to	TO	aux
determine	VB	acl
whether	IN	mark
the	DT	det
challenger	NN	nsubj
have	VBZ	aux
meet	VBN	ccomp
-PRON-	PRP$	poss
burden	NN	dobj
by	IN	prep
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
by	IN	prep
consider	VBG	pcomp
the	DT	det
totality	NN	dobj
of	IN	prep
the	DT	det
evidence	NN	pobj
,	,	punct
include	VBG	prep
any	DT	det
rebuttal	JJ	amod
evidence	NN	pobj
present	VBN	acl
by	IN	agent
the	DT	det
patentee	NN	pobj
.	.	punct

Stratoflex	NNP	ROOT
,	,	punct
Inc.	NNP	appos
v.	IN	prep
Aeroquip	NNP	compound
Corp.	NNP	pobj
,	,	punct
713	CD	nummod
f.2d	CD	appos
1530	CD	npadvmod
,	,	punct
1534	CD	npadvmod
(	-LRB-	punct
Fed	NNP	compound
.	.	punct
Cir.1983	LS	ccomp
)	-RRB-	punct
.	.	punct

  	_SP	

the	DT	det
basis	NN	nsubj
(	-LRB-	punct
as	IN	mark
oppose	VBN	acl
to	IN	prep
the	DT	det
mere	JJ	amod
existence	NN	pobj
)	-RRB-	punct
of	IN	prep
an	DT	det
examiner	NN	poss
's	POS	case
initial	JJ	amod
finding	NN	pobj
of	IN	prep
prima	NN	amod
facie	NN	pobj
obviousness	JJ	appos
of	IN	prep
an	DT	det
issue	VBN	amod
patent	NN	pobj
be	VBZ	ROOT
therefore	RB	advmod
,	,	punct
at	IN	prep
most	RBS	amod
only	RB	advmod
one	CD	nummod
factual	JJ	amod
consideration	NN	pobj
that	IN	dobj
the	DT	det
trial	NN	compound
court	NN	nsubj
must	MD	aux
consider	VB	relcl
in	IN	prep
context	NN	pobj
of	IN	prep
the	DT	det
totality	NN	pobj
of	IN	prep
the	DT	det
evidence	NN	pobj
"	''	punct
in	IN	prep
determine	VBG	pcomp
whether	IN	mark
the	DT	det
party	NN	nmod
assert	VBG	acl
invalidity	NN	nsubj
have	VBZ	aux
meet	VBN	ccomp
-PRON-	PRP$	poss
statutory	JJ	amod
burden	NN	dobj
by	IN	prep
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
"	''	punct
.	.	punct

Fromson	NNP	ROOT
,	,	punct
755	CD	nummod
f.2d	CD	appos
at	IN	prep
1555	CD	pobj
.	.	punct

-PRON-	PRP	nsubj
do	VBZ	aux
not	RB	neg
,	,	punct
however	RB	advmod
,	,	punct
lessen	VBP	ROOT
or	CC	cc
otherwise	RB	advmod
affect	VB	conj
the	DT	det
burden	NN	dobj
of	IN	prep
proof	NN	pobj
,	,	punct
nor	CC	cc
do	VBZ	aux
-PRON-	PRP	nsubj
require	VB	conj
that	IN	mark
unless	IN	mark
the	DT	det
patentee	NN	nsubj
introduce	VBZ	advcl
evidence	NN	dobj
of	IN	prep
secondary	JJ	amod
consideration	NNS	pobj
to	TO	aux
establish	VB	advcl
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	advmod
,	,	punct
the	DT	det
patent	NN	compound
challenger	NN	nsubj
will	MD	aux
necessarily	RB	advmod
prevail	VB	ccomp
.	.	punct

 	_SP	

the	DT	det
underlying	JJ	amod
factual	JJ	amod
determination	NNS	nsubj
make	VBN	acl
by	IN	agent
the	DT	det
trial	NN	compound
court	NN	pobj
that	IN	mark
this	DT	det
court	NN	nsubj
must	MD	aux
review	VB	relcl
for	IN	prep
clear	JJ	amod
error	NN	pobj
include	VBP	ROOT
(	-LRB-	punct
1	LS	meta
)	-RRB-	punct
the	DT	det
scope	NN	dobj
and	CC	cc
content	NN	conj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
(	-LRB-	punct
2	LS	appos
)	-RRB-	punct
the	DT	det
level	NN	conj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
,	,	punct
(	-LRB-	punct
3	LS	appos
)	-RRB-	punct
the	DT	det
difference	NNS	conj
between	IN	prep
the	DT	det
claim	VBN	amod
invention	NN	pobj
and	CC	cc
the	DT	det
prior	JJ	amod
art	NN	conj
,	,	punct
and	CC	cc
(	-LRB-	punct
4	LS	nummod
)	-RRB-	punct
objective	JJ	amod
indicia	NN	conj
of	IN	prep
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	pobj
.	.	punct

Graham	NNP	ROOT
v.	IN	prep
John	NNP	compound
Deere	NNP	compound
Co.	NNP	pobj
,	,	punct
383	CD	nummod
U.S.	NNP	conj
1	CD	nummod
,	,	punct
17	CD	nummod
,	,	punct
86	CD	nummod
S.Ct	NNP	subtok
.	.	punct

684	CD	ROOT
,	,	punct
15	CD	nummod
l.ed.2d	NN	nmod
545	CD	nummod
(	-LRB-	punct
1966	CD	appos
)	-RRB-	punct
.	.	punct

-PRON-	PRP	nsubj
start	VBP	ROOT
by	IN	prep
note	VBG	pcomp
that	IN	mark
the	DT	det
party	NNS	ccomp
stipulate	VBD	acl
to	IN	prep
many	JJ	pobj
of	IN	prep
the	DT	det
fact	NNS	pobj
,	,	punct
but	CC	cc
disagree	VB	conj
as	IN	prep
to	IN	prep
the	DT	det
ultimate	JJ	amod
legal	JJ	amod
outcome	NN	pobj
of	IN	prep
obviousness	NN	pobj
base	VBN	acl
upon	IN	prep
those	DT	det
fact	NNS	pobj
.	.	punct

the	DT	det
party	NNS	nsubj
do	VBP	aux
not	RB	neg
dispute	VB	ROOT
that	DT	mark
benzene	NN	compound
sulphonate	NN	nsubjpass
be	VBD	auxpass
know	VBN	ccomp
in	IN	prep
the	DT	det
art	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
of	IN	prep
the	DT	det
invention	NNS	pobj
claim	VBD	acl
in	IN	prep
the	DT	det
¡¬909	NN	nmod
and	CC	cc
¡¬303	JJ	conj
patent	NNS	pobj
.	.	punct

Pfizer	NNP	nsubj
admit	VBD	ROOT
that	IN	mark
several	JJ	amod
publication	NNS	nsubj
,	,	punct
include	VBG	prep
the	DT	det
Berge	NNP	compound
article	NN	pobj
,	,	punct
be	VBD	ccomp
prior	JJ	amod
art	NN	attr
to	IN	aux
claim	VBZ	relcl
1	CD	npadvmod
-	SYM	punct
3	CD	prep
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
and	CC	cc
pertinent	JJ	conj
to	IN	prep
the	DT	det
problem	NN	pobj
the	DT	det
inventor	NNS	nsubj
seek	VBD	relcl
to	TO	aux
overcome	VB	xcomp
.	.	punct

neither	DT	det
party	NN	nsubj
dispute	VBZ	ROOT
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
characterization	NN	dobj
of	IN	prep
the	DT	det
ordinarily	RB	advmod
skilled	JJ	amod
artisan	NN	pobj
.	.	punct

 	_SP	

further	RB	advmod
,	,	punct
there	EX	expl
be	VBZ	ROOT
really	RB	advmod
no	DT	det
dispute	NN	attr
as	IN	prep
to	IN	prep
the	DT	det
scope	NN	pobj
of	IN	prep
the	DT	det
¡¬909	JJR	nummod
patent	NN	pobj
and	CC	cc
the	DT	det
difference	NNS	conj
between	IN	prep
-PRON-	PRP	pobj
and	CC	cc
the	DT	det
claim	VBN	amod
invention	NN	conj
.	.	punct

the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubj
specifically	RB	advmod
state	VBZ	ROOT
that	IN	mark
the	DT	det
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
salt	NNS	nsubj
of	IN	prep
amlodipine	NN	pobj
"	''	punct
be	VBP	ccomp
those	DT	attr
form	VBN	acl
from	IN	prep
acid	NNS	pobj
which	WDT	nsubj
form	VBP	relcl
non	JJ	subtok
-	JJ	subtok
toxic	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NNS	dobj
contain	VBG	acl
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
anion	NNS	dobj
"	''	punct
.	.	punct

¡¬909	NN	nummod
patent	NN	compound
col.2	NN	ROOT
ll.3	JJR	compound
-	SYM	punct
6	CD	nummod
.	.	punct

the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubj
list	VBZ	ROOT
a	DT	det
genus	NN	dobj
of	IN	prep
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
anion	NNS	pobj
"	''	punct
such	JJ	amod
as	IN	prep
the	DT	det
hydrochloride	NN	pobj
,	,	punct
hydrobromide	NN	conj
,	,	punct
sulphate	NN	conj
,	,	punct
phosphate	NN	conj
or	CC	cc
acid	JJ	conj
phosphate	NN	conj
,	,	punct
acetate	JJ	amod
,	,	punct
maleate	JJ	conj
,	,	punct
fumarate	VB	conj
,	,	punct
lactate	VBP	conj
,	,	punct
tartrate	NN	conj
,	,	punct
citrate	VB	conj
and	CC	cc
gluconate	VB	conj
"	''	punct
.	.	punct

¡¬909	NN	nummod
patent	NN	compound
col.2	NN	ROOT
ll.6	NNP	compound
-	HYPH	punct
9	CD	nummod
.	.	punct

the	DT	det
only	JJ	amod
example	NNS	nsubj
of	IN	prep
acid	NN	compound
addition	NN	compound
salt	NNS	pobj
of	IN	prep
amlodipine	NN	pobj
be	VBP	ROOT
maleate	NNS	attr
.	.	punct

the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubj
do	VBZ	aux
not	RB	neg
expressly	RB	advmod
disclose	VB	ROOT
the	DT	det
benzene	NN	compound
sulphonate	JJ	compound
anion	NN	dobj
nor	CC	cc
salt	NNS	conj
form	VBN	acl
from	IN	prep
benzene	NN	amod
sulphonic	JJ	amod
acid	NN	pobj
or	CC	cc
a	DT	det
large	JJR	amod
class	NN	conj
of	IN	prep
sulphonic	JJ	amod
acid	NNS	pobj
in	IN	prep
general	JJ	amod
.	.	punct

but	CC	cc
,	,	punct
while	IN	mark
neither	CC	preconj
the	DT	det
claim	NNS	nsubj
nor	CC	cc
the	DT	det
write	VBN	amod
description	NN	conj
of	IN	prep
the	DT	det
¡¬909	JJR	nummod
patent	NN	pobj
expressly	RB	advmod
disclose	VB	advcl
amlodipine	JJ	compound
besylate	NN	dobj
or	CC	cc
the	DT	det
benzene	NN	compound
sulphonate	JJ	compound
anion	NN	conj
,	,	punct
neither	RB	preconj
do	VBP	aux
-PRON-	PRP	nsubj
exclude	VB	ROOT
amlodipine	NN	compound
besylate	NN	dobj
or	CC	cc
the	DT	det
benzene	NN	compound
sulphonate	JJ	compound
anion	NN	conj
.	.	punct

rather	RB	advmod
,	,	punct
the	DT	det
only	JJ	amod
limitation	NNS	nsubj
place	VBN	acl
on	IN	prep
the	DT	det
anion	NN	pobj
be	VBP	ROOT
that	IN	mark
-PRON-	PRP	nsubj
be	VBZ	ccomp
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	acomp
,	,	punct
and	CC	cc
that	IN	mark
in	IN	prep
salt	NN	compound
form	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
be	VBZ	conj
able	JJ	acomp
to	TO	aux
produce	VB	xcomp
a	DT	det
non	JJ	subtok
-	JJ	subtok
toxic	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NN	dobj
.	.	punct

thus	RB	advmod
,	,	punct
as	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	advcl
and	CC	cc
the	DT	det
party	NNS	nsubj
agree	VBP	conj
,	,	punct
the	DT	det
¡¬	NNP	nmod
909	CD	nummod
patent	NN	compound
claim	NNS	nsubj
literally	RB	advmod
encompass	VBP	ROOT
amlodipine	JJ	compound
besylate	NN	dobj
.	.	punct

  	_SP	

By	IN	prep
statute	NN	pobj
,	,	punct
a	DT	det
claim	VBN	amod
invention	NN	nsubj
be	VBZ	ROOT
unpatentable	JJ	acomp
if	IN	mark
the	DT	det
difference	NNS	nsubj
between	IN	prep
-PRON-	PRP	pobj
and	CC	cc
the	DT	det
prior	JJ	amod
art	NN	conj
"	''	punct
be	VBP	advcl
such	JJ	acomp
that	IN	mark
the	DT	det
subject	JJ	amod
matter	NN	nsubj
as	IN	prep
a	DT	det
whole	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
at	IN	prep
the	DT	det
time	NN	pobj
the	DT	det
invention	NN	nsubjpass
be	VBD	auxpass
make	VBN	relcl
to	IN	prep
a	DT	det
person	NN	pobj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
in	IN	prep
the	DT	det
art	NN	pobj
"	''	punct
.	.	punct

35	CD	ROOT
u.s.c.	NN	subtok
¡±	NNP	punct
103(a	CD	npadvmod
)	-RRB-	punct
.	.	punct

subsume	VBN	advcl
within	IN	prep
the	DT	det
Graham	NNP	compound
factor	NNS	pobj
be	VBZ	auxpass
a	DT	det
subsidiary	JJ	amod
requirement	NN	attr
articulate	VBN	acl
by	IN	agent
this	DT	det
court	NN	pobj
that	IN	mark
where	WRB	advmod
,	,	punct
as	IN	prep
here	RB	pcomp
,	,	punct
all	DT	det
claim	NN	compound
limitation	NNS	nsubjpass
be	VBP	auxpass
find	VBN	acl
in	IN	prep
a	DT	det
number	NN	pobj
of	IN	prep
prior	JJ	amod
art	NN	compound
reference	NNS	pobj
,	,	punct
the	DT	det
burden	NN	nsubj
fall	VBZ	ROOT
on	IN	prep
the	DT	det
challenger	NN	pobj
of	IN	prep
the	DT	det
patent	NN	pobj
to	TO	aux
show	VB	xcomp
by	IN	prep
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
that	IN	mark
a	DT	det
skilled	JJ	amod
artisan	NN	nsubjpass
would	MD	aux
have	VB	aux
be	VBN	auxpass
motivate	VBN	acl
to	TO	aux
combine	VB	xcomp
the	DT	det
teaching	NNS	dobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	pobj
to	TO	aux
achieve	VB	advcl
the	DT	det
claim	VBN	amod
invention	NN	dobj
,	,	punct
and	CC	cc
that	IN	mark
the	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
have	VB	aux
have	VBN	conj
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
in	IN	prep
do	VBG	pcomp
so	RB	advmod
.	.	punct

DyStar	NNP	compound
Textilfarben	NNP	compound
GmbH	NNP	ROOT
v.	CC	prep
C.H.	NNP	compound
Patrick	NNP	compound
Co.	NNP	pobj
,	,	punct
464	CD	nummod
f.3d	CD	appos
1356	CD	nummod
,	,	punct
1360	CD	npadvmod
(	-LRB-	punct
Fed	NNP	amod
.	.	punct
Cir.2006	LS	appos
)	-RRB-	punct

;	:	punct
Velander	NNP	nsubj
v.	IN	prep
Garner	NNP	pobj
,	,	punct
348	CD	nummod
f.3d	CD	appos
1359	CD	appos
,	,	punct
1363	CD	npadvmod
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.2003	NFP	ROOT
)	-RRB-	punct
.	.	punct

here	RB	advmod
,	,	punct
the	DT	det
party	NNS	nsubj
vigorously	RB	advmod
disagree	VBP	ROOT
.	.	punct

  	_SP	

a	DT	det
difficulty	NN	nsubj
in	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
opinion	NN	pobj
arise	VBZ	ROOT
because	IN	mark
,	,	punct
in	IN	prep
assume	VBG	pcomp
a	DT	det
prima	NN	amod
facie	NN	compound
case	NN	dobj
of	IN	prep
obviousness	JJ	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
fully	RB	advmod
address	VB	advcl
whether	IN	mark
Apotex	NNP	nsubj
show	VBN	ccomp
by	IN	agent
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
that	IN	mark
a	DT	det
skilled	JJ	amod
artisan	NN	nsubjpass
would	MD	aux
have	VB	aux
be	VBN	auxpass
motivate	VBN	acl
to	TO	aux
combine	VB	xcomp
the	DT	det
teaching	NNS	dobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	pobj
rely	VBD	acl
on	RP	prep
,	,	punct
especially	RB	advmod
the	DT	det
¡¬909	JJR	nummod
patent	NN	appos
and	CC	cc
Berge	NNP	conj
,	,	punct
to	TO	aux
achieve	VB	advcl
the	DT	det
claim	VBN	amod
invention	NN	dobj
.	.	punct

however	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
omission	NN	nsubj
in	IN	prep
this	DT	det
case	NN	pobj
be	VBZ	ROOT
harmless	JJ	amod
error	NN	attr
because	IN	mark
evidence	NN	nsubj
of	IN	prep
record	NN	pobj
easily	RB	advmod
satisfy	VBZ	advcl
-PRON-	PRP	dobj
that	IN	mark
a	DT	det
reasonable	JJ	amod
fact	NN	compound
-	HYPH	punct
finder	NN	nsubj
could	MD	aux
only	RB	advmod
conclude	VB	ccomp
that	IN	dobj
Apotex	NNP	nsubj
have	VBZ	aux
show	VBN	ccomp
by	IN	prep
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
that	IN	mark
the	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
indeed	RB	advmod
have	VB	aux
be	VBN	ccomp
so	RB	advmod
motivated	JJ	acomp
to	TO	aux
combine	VB	xcomp
the	DT	det
prior	JJ	amod
art	NN	dobj
to	TO	aux
produce	VB	advcl
the	DT	det
besylate	NN	compound
salt	NN	dobj
of	IN	prep
amlodipine	NN	pobj
.	.	punct

the	DT	det
record	NN	nsubj
also	RB	advmod
satisfy	VBZ	ROOT
-PRON-	PRP	dobj
that	IN	mark
,	,	punct
contrary	JJ	advcl
to	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
finding	NN	pobj
,	,	punct
a	DT	det
reasonable	JJ	amod
fact	NN	compound
-	HYPH	punct
finder	NN	nsubj
could	MD	aux
only	RB	advmod
conclude	VB	ccomp
that	IN	mark
the	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
have	VB	aux
have	VBN	ccomp
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
with	IN	prep
the	DT	det
besylate	NN	compound
salt	NN	compound
form	NN	pobj
of	IN	prep
amlodipine	NN	pobj
for	IN	prep
the	DT	det
reason	NNS	pobj
elaborate	VBN	acl
,	,	punct
post	VB	npadvmod
.	.	punct

 	_SP	

Motivation	NNP	ROOT
to	IN	aux
combine	VB	acl
Prior	NNP	compound
Art	NNP	compound
References	NNPS	dobj
to	TO	aux
Achieve	NNP	advcl
the	DT	det
Claimed	NNP	compound
Invention	NNP	dobj

 	_SP	

Pfizer	NNP	nsubj
do	VBZ	aux
not	RB	neg
argue	VB	ROOT
that	IN	mark
there	EX	expl
be	VBD	ccomp
no	DT	det
motivation	NN	attr
to	TO	aux
combine	VB	acl
the	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	dobj
per	IN	advmod
se	FW	advmod
.	.	punct

rather	RB	advmod
,	,	punct
Pfizer	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
(	-LRB-	punct
1	LS	meta
)	-RRB-	punct
the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubj
do	VBZ	aux
not	RB	neg
suggest	VB	ccomp
or	CC	cc
motivate	VB	conj
the	DT	det
skilled	JJ	amod
artisan	NN	dobj
to	TO	aux
make	VB	advcl
amlodipine	JJ	compound
besylate	NN	dobj
because	IN	mark
none	NN	nsubj
of	IN	prep
the	DT	det
anion	NNS	pobj
list	VBN	acl
in	IN	prep
the	DT	det
¡¬909	NN	nummod
patent	NN	pobj
have	VBP	advcl
a	DT	det
cyclic	JJ	amod
structure	NN	dobj
as	IN	mark
do	VBZ	aux
besylate	VB	advcl
,	,	punct
and	CC	cc
(	-LRB-	punct
2	LS	meta
)	-RRB-	punct
even	RB	advmod
if	IN	mark
the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubjpass
be	VBD	auxpass
combine	VBN	advcl
with	IN	prep
Berge	NNP	pobj
,	,	punct
the	DT	det
skilled	JJ	amod
artisan	NN	nsubjpass
would	MD	aux
not	RB	neg
have	VB	aux
be	VBN	auxpass
motivate	VBN	conj
to	TO	aux
make	VB	xcomp
amlodipine	JJ	compound
besylate	NN	dobj
because	IN	mark
Berge	NNP	nsubj
show	VBZ	advcl
that	IN	mark
besylate	NN	nsubj
be	VBD	ccomp
actually	RB	advmod
one	CD	attr
of	IN	prep
the	DT	det
most	RBS	advmod
rarely	RB	advmod
use	VBN	amod
anion	NNS	pobj
in	IN	prep
the	DT	det
pharmaceutical	NN	compound
industry	NN	pobj
,	,	punct
as	IN	mark
only	RB	advmod
0.25	CD	nummod
%	NN	nsubj
of	IN	prep
approve	VBN	amod
drug	NNS	pobj
as	IN	prep
of	IN	prep
1974	CD	pobj
be	VBD	advcl
besylate	NN	compound
salt	NNS	attr
.	.	punct

finally	RB	advmod
,	,	punct
Pfizer	NNP	nsubj
assert	VBZ	ROOT
that	IN	mark
other	JJ	amod
prior	JJ	amod
art	NN	compound
reference	NNS	nsubj
rely	VBN	acl
upon	IN	prep
by	IN	agent
Apotex	NNP	pobj
be	VBP	ccomp
not	RB	neg
relevant	JJ	acomp
because	IN	mark
the	DT	det
example	NNS	nsubj
of	IN	prep
besylate	NN	compound
salt	NNS	pobj
disclose	VBN	acl
in	IN	prep
these	DT	det
reference	NNS	pobj
be	VBP	advcl
limit	VBN	acomp
to	IN	prep
pharmaceutical	NNS	pobj
unrelated	JJ	amod
to	TO	aux
amlodipine	VB	xcomp
.	.	punct

  	_SP	

-PRON-	PRP	nsubj
reject	VBP	ROOT
Pfizer	NNP	poss
's	POS	case
first	JJ	amod
argument	NN	dobj
,	,	punct
since	IN	mark
a	DT	det
suggestion	NN	nsubj
,	,	punct
teaching	NN	conj
,	,	punct
or	CC	cc
motivation	NN	conj
to	TO	aux
combine	VB	acl
the	DT	det
relevant	JJ	amod
prior	JJ	amod
art	NN	compound
teaching	NNS	dobj
to	TO	aux
achieve	VB	advcl
the	DT	det
claim	VBN	amod
invention	NN	dobj
do	VBZ	aux
not	RB	neg
have	VB	advcl
to	TO	aux
be	VB	auxpass
find	VBN	xcomp
explicitly	RB	advmod
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	pobj
seek	VBD	acl
to	TO	aux
be	VB	auxpass
combine	VBN	xcomp
,	,	punct
but	CC	cc
rather	RB	advmod
"	``	punct
may	MD	aux
be	VB	auxpass
find	VBN	conj
in	IN	prep
any	DT	det
number	NN	pobj
of	IN	prep
source	NNS	pobj
,	,	punct
include	VBG	prep
common	JJ	amod
knowledge	NN	pobj
,	,	punct
the	DT	det
prior	JJ	amod
art	NN	conj
as	IN	prep
a	DT	det
whole	NN	pobj
,	,	punct
or	CC	cc
the	DT	det
nature	NN	conj
of	IN	prep
the	DT	det
problem	NN	pobj
-PRON-	PRP	appos
"	''	punct
.	.	punct

DyStar	NNP	nsubj
,	,	punct
464	CD	nummod
f.3d	CD	appos
at	IN	prep
1361	CD	pobj
;	:	punct
see	VB	ROOT
also	RB	advmod
Ormco	NNP	compound
Corp.	NNP	dobj
v.	CC	prep
Align	NNP	compound
Tech	NNP	pobj
.	.	nmod
,	,	punct
Inc.	NNP	conj
,	,	punct
463	CD	nummod
F.3d	NNP	appos
1299	CD	nummod
,	,	punct
1307	CD	npadvmod
-	SYM	punct
08	CD	prep
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.2006	LS	appos
)	-RRB-	punct
.	.	punct

In	IN	prep
other	JJ	amod
word	NNS	pobj
,	,	punct
-PRON-	PRP	nsubj
be	VBZ	ROOT
irrelevant	JJ	acomp
that	IN	mark
none	NN	nsubj
of	IN	prep
the	DT	det
anion	NNS	pobj
specifically	RB	advmod
list	VBN	acl
in	IN	prep
the	DT	det
¡¬909	NN	nummod
patent	NN	pobj
have	VBP	ccomp
a	DT	det
cyclic	JJ	amod
structure	NN	dobj
,	,	punct
because	IN	mark
the	DT	det
motivation	NN	nsubjpass
to	TO	aux
make	VB	acl
amlodipine	JJ	compound
besylate	NN	dobj
here	RB	advmod
be	VBZ	auxpass
glean	VBN	advcl
not	RB	preconj
only	RB	advmod
from	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
as	IN	prep
a	DT	det
whole	NN	pobj
rather	RB	advmod
than	IN	cc
the	DT	det
¡¬909	JJR	nummod
patent	NN	pobj
alone	RB	advmod
,	,	punct
but	CC	cc
also	RB	advmod
from	IN	conj
the	DT	det
nature	NN	pobj
of	IN	prep
the	DT	det
problem	NNS	pobj
encounter	VBN	acl
with	IN	prep
the	DT	det
amlodipine	JJ	compound
maleate	JJ	compound
tablet	NN	compound
formulation	NNS	pobj
seek	VBN	acl
to	TO	aux
be	VB	auxpass
solve	VBN	xcomp
by	IN	agent
the	DT	det
inventor	NNS	pobj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
.	.	punct

In	IN	prep
this	DT	det
regard	NN	pobj
,	,	punct
testimony	NN	ROOT
of	IN	prep
record	NN	compound
evidence	NNS	pobj
that	WDT	mark
one	CD	nsubjpass
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	auxpass
motivate	VBN	acl
to	TO	aux
choose	VB	xcomp
an	DT	det
anion	NN	dobj
have	VBG	acl
a	DT	det
different	JJ	amod
structure	NN	dobj
than	IN	prep
that	DT	pobj
of	IN	prep
maleate	NN	pobj
.	.	punct

the	DT	det
maleate	JJ	compound
salt	NN	compound
ion	NN	nsubj
be	VBZ	ROOT
acyclic	JJ	acomp
and	CC	cc
consist	VBZ	conj
of	IN	prep
a	DT	det
double	JJ	amod
bond	NN	pobj
between	IN	prep
the	DT	det
carbon	NN	compound
atom	NNS	pobj
,	,	punct
whereas	IN	mark
the	DT	det
besylate	NN	compound
salt	NN	compound
ion	NN	nsubj
be	VBZ	advcl
cyclic	JJ	acomp
and	CC	cc
lack	VBZ	conj
the	DT	det
same	JJ	amod
double	JJ	amod
bond	NN	dobj
.	.	punct

early	RB	advmod
in	IN	prep
development	NN	pobj
,	,	punct
Pfizer	NNP	nsubj
discover	VBD	ROOT
that	IN	mark
amlodipine	NN	compound
maleate	NN	nsubj
be	VBD	ccomp
susceptible	JJ	acomp
to	IN	prep
degradation	NN	pobj
from	IN	prep
a	DT	det
Michael	NNP	compound
addition	NN	compound
reaction	NN	pobj
in	IN	prep
which	WDT	pobj
the	DT	det
double	JJ	amod
bond	NN	nsubj
of	IN	prep
maleate	NN	pobj
undergo	VBD	relcl
an	DT	det
addition	NN	compound
reaction	NN	dobj
cause	VBG	acl
the	DT	det
formation	NN	dobj
of	IN	prep
degradation	NN	compound
product	NNS	pobj
.	.	punct

Apotex	NNP	nsubj
aver	VBZ	ROOT
that	IN	mark
unrebutted	JJ	amod
testimony	NN	nsubj
from	IN	prep
-PRON-	PRP$	poss
expert	NN	pobj
,	,	punct
which	WDT	nsubj
-PRON-	PRP	nsubj
find	VBP	relcl
compelling	JJ	dobj
,	,	punct
support	VBZ	ccomp
an	DT	det
inference	NN	dobj
that	IN	mark
the	DT	det
skilled	JJ	amod
artisan	NN	nsubjpass
actually	RB	advmod
would	MD	aux
have	VB	aux
be	VBN	auxpass
encourage	VBN	acl
,	,	punct
rather	RB	advmod
than	IN	cc
discourage	VBN	conj
,	,	punct
to	TO	aux
choose	VB	advcl
an	DT	det
anion	NN	dobj
without	IN	prep
the	DT	det
same	JJ	amod
double	JJ	amod
bond	NN	pobj
,	,	punct
such	JJ	amod
as	IN	prep
benzene	NN	compound
sulphonate	VBP	pobj
,	,	punct
in	IN	prep
order	NN	pobj
to	TO	aux
avoid	VB	acl
the	DT	det
Michael	NNP	compound
addition	NN	compound
reaction	NN	dobj
.	.	punct

thus	RB	advmod
,	,	punct
the	DT	det
fact	NN	nsubj
that	IN	mark
none	NN	nsubj
of	IN	prep
the	DT	det
anion	NNS	pobj
list	VBN	acl
in	IN	prep
the	DT	det
¡¬909	NN	nummod
patent	NN	pobj
have	VBP	acl
a	DT	det
cyclic	JJ	amod
structure	NN	dobj
be	VBZ	ROOT
hardly	RB	advmod
dispositive	JJ	acomp
to	IN	prep
the	DT	det
question	NN	pobj
of	IN	prep
whether	IN	mark
the	DT	det
skilled	JJ	amod
artisan	NN	nsubjpass
would	MD	aux
have	VB	aux
be	VBN	auxpass
motivate	VBN	pcomp
to	TO	aux
combine	VB	xcomp
the	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	dobj
to	TO	aux
achieve	VB	advcl
amlodipine	JJ	compound
besylate	NN	dobj
.	.	punct

  	_SP	

-PRON-	PRP	nsubjpass
similarly	RB	advmod
be	VBP	auxpass
not	RB	neg
persuade	VBN	ROOT
by	IN	agent
Pfizer	NNP	poss
's	POS	case
second	JJ	amod
argument	NN	pobj
,	,	punct
as	RB	advmod
clear	JJ	advmod
and	CC	cc
convincing	JJ	conj
evidence	NN	dobj

show	VBZ	ROOT
that	IN	mark
a	DT	det
skilled	JJ	amod
artisan	NN	nsubjpass
would	MD	aux
have	VB	aux
be	VBN	auxpass
motivate	VBN	ccomp
to	TO	aux
combine	VB	xcomp
the	DT	det
¡¬909	JJR	nummod
patent	NN	dobj
and	CC	cc
Berge	NNP	conj
to	TO	aux
make	VB	advcl
amlodipine	JJ	compound
besylate	NN	dobj
.	.	punct

Pfizer	NNP	poss
's	POS	case
expert	NN	nsubj
,	,	punct
Dr.	NNP	compound
Anderson	NNP	appos
,	,	punct
testify	VBD	ROOT
that	IN	mark
there	EX	expl
be	VBD	ccomp
an	DT	det
unlimited	JJ	amod
number	NN	attr
of	IN	prep
anion	NNS	pobj
,	,	punct
many	DT	nsubjpass
of	IN	prep
which	WDT	pobj
could	MD	aux
be	VB	auxpass
use	VBN	relcl
to	TO	aux
form	VB	xcomp
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NNS	dobj
.	.	punct

yet	RB	advmod
a	DT	det
reasonable	JJ	amod
fact	NN	compound
-	HYPH	punct
finder	NN	nsubj
could	MD	aux
not	RB	neg
accept	VB	ROOT
Dr.	NNP	compound
Anderson	NNP	poss
's	POS	case
testimony	NN	dobj
that	IN	mark
the	DT	det
number	NN	nsubj
of	IN	prep
acceptable	JJ	amod
anion	NNS	pobj
be	VBD	acl
"	``	punct
unlimited	JJ	acomp
"	''	punct
.	.	punct

of	RB	advmod
course	RB	advmod
,	,	punct
new	JJ	amod
salt	NNS	nsubjpass
can	MD	aux
always	RB	advmod
be	VB	auxpass
make	VBN	ROOT
or	CC	cc
attempt	VBN	conj
.	.	punct

however	RB	advmod
,	,	punct
irrefutable	JJ	amod
evidence	NN	nsubj
show	VBZ	ROOT
that	IN	mark
a	DT	det
skilled	JJ	amod
chemist	NN	nsubj
at	IN	prep
the	DT	det
time	NN	pobj
would	MD	aux
simply	RB	advmod
make	VB	ccomp
know	VBN	amod
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
salt	NNS	dobj
of	IN	prep
whatever	WDT	det
active	JJ	amod
ingredient	NN	pobj
with	IN	prep
which	WDT	pobj
-PRON-	PRP	nsubj
or	CC	cc
-PRON-	PRP	conj
be	VBD	aux
work	VBG	relcl
at	IN	prep
the	DT	det
time	NN	pobj
.	.	punct

indeed	RB	advmod
,	,	punct
Mr.	NNP	compound
Davison	NNP	nsubj
,	,	punct
an	DT	det
inventor	NN	appos
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
,	,	punct
testify	VBD	ROOT
that	IN	mark
-PRON-	PRP	nsubj
"	``	punct
would	MD	aux
have	VB	aux
be	VBN	ccomp
a	DT	det
mistake	NN	attr
"	''	punct
to	TO	aux
choose	VB	advcl
a	DT	det
novel	JJ	amod
anion	NN	dobj
.	.	punct

rather	RB	advmod
,	,	punct
"	``	punct
part	NN	nsubj
and	CC	cc
parcel	NN	conj
of	IN	prep
pharmaceutically	RB	advmod
accept	VBN	pcomp
[	-LRB-	punct
]	-RRB-	punct
be	VBD	ROOT
to	TO	aux
look	VB	xcomp
in	IN	prep
pharmacopoeia	NNS	pobj
and	CC	cc
compendia	NN	conj
"	''	punct
to	TO	aux
find	VB	advcl
an	DT	det
anion	NN	dobj
have	VBG	acl
"	``	punct
precedence	NN	dobj
for	IN	prep
use	NN	pobj
within	IN	prep
the	DT	det
pharmaceutical	NN	compound
industry	NN	pobj
"	''	punct
.	.	punct

Dr.	NNP	compound
Anderson	NNP	nsubj
similarly	RB	advmod
admit	VBD	ROOT
in	IN	prep
-PRON-	PRP$	poss
testimony	NN	pobj
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
logical	JJ	acomp
to	TO	aux
use	VB	xcomp
Berge	NNP	poss
's	POS	case
list	NN	dobj
of	IN	prep
FDA	NNP	npadvmod
-	HYPH	punct
approve	VBN	amod
anion	NNS	pobj
to	TO	aux
produce	VB	xcomp
a	DT	det
drug	NN	compound
formulation	NN	dobj
:	:	punct

 	_SP	

court	NN	ROOT
:	:	punct

what	WP	dep
if	IN	mark
-PRON-	PRP	nsubj
sic	VBP	ROOT
-PRON-	PRP$	poss
phalanx	NN	dobj
of	IN	prep
zealous	JJ	amod
scientist	NNS	pobj
on	IN	prep
that	DT	det
list	NN	pobj
and	CC	cc
then	RB	advmod
come	VB	conj
up	RP	prt
with	IN	prep
a	DT	det
product	NN	pobj
.	.	punct

Would	MD	aux
that	DT	nsubj
be	VB	ROOT
a	DT	det
logical	JJ	amod
thing	NN	attr
for	IN	mark
-PRON-	PRP	nsubj
to	TO	aux
do	VB	relcl
?	.	punct

the	DT	det
witness	NN	ROOT
:	:	punct
-PRON-	PRP	nsubj
would	MD	aux
be	VB	acl
logical	JJ	acomp
to	TO	aux
try	VB	xcomp
that	DT	dobj
.	.	punct

 	_SP	

This	DT	nsubj
be	VBZ	ROOT
true	JJ	acomp
especially	RB	advmod
give	VBN	prep
the	DT	det
fact	NN	pobj
that	IN	mark
the	DT	det
genus	NN	nsubj
of	IN	prep
FDA	NNP	npadvmod
-	HYPH	punct
approve	VBN	amod
anion	NNS	pobj
at	IN	prep
the	DT	det
time	NN	pobj
be	VBD	acl
small	JJ	acomp
,	,	punct
i.e.	FW	advmod
,	,	punct
only	RB	advmod
53	CD	attr
.	.	punct

that	DT	det
benzene	NN	compound
sulphonate	NN	nsubjpass
be	VBD	auxpass
only	RB	advmod
use	VBN	ROOT
in	IN	prep
create	VBG	pcomp
0.25	CD	nummod
%	NN	dobj
of	IN	prep
FDA	NNP	npadvmod
-	HYPH	punct
approve	VBN	amod
drug	NNS	pobj
be	VBZ	conj
not	RB	neg
highly	RB	advmod
probative	JJ	acomp
,	,	punct
much	RB	advmod
less	RBR	advmod
dispositive	JJ	conj
.	.	punct

indeed	RB	advmod
,	,	punct
beyond	IN	prep
hydrochloride	NN	pobj
,	,	punct
which	WDT	nsubjpass
be	VBD	auxpass
use	VBN	relcl
in	IN	prep
approximately	RB	advmod
43	CD	nummod
%	NN	pobj
of	IN	prep
approve	VBN	amod
drug	NNS	pobj
,	,	punct
almost	RB	advmod
all	DT	nummod
other	JJ	amod
salt	NNS	nsubjpass
could	MD	aux
be	VB	auxpass
characterize	VBN	ROOT
as	IN	mark
"	``	punct
rarely	RB	advmod
use	VBD	advcl
"	''	punct
.	.	punct

see	VB	ROOT
Berge	NNP	dobj
,	,	punct
Table	NNP	appos
1	CD	nummod
(	-LRB-	punct
show	VBG	advcl
that	IN	mark
40	CD	nsubjpass
out	IN	advmod
of	IN	prep
53	CD	nummod
anion	NNS	pobj
be	VBD	auxpass
use	VBN	ccomp
in	IN	prep
less	JJR	amod
than	IN	quantmod
1	CD	nummod
%	NN	pobj
of	IN	prep
drug	NNS	pobj
and	CC	cc
23	CD	nsubjpass
out	IN	prep
of	IN	prep
53	CD	pobj
be	VBD	auxpass
use	VBN	ccomp
in	IN	prep
0.25	CD	nummod
%	NN	pobj
or	CC	cc
less	JJR	nummod
of	IN	prep
drug	NNS	pobj
)	-RRB-	punct
.	.	punct

 	_SP	

but	CC	cc
the	DT	det
outcome	NN	nsubj
of	IN	prep
this	DT	det
case	NN	pobj
nee	MD	aux
not	RB	neg
rest	VB	ROOT
heavily	RB	advmod
on	IN	prep
the	DT	det
size	NN	pobj
of	IN	prep
the	DT	det
genus	NN	pobj
of	IN	prep
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
anion	NNS	pobj
disclose	VBN	acl
by	IN	agent
Berge	NNP	pobj
because	IN	mark
clear	JJ	nsubj
and	CC	cc
convincing	JJ	conj
evidence	NN	dobj
establish	VBZ	advcl
that	IN	mark
,	,	punct
out	IN	prep
of	IN	prep
the	DT	det
list	NN	pobj
of	IN	prep
53	CD	nummod
anion	NNS	pobj
,	,	punct
one	CD	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	aux
favorably	RB	advmod
consider	VBN	ccomp
benzene	NN	compound
sulphonate	JJ	oprd
because	IN	prep
of	IN	pcomp
-PRON-	PRP$	poss
known	JJ	amod
acid	NN	compound
strength	NN	pobj
,	,	punct
solubility	NN	conj
,	,	punct
and	CC	cc
other	JJ	amod
known	JJ	amod
chemical	NN	compound
characteristic	NNS	conj
as	IN	mark
report	VBN	advcl
in	IN	prep
several	JJ	amod
other	JJ	amod
publication	NNS	pobj
Pfizer	NNP	nsubj
have	VBZ	aux
admit	VBN	relcl
be	VBP	advcl
prior	JJ	amod
art	NN	attr
.	.	punct

Schmidt	NNP	nsubj
disclose	VBZ	ROOT
that	IN	det
aryl	NN	nmod
sulphonic	JJ	amod
acid	NNS	dobj
,	,	punct
such	JJ	amod
as	IN	prep
benzene	NN	amod
sulphonic	JJ	amod
acid	NNS	pobj
,	,	punct
considerably	RB	advmod
increase	VB	conj
the	DT	det
solubility	NN	dobj
of	IN	prep
pharmaceutical	NNS	pobj
contain	VBG	acl
one	CD	dobj
or	CC	cc
more	RBR	conj
basically	RB	advmod
react	VBG	advcl
nitrogen	NN	compound
atom	NNS	dobj
.	.	punct

¡¬612	NN	nummod
patent	NN	compound
col.2	NN	ROOT

ll.14	NNP	advmod
-	HYPH	punct
41	CD	ROOT
.	.	punct

Spiegel	NNP	nsubj
specifically	RB	advmod
identifie	NNS	nsubj
besylate	VBP	ROOT
as	IN	prep
the	DT	det
prefer	VBN	amod
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NN	compound
form	NN	pobj
of	IN	prep
a	DT	det
pharmaceutical	NN	amod
compound	NN	pobj
.	.	punct
¡¬637	JJ	compound
patent	NN	compound
col.2	NN	npadvmod

ll.38	NN	ROOT
-	HYPH	punct
39	CD	nummod
.	.	punct

other	JJ	amod
patent	NNS	nsubj
not	RB	neg
before	IN	prep
the	DT	det
examiner	NN	pobj
during	IN	prep
prosecution	NN	pobj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
also	RB	advmod
point	VBP	ROOT
to	TO	prep
benzene	VB	compound
sulphonate	NN	pobj
.	.	punct

U.S.	NNP	compound
patent	NN	nsubj
3,970,662	CD	nummod
to	IN	prep
Carabateas	NNP	pobj
(	-LRB-	punct
1976	CD	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
Carabateas	NNP	appos
"	''	punct
)	-RRB-	punct
disclose	VBZ	ROOT
an	DT	det
intermediate	JJ	amod
dihydropyridine	NN	compound
compound	NN	dobj
useful	JJ	amod
in	IN	prep
the	DT	det
form	NN	pobj
of	IN	prep
an	DT	det
acid	JJ	compound
addition	NN	compound
salt	NN	pobj
derive	VBN	acl
from	IN	prep
benzene	NN	compound
sulphonate	NN	pobj
.	.	punct

¡¬662	NN	nummod
patent	NN	compound
col.3	NN	ROOT

ll.35	NN	dep
-	:	punct
49	CD	nummod
&	CC	cc
col.4	NN	conj
ll.20	NN	npadvmod
-	HYPH	punct
24	CD	ROOT
.	.	punct

U.S.	NNP	compound
patent	NN	nsubj
4,432,987	CD	nummod
to	IN	prep
Barth	NNP	pobj
(	-LRB-	punct
1984	CD	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
Barth	NNP	appos
"	''	punct
)	-RRB-	punct
,	,	punct
assign	VBN	acl
to	IN	prep
Pfizer	NNP	pobj
,	,	punct
disclose	VBZ	ROOT
the	DT	det
besylate	NN	compound
acid	NN	compound
addition	NN	compound
salt	NN	compound
form	NN	dobj
of	IN	prep
a	DT	det
pharmaceutical	JJ	amod
composition	NN	pobj
have	VBG	acl
excellent	JJ	amod
pharmacokinetic	JJ	amod
property	NNS	dobj
,	,	punct
near	IN	advmod
-	HYPH	punct
optimal	JJ	amod
solubility	NN	conj
,	,	punct
and	CC	cc
improve	VBN	amod
stability	NN	conj
.	.	punct

¡¬987	NNS	amod
patent	NN	compound
col.2	NN	ROOT

ll.45	NN	compound
-	HYPH	punct
46	CD	ROOT
.	.	punct

take	VBN	advcl
together	RB	advmod
,	,	punct
these	DT	det
reference	NNS	nsubj
provide	VBP	ROOT
ample	JJ	amod
motivation	NN	dobj
to	TO	aux
narrow	VB	acl
the	DT	det
genus	NN	dobj
of	IN	prep
53	CD	nummod
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
anion	NNS	pobj
disclose	VBN	acl
by	IN	agent
Berge	NNP	pobj
to	IN	prep
a	DT	det
few	JJ	pobj
,	,	punct
include	VBG	prep
benzene	NN	compound
sulphonate	VBP	pobj
.	.	punct

 	_SP	

the	DT	det
district	NN	compound
court	NN	nsubj
ignore	VBD	ROOT
the	DT	det
significance	NN	dobj
of	IN	prep
these	DT	det
other	JJ	amod
prior	JJ	amod
art	NN	compound
reference	NNS	pobj
suggest	VBG	acl
the	DT	det
besylate	NN	compound
salt	NN	dobj
because	IN	mark
the	DT	det
pharmaceutical	NNS	nsubj
disclose	VBN	advcl
in	IN	prep
those	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	pobj
be	VBD	auxpass
not	RB	neg
describe	VBN	advcl
as	IN	prep
useful	JJ	amod
to	TO	aux
treat	VB	advcl
hypertension	NN	dobj
or	CC	cc
angina	NN	conj
,	,	punct
as	IN	mark
be	VBZ	advcl
amlodipine	JJ	acomp
.	.	punct

By	IN	prep
not	RB	neg
consider	VBG	pcomp
these	DT	det
reference	NNS	dobj
in	IN	prep
-PRON-	PRP$	poss
obviousness	JJ	amod
analysis	NN	pobj
,	,	punct
however	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
clearly	RB	advmod
err	VBD	ROOT
.	.	punct

As	IN	prep
here	RB	pcomp
,	,	punct
the	DT	det
besylate	NN	compound
acid	NN	compound
addition	NN	compound
salt	NN	compound
form	NN	nsubjpass
be	VBD	auxpass
describe	VBN	ROOT
in	IN	prep
these	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	pobj
as	IN	prep
useful	JJ	amod
in	IN	prep
promote	VBG	pcomp
stability	NN	dobj
and	CC	cc
solubility	NN	conj
,	,	punct
as	RB	advmod
well	RB	advmod
as	IN	cc
improve	VBG	conj
other	JJ	amod
physicochemical	JJ	amod
characteristic	NNS	dobj
.	.	punct

that	IN	mark
none	NN	nsubj
of	IN	prep
these	DT	det
reference	NNS	pobj
disclose	VBZ	csubj
a	DT	det
medication	NN	dobj
for	IN	prep
treat	VBG	pcomp
hypertension	NN	dobj
or	CC	cc
angina	NN	conj
like	IN	prep
amlodipine	NN	pobj
be	VBZ	ROOT
therefore	RB	advmod
unimportant	JJ	acomp
,	,	punct
if	IN	mark
not	RB	neg
actually	RB	advmod
irrelevant	JJ	advcl
.	.	punct

As	IN	mark
Pfizer	NNP	nsubj
concede	VBZ	advcl
,	,	punct
the	DT	det
besylate	NN	compound
part	NN	nsubj
of	IN	prep
the	DT	det
acid	JJ	compound
addition	NN	compound
salt	NN	pobj
have	VBZ	ROOT
no	DT	det
therapeutic	JJ	amod
effect	NN	dobj
,	,	punct
but	CC	cc
merely	RB	advmod
serve	VBZ	conj
as	IN	prep
a	DT	det
means	NN	pobj
to	TO	aux
deliver	VB	acl
the	DT	det
amlodipine	JJ	compound
part	NN	dobj
of	IN	prep
the	DT	det
molecule	NN	pobj
to	IN	prep
the	DT	det
body	NN	pobj
.	.	punct

prior	JJ	amod
art	NN	nsubj
disclose	VBG	acl
the	DT	det
use	NN	dobj
of	IN	prep
benzene	NN	compound
sulphonate	NN	pobj
for	IN	prep
improve	VBG	pcomp
the	DT	det
bioavailability	NN	dobj
of	IN	prep
other	JJ	amod
pharmaceutical	NNS	pobj
-	,	punct
especially	RB	advmod
a	DT	det
dihydropyridine	NN	appos
as	IN	mark
disclose	VBN	advcl
by	IN	agent
Carabateas	NNP	pobj
-	,	punct
be	VBZ	ROOT
therefore	RB	advmod
highly	RB	advmod
relevant	JJ	acomp
in	IN	prep
weigh	VBG	pcomp
the	DT	det
factor	NNS	dobj
relate	VBG	acl
to	IN	prep
obviousness	JJ	pobj
.	.	punct

 	_SP	

consider	VBG	advcl
all	DT	dobj
of	IN	prep
the	DT	det
evidence	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
hold	VBP	ROOT
that	IN	mark
a	DT	det
reasonable	JJ	amod
fact	NN	compound
-	HYPH	punct
finder	NN	nsubj
could	MD	aux
only	RB	advmod
conclude	VB	ccomp
that	IN	mark
Apotex	NNP	nsubj
indeed	RB	advmod
produce	VBD	ccomp
clear	JJ	advmod
and	CC	cc
convincing	JJ	conj
evidence	NN	dobj
that	IN	mark
one	CD	nsubj
skilled	JJ	acl
in	IN	prep
the	DT	det
art	NN	pobj
,	,	punct
face	VBG	advcl
the	DT	det
problem	NNS	dobj
include	VBG	prep
the	DT	det
stickiness	NN	pobj
of	IN	prep
the	DT	det
tablet	NN	compound
form	NN	pobj
of	IN	prep
the	DT	det
maleate	JJ	compound
acid	NN	compound
addition	NN	compound
salt	NN	pobj
,	,	punct
would	MD	aux
have	VB	aux
be	VBN	auxpass
motivate	VBN	ccomp
to	TO	aux
combine	VB	xcomp
the	DT	det
teaching	NNS	dobj
of	IN	prep
the	DT	det
¡¬909	JJR	nummod
patent	NN	pobj
,	,	punct
Berge	NNP	conj
,	,	punct
and	CC	cc
other	JJ	amod
prior	JJ	amod
art	NN	conj
,	,	punct
to	TO	aux
produce	VB	conj
the	DT	det
besylate	NN	compound
salt	NN	dobj
of	IN	prep
amlodipine	NN	pobj
.	.	punct

 	_SP	

reasonable	JJ	amod
expectation	NN	ROOT
of	IN	prep
Success	NNP	pobj

  	_SP	

As	IN	mark
note	VBN	advcl
above	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
the	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
have	VB	aux
have	VBN	ccomp
no	DT	det
expectation	NN	dobj
of	IN	prep
success	NN	pobj
in	IN	prep
make	VBG	pcomp
a	DT	det
besylate	NN	compound
salt	NN	dobj
of	IN	prep
amlodipine	NN	pobj
because	IN	mark
there	EX	expl
be	VBD	advcl
no	DT	det
reliable	JJ	amod
way	NN	attr
to	TO	aux
predict	VB	relcl
the	DT	det
influence	NN	dobj
of	IN	prep
a	DT	det
particular	JJ	amod
salt	NN	compound
specie	NNS	pobj
on	IN	prep
the	DT	det
active	JJ	amod
part	NN	pobj
of	IN	prep
the	DT	det
compound	NN	pobj
.	.	punct

-PRON-	PRP	nsubj
can	MD	aux
not	RB	neg
reject	VB	ROOT
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
finding	NN	dobj
that	IN	mark
in	IN	prep
1986	CD	pobj
,	,	punct
-PRON-	PRP	nsubj
be	VBD	acl
generally	RB	advmod
unpredictable	JJ	acomp
as	IN	prep
to	IN	prep
whether	IN	mark
a	DT	det
particular	JJ	amod
salt	NN	nsubj
would	MD	aux
form	VB	pcomp
and	CC	cc
what	WP	attr
-PRON-	PRP$	poss
exact	JJ	amod
property	NNS	nsubj
would	MD	aux
be	VB	conj
.	.	punct

the	DT	det
problem	NN	nsubj
with	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
ultimate	JJ	amod
conclusion	NN	pobj
of	IN	prep
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	pobj
base	VBN	acl
on	IN	prep
that	DT	det
factual	JJ	amod
finding	NN	pobj
,	,	punct
however	RB	advmod
,	,	punct
be	VBZ	ROOT
that	DT	mark
case	NN	compound
law	NN	nsubj
be	VBZ	ccomp
clear	JJ	acomp
that	IN	mark
obviousness	NN	nsubjpass
can	MD	aux
not	RB	neg
be	VB	auxpass
avoid	VBN	ccomp
simply	RB	advmod
by	IN	agent
a	DT	det
showing	NN	pobj
of	IN	prep
some	DT	det
degree	NN	pobj
of	IN	prep
unpredictability	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
so	RB	advmod
long	RB	advmod
as	IN	mark
there	EX	expl
be	VBD	advcl
a	DT	det
reasonable	JJ	amod
probability	NN	attr
of	IN	prep
success	NN	pobj
.	.	punct

see	VB	ROOT

In	IN	prep
re	IN	pobj
Corkill	NNP	pobj
,	,	punct
771	CD	nummod
f.2d	CD	nummod
1496	CD	nummod
,	,	punct
1500	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1985	LS	ROOT
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
Although	IN	mark
[	-LRB-	punct
the	DT	det
inventor	NN	nsubj
]	-RRB-	punct
declare	VBD	advcl
that	IN	mark
-PRON-	PRP	nsubjpass
can	MD	aux
not	RB	neg
be	VB	auxpass
predict	VBN	ccomp
how	WRB	advmod
any	DT	det
candidate	NN	nsubj
will	MD	aux
work	VB	ccomp
in	IN	prep
a	DT	det
detergent	NN	compound
composition	NN	pobj
,	,	punct
but	CC	cc
that	IN	mark
-PRON-	PRP	nsubjpass
must	MD	aux
be	VB	auxpass
test	VBN	conj
,	,	punct
this	DT	nsubj
do	VBZ	aux
not	RB	neg
overcome	VB	acl
[	-LRB-	punct
the	DT	det
prior	JJ	amod
art	NN	dobj
's	POS	case
]	-RRB-	punct
teaching	NN	advcl
that	WDT	mark
hydrate	VBD	amod
zeolite	NNS	nsubj
will	MD	aux
work	VB	ccomp
"	''	punct
.	.	punct
)	-RRB-	punct
;	:	punct
see	VB	appos
also	RB	advmod
Brown	NNP	attr
&	CC	cc
Williamson	NNP	compound
Tobacco	NNP	compound
Corp.	NNP	conj
v.	IN	cc
Philip	NNP	compound
Morris	NNP	compound
Inc.	NNP	pobj
,	,	punct
229	CD	nummod
f.3d	CD	appos
1120	CD	nummod
,	,	punct
1125	CD	appos
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.2000	LS	appos
)	-RRB-	punct
;	:	punct
Merck	NNP	conj
&	CC	cc
Co.	NNP	conj
,	,	punct
Inc.	NNP	conj
v.	CC	prep

Biocraft	NNP	nmod
Labs.	NNP	nmod
,	,	punct
Inc.	NNP	ROOT
,	,	punct
874	CD	nummod
f.2d	CD	compound
804	CD	appos
,	,	punct
809	CD	nummod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1989	LS	appos
)	-RRB-	punct
;	.	punct

In	IN	ROOT
re	IN	pobj
Merck	NNP	pobj
&	CC	cc
Co.	NNP	conj
,	,	punct
Inc.	NNP	appos
,	,	punct
800	CD	nummod
f.2d	CD	appos
1091	CD	nummod
,	,	punct
1097	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1986	NN	pobj
)	-RRB-	punct
.	.	punct

indeed	RB	advmod
,	,	punct
a	DT	det
rule	NN	nsubj
of	IN	prep
law	NN	pobj
equating	NN	advcl
unpredictability	NN	dobj
to	IN	prep
patentability	NN	pobj
,	,	punct
apply	VBN	conj
in	IN	prep
this	DT	det
case	NN	pobj
,	,	punct
would	MD	aux
mean	VB	ROOT
that	IN	mark
any	DT	det
new	JJ	amod
salt	NN	nsubj
-	,	punct
include	VBG	prep
those	DT	pobj
specifically	RB	advmod
list	VBN	acl
in	IN	prep
the	DT	det
¡¬909	NN	nummod
patent	NN	pobj
-PRON-	PRP	appos
-	:	punct
would	MD	aux
be	VB	ccomp
separately	RB	advmod
patentable	JJ	acomp
,	,	punct
simply	RB	advmod
because	IN	mark
the	DT	det
formation	NN	nsubjpass
and	CC	cc
property	NNS	conj
of	IN	prep
each	DT	det
salt	NN	pobj
must	MD	aux
be	VB	auxpass
verify	VBN	advcl
through	IN	prep
testing	NN	pobj
.	.	punct

This	DT	nsubj
can	MD	aux
not	RB	neg
be	VB	ROOT
the	DT	det
proper	JJ	amod
standard	NN	attr
since	IN	mark
the	DT	det
expectation	NN	nsubj
of	IN	prep
success	NN	pobj
need	VBP	acl
only	RB	advmod
be	VB	advcl
reasonable	JJ	amod
,	,	punct
not	RB	neg
absolute	JJ	acomp
.	.	punct

Merck	NNP	ROOT
,	,	punct
874	CD	nummod
f.2d	CD	appos
at	IN	prep
809	CD	pobj
;	:	punct
In	IN	pobj
re	NN	pobj
O'Farrell	NNP	pobj
,	,	punct
853	CD	nummod
f.2d	CD	nummod
894	CD	pobj
,	,	punct
903	CD	nummod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1988	CD	appos
)	-RRB-	punct
.	.	punct

  	_SP	

the	DT	det
evidence	NN	nsubj
would	MD	aux
convince	VB	ROOT
a	DT	det
reasonable	JJ	amod
finder	NN	dobj
of	IN	prep
fact	NN	pobj
that	IN	mark
the	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
have	VB	aux
have	VBN	acl
that	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
that	WDT	mark
an	DT	det
acid	NN	compound
addition	NN	compound
salt	NN	nsubj
of	IN	prep
besylate	NN	pobj
would	MD	aux
form	VB	relcl
and	CC	cc
would	MD	aux
work	VB	conj
for	IN	prep
-PRON-	PRP$	poss
intended	JJ	amod
purpose	NN	pobj
.	.	punct

see	VB	ROOT

In	IN	ROOT
re	IN	pobj
Rinehart	NNP	pobj
,	,	punct
531	CD	nummod
f.2d	CD	nummod
1048	CD	appos
,	,	punct
1053	CD	npadvmod
-	SYM	punct
54	CD	prep
(	-LRB-	punct
C.C.P.A.1976	NNP	appos
)	-RRB-	punct
.	.	punct

specifically	RB	advmod
,	,	punct
the	DT	det
evidence	NN	nsubj
clearly	RB	advmod
show	VBZ	ROOT
that	IN	mark
as	RB	advmod
soon	RB	advmod
as	IN	mark
tablet	NN	compound
processing	NN	compound
problem	NNS	nsubj
arise	VBD	advcl
with	IN	prep
the	DT	det
amlodipine	JJ	compound
maleate	JJ	compound
tablet	NN	compound
formulation	NNS	pobj
,	,	punct
Dr.	NNP	compound
Wells	NNP	nsubj
readily	RB	advmod
compile	VBD	ccomp
a	DT	det
list	NN	dobj
of	IN	prep
seven	CD	nummod
alternative	JJ	amod
anion	NNS	pobj
-	,	punct
include	VBG	prep
the	DT	det
besylate	NN	pobj
-	:	punct
each	DT	nsubj
of	IN	prep
which	WDT	pobj
-PRON-	PRP	nsubj
expect	VBD	relcl
would	MD	aux
form	VB	relcl
an	DT	det
amlodipine	JJ	compound
acid	NN	compound
addition	NN	compound
salt	NN	dobj
:	:	punct

 	_SP	

Q.	NNP	ROOT

and	CC	cc
one	CD	npadvmod
of	IN	prep
the	DT	det
reason	NNS	pobj
why	WRB	advmod
-PRON-	PRP	nsubj
choose	VBD	relcl
these	DT	det
various	JJ	amod
salt	NNS	dobj
[	-LRB-	punct
sic	NN	amod
]	-RRB-	punct
,	,	punct
or	CC	cc
suggest	VBD	conj
these	DT	det
various	JJ	amod
salt	NNS	dobj
[	-LRB-	punct
sic	NN	advmod
]	-RRB-	punct
,	,	punct
be	VBZ	ROOT
because	IN	mark
-PRON-	PRP	nsubj
expect	VBD	advcl
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
be	VB	ccomp
able	JJ	acomp
to	TO	aux
make	VB	xcomp
a	DT	det
salt	NN	dobj
of	IN	prep
-PRON-	PRP	pobj
,	,	punct
correct	JJ	acomp
?	.	punct

 	_SP	

a.	NN	ROOT

there	EX	expl
be	VBD	ROOT
an	DT	det
expectation	NN	attr
,	,	punct
but	CC	cc
that	DT	nsubjpass
be	VBD	auxpass
not	RB	neg
guarantee	VBN	conj
.	.	punct

 	_SP	

but	CC	cc
,	,	punct
once	RB	advmod
again	RB	advmod
,	,	punct
only	RB	advmod
a	DT	det
reasonable	JJ	amod
expectation	NN	nsubjpass
of	IN	prep
success	NN	pobj
,	,	punct
not	RB	neg
a	DT	det
guarantee	NN	appos
,	,	punct
be	VBZ	auxpass
need	VBN	ROOT
.	.	punct

O'Farrell	NNP	ROOT
,	,	punct
853	CD	nummod
f.2d	CD	appos
at	IN	prep
903	CD	pobj
;	:	punct
Brown	NNP	conj
&	CC	cc
Williamson	NNP	conj
,	,	punct
229	CD	nummod
f.3d	CD	appos
at	IN	prep
1125	CD	pobj
.	.	punct

that	DT	det
reasonable	JJ	amod
expectation	NN	nsubjpass
of	IN	prep
success	NN	pobj
be	VBZ	auxpass
further	RBR	advmod
amply	RB	advmod
reflect	VBN	ROOT
in	IN	prep
Dr.	NNP	compound
Wells	NNP	poss
'	POS	case
further	JJ	amod
testimony	NN	pobj
that	IN	mark
-PRON-	PRP	nsubj
expect	VBD	ccomp
these	DT	det
seven	CD	nummod
amlodipine	JJ	compound
acid	NN	compound
addition	NN	compound
salt	NNS	nsubj
would	MD	aux
show	VB	ccomp
improve	VBN	amod
physicochemical	JJ	amod
characteristic	NNS	dobj
over	IN	prep
the	DT	det
maleate	JJ	compound
salt	NN	pobj
,	,	punct
include	VBG	prep
improve	VBN	amod
stability	NN	pobj
and	CC	cc
non	JJ	subtok
-	JJ	subtok
stickiness	JJ	punct
:	:	punct

 	_SP	

Q.	NNP	ROOT

and	CC	cc
when	WRB	advmod
-PRON-	PRP	nsubj
choose	VBD	advcl
these	DT	det
salt	NNS	dobj
...	NFP	punct
-PRON-	PRP	nsubj
believe	VBD	ROOT
that	IN	mark
if	IN	mark
-PRON-	PRP	nsubj
could	MD	aux
,	,	punct
in	IN	prep
fact	NN	pobj
,	,	punct
make	VB	advcl
an	DT	det
amlodipine	JJ	compound
salt	NN	dobj
out	IN	prep
of	IN	prep
-PRON-	PRP	pobj
,	,	punct
these	DT	nsubj
may	MD	aux
be	VB	ccomp
a	DT	det
cure	NN	attr
for	IN	prep
the	DT	det
problem	NNS	pobj
-PRON-	PRP	nsubj
be	VBD	aux
have	VBG	relcl
with	IN	prep
maleate	JJ	pobj
,	,	punct
correct	JJ	conj
?	.	punct

 	_SP	

-PRON-	PRP	nsubj
also	RB	advmod
note	VBP	ROOT
that	IN	mark
the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubj
place	VBD	ccomp
no	DT	det
limitation	NNS	dobj
on	IN	prep
the	DT	det
acid	NN	compound
addition	NN	compound
salt	NN	pobj
whatsoever	RB	advmod
,	,	punct
except	IN	prep
that	IN	mark
-PRON-	PRP	nsubj
be	VB	pcomp
non	JJ	subtok
-	JJ	subtok
toxic	JJ	acomp
and	CC	cc
form	VBN	conj
from	IN	prep
an	DT	det
acid	NN	pobj
contain	VBG	acl
a	DT	det
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
anion	NN	dobj
.	.	punct

accordingly	RB	advmod
,	,	punct
the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubj
contain	VBD	ROOT
a	DT	det
strong	JJ	amod
suggestion	NN	dobj
that	IN	mark
any	DT	nsubj
and	CC	cc
all	DT	det
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
anion	NNS	conj
would	MD	aux
form	VB	acl
non	JJ	subtok
-	JJ	subtok
toxic	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NNS	dobj
and	CC	cc
would	MD	aux
work	VB	conj
for	IN	prep
-PRON-	PRP$	poss
intend	VBN	amod
purpose	NN	pobj
-	:	punct
that	RB	advmod
is	RB	advmod
,	,	punct
to	TO	aux
improve	VB	advcl
bioavailability	NN	dobj
of	IN	prep
the	DT	det
active	JJ	amod
ingredient	NN	compound
amlodipine	NN	pobj
and	CC	cc
to	TO	aux
improve	VB	conj
handling	NN	dobj
and	CC	cc
storage	NN	conj
of	IN	prep
amlodipine	NN	pobj
.	.	punct

indeed	RB	advmod
,	,	punct
in	IN	prep
proceeding	NNS	pobj
before	IN	pobj
this	DT	det
court	NN	pobj
in	IN	prep
Pfizer	NNP	pobj
v.	IN	prep
Dr.	NNP	compound
Reddy	NNP	poss
's	POS	case
laboratory	NNS	pobj
involve	VBG	acl
the	DT	det
¡¬909	JJR	nummod
patent	NN	dobj
,	,	punct
Pfizer	NNP	nsubj
downplay	VBD	ROOT
any	DT	det
difference	NN	dobj
between	IN	prep
amlodipine	NN	compound
maleate	NN	pobj
and	CC	cc
any	DT	det
other	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NN	compound
form	NN	conj
of	IN	prep
amlodipine	NN	pobj
,	,	punct
include	VBG	prep
the	DT	det
besylate	NN	pobj
,	,	punct
prompt	VBG	advcl
this	DT	det
court	NN	dobj
to	TO	aux
observe	VB	xcomp
that	IN	mark
the	DT	det
sole	JJ	amod
active	JJ	amod
ingredient	NN	nsubj
be	VBZ	ccomp
amlodipine	JJ	attr
,	,	punct
and	CC	cc
that	IN	mark
-PRON-	PRP	nsubj
act	VBZ	conj
the	DT	det
same	JJ	dobj
in	IN	prep
the	DT	det
human	JJ	amod
body	NN	pobj
whether	IN	mark
administer	VBD	ccomp
as	IN	prep
a	DT	det
besylate	NN	compound
salt	NN	pobj
or	CC	cc
as	IN	conj
a	DT	det
maleate	JJ	compound
salt	NN	pobj
.	.	punct

359	CD	nummod
f.3d	CD	ROOT
at	IN	prep
1366	CD	pobj
.	.	punct

 	_SP	

finally	RB	advmod
,	,	punct
there	EX	expl
be	VBZ	ccomp
a	DT	det
suggestion	NN	attr
in	IN	prep
Pfizer	NNP	poss
's	POS	case
supplemental	JJ	amod
filing	NN	pobj
with	IN	prep
the	DT	det
FDA	NNP	pobj
that	IN	mark
-PRON-	PRP	nsubjpass
be	VBD	auxpass
know	VBN	acl
that	IN	mark
the	DT	det
besylate	NN	compound
salt	NN	nsubj
of	IN	prep
amlodipine	NN	pobj
would	MD	aux
work	VB	ccomp
for	IN	prep
-PRON-	PRP$	poss
intended	JJ	amod
purpose	NN	pobj
:	:	punct
"	``	punct
-PRON-	PRP	nsubj
feel	VBP	ROOT
that	IN	mark
the	DT	det
change	NN	nsubjpass
in	IN	prep
salt	NN	compound
form	NN	pobj
[	-LRB-	punct
from	IN	prep
maleate	NN	pobj
to	TO	aux
besylate	VB	relcl
]	-RRB-	punct
be	VBZ	auxpass
justify	VBN	ccomp
since	IN	mark
benzenesulfonate	NN	nsubj
be	VBZ	advcl
a	DT	det
commercially	RB	advmod
acceptable	JJ	amod
salt	NN	attr
,	,	punct
as	IN	mark
exemplify	VBN	advcl
by	IN	agent
the	DT	det
tranquilizer	NN	amod
mesoridazine	NN	pobj
(	-LRB-	punct
Serentil	NNP	appos
)	-RRB-	punct
.	.	punct
"	''	punct

thus	RB	advmod
,	,	punct
although	IN	mark
Dr.	NNP	compound
Wells	NNP	nsubj
testify	VBD	advcl
that	IN	mark
-PRON-	PRP	nsubjpass
be	VBD	auxpass
not	RB	neg
guarantee	VBN	ccomp
whether	IN	mark
amlodipine	JJ	compound
besylate	NN	nsubj
would	MD	aux
form	VB	ccomp
and	CC	cc
what	WP	attr
-PRON-	PRP$	poss
salient	NN	amod
characteristic	NNS	nsubj
would	MD	aux
be	VB	conj
,	,	punct
"	``	punct
this	DT	nsubj
do	VBZ	aux
not	RB	neg
overcome	VB	ROOT
[	-LRB-	punct
the	DT	det
prior	JJ	amod
art	NN	dobj
's	POS	case
]	-RRB-	punct
teach	VBG	advcl
that	IN	mark
[	-LRB-	punct
amlodipine	JJ	compound
besylate	NN	nsubj
]	-RRB-	punct
will	MD	aux
work	VB	ccomp
"	''	punct
.	.	punct

Corkill	NNP	ROOT
,	,	punct
771	CD	nummod
f.2d	CD	appos
at	IN	prep
1500	CD	pobj
.	.	punct

 	_SP	

consider	VBG	advcl
all	DT	dobj
of	IN	prep
the	DT	det
evidence	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
conclude	VBP	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
clearly	RB	advmod
err	VBD	ccomp
in	IN	prep
find	VBG	pcomp
that	DT	mark
Apotex	NNP	nsubj
fail	VBD	ccomp
to	TO	aux
produce	VB	xcomp
clear	JJ	advmod
and	CC	cc
convincing	JJ	conj
evidence	NN	dobj
that	IN	mark
one	CD	nsubj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	aux
have	VBN	acl
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
with	IN	prep
the	DT	det
besylate	NN	compound
salt	NN	pobj
of	IN	prep
amlodipine	NN	pobj
.	.	punct

  	_SP	

to	TO	aux
be	VB	advcl
sure	JJ	acomp
,	,	punct
"	''	punct
to	TO	aux
have	VB	advcl
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
,	,	punct
one	PRP	nsubjpass
must	MD	aux
be	VB	auxpass
motivate	VBN	ROOT
to	TO	aux
do	VB	xcomp
more	JJR	dobj
than	IN	prep
merely	RB	pcomp
to	TO	aux
vary	VB	advcl
all	DT	det
parameter	NNS	dobj
or	CC	cc
try	VB	conj
each	DT	dobj
of	IN	prep
numerous	JJ	amod
possible	JJ	amod
choice	NNS	pobj
until	IN	prep
one	CD	pobj
possibly	RB	advmod
arrive	VBD	acl
at	IN	prep
a	DT	det
successful	JJ	amod
result	NN	pobj
,	,	punct
where	WRB	advmod
the	DT	det
prior	JJ	amod
art	NN	nsubj
give	VBD	relcl
either	CC	preconj
no	DT	det
indication	NN	dobj
of	IN	prep
which	WDT	pobj
parameter	NNS	nsubj
be	VBD	relcl
critical	JJ	acomp
or	CC	cc
no	DT	det
direction	NN	conj
as	IN	mark
to	IN	prep
which	WDT	pobj
of	IN	prep
many	JJ	amod
possible	JJ	amod
choice	NNS	pobj
be	VBZ	advcl
likely	JJ	acomp
to	TO	aux
be	VB	xcomp
successful	JJ	acomp
"	''	punct
.	.	punct

Medichem	NNP	npadvmod
,	,	punct
S.A.	NNP	appos
v.	CC	prep
Rolabo	NNP	pobj
,	,	punct
S.L.	NNP	appos
,	,	punct
437	CD	nummod
f.3d	CD	appos
1157	CD	nummod
,	,	punct
1165	CD	conj
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.2006	ADD	appos
)	-RRB-	punct
(	-LRB-	punct
internal	JJ	amod
quotation	NNS	nsubj
omit	VBN	ROOT
)	-RRB-	punct
.	.	punct

Pfizer	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
,	,	punct
if	IN	mark
anything	NN	advcl
,	,	punct
amlodipine	VBP	csubj
in	IN	prep
-PRON-	PRP$	poss
besylate	NN	compound
salt	NN	compound
form	NN	pobj
would	MD	aux
at	IN	advmod
most	RBS	advmod
be	VB	ccomp
"	``	punct
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
,	,	punct
"	''	punct
i.e.	FW	advmod
,	,	punct
to	TO	aux
vary	VB	xcomp
all	DT	det
parameter	NNS	dobj
or	CC	cc
try	VB	conj
each	DT	dobj
of	IN	prep
numerous	JJ	amod
possible	JJ	amod
choice	NNS	pobj
to	TO	aux
see	VB	xcomp
if	IN	mark
a	DT	det
successful	JJ	amod
result	NN	nsubjpass
be	VBD	auxpass
obtain	VBN	ccomp
.	.	punct

O'Farrell	NNP	ROOT
,	,	punct
853	CD	nummod
f.2d	CD	appos
at	IN	prep
903	CD	pobj
.	.	punct

 	_SP	

party	NNS	nsubj
before	IN	mark
this	DT	det
court	NN	nsubj
often	RB	advmod
complain	VBP	ROOT
that	IN	mark
holding	NNS	nsubjpass
of	IN	prep
obviousness	JJ	pobj
be	VBD	auxpass
base	VBN	ccomp
on	IN	prep
the	DT	det
impermissible	JJ	amod
"	''	punct
obvious	JJ	pobj
to	TO	aux
try	VB	xcomp
"	``	punct
standard	NN	dobj
,	,	punct
and	CC	cc
this	DT	det
court	NN	nsubj
have	VBZ	aux
accordingly	RB	advmod
struggle	VBN	conj
to	TO	aux
strike	VB	xcomp
a	DT	det
balance	NN	dobj
between	IN	prep
the	DT	det
seemingly	RB	advmod
conflicting	JJ	amod
truism	NNS	pobj
that	IN	mark
,	,	punct
under	IN	quantmod
35	CD	advcl
u.s.c.	NN	npadvmod
¡±	CD	nummod
103	CD	nummod
,	,	punct
"	''	punct
obvious	JJ	csubj
to	TO	aux
try	VB	relcl
"	''	punct
be	VBZ	relcl
not	RB	neg
the	DT	det
proper	JJ	amod
standard	NN	attr
by	IN	prep
which	WDT	pobj
to	TO	aux
evaluate	VB	relcl
obviousness	JJ	dobj
,	,	punct

In	IN	ROOT
re	NN	compound
Antonie	NNP	pobj
,	,	punct
559	CD	nummod
f.2d	CD	nummod
618	CD	appos
,	,	punct
620	CD	appos
(	-LRB-	punct
C.C.P.A.1977	NNP	appos
)	-RRB-	punct
,	,	punct
but	CC	cc
that	IN	mark
,	,	punct
under	IN	prep
O'Farrell	NNP	pobj
and	CC	cc
other	JJ	amod
precedent	NN	conj
,	,	punct
absolute	JJ	amod
predictability	NN	nsubjpass
of	IN	prep
success	NN	pobj
be	VBZ	auxpass
not	RB	neg
require	VBN	conj
.	.	punct

853	CD	nummod
f.2d	CD	ROOT
at	IN	prep
903	CD	pobj
.	.	punct

reconcile	VBG	csubj
the	DT	det
two	CD	dobj
be	VBZ	ROOT
particularly	RB	advmod
germane	NN	acomp
to	IN	prep
a	DT	det
situation	NN	pobj
where	WRB	advmod
,	,	punct
as	IN	prep
here	RB	pcomp
,	,	punct
a	DT	det
formulation	NN	nsubjpass
must	MD	aux
be	VB	auxpass
test	VBN	relcl
by	IN	agent
routine	JJ	amod
procedure	NNS	pobj
to	TO	aux
verify	VB	advcl
-PRON-	PRP$	poss
expect	VBN	amod
property	NNS	dobj
.	.	punct

the	DT	det
question	NN	nsubj
become	VBZ	ccomp
then	RB	advmod
,	,	punct
when	WRB	advmod
the	DT	det
skilled	JJ	amod
artisan	NN	nsubj
must	MD	aux
test	VB	advcl
,	,	punct
how	WRB	advmod
far	RB	advmod
do	VBZ	aux
that	DT	nsubj
need	VB	ROOT
for	IN	prep
testing	NN	nsubj
go	VB	pcomp
toward	IN	prep
support	VBG	pcomp
a	DT	det
conclusion	NN	dobj
of	IN	prep
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	pobj
?	.	punct

  	_SP	

As	IN	mark
-PRON-	PRP	nsubj
have	VBP	aux
say	VBN	advcl
before	RB	advmod
,	,	punct
"	''	punct
every	DT	det
case	NN	nsubjpass
,	,	punct
particularly	RB	advmod
those	DT	appos
raise	VBG	acl
the	DT	det
issue	NN	dobj
of	IN	prep
obviousness	NN	pobj
under	IN	prep
section	NN	pobj
103	CD	nummod
,	,	punct
must	MD	aux
necessarily	RB	advmod
be	VB	auxpass
decide	VBN	ROOT
upon	IN	prep
-PRON-	PRP$	poss
own	JJ	amod
fact	NNS	pobj
"	''	punct
.	.	punct

In	IN	ROOT
re	IN	pobj
Jones	NNP	pobj
,	,	pobj
958	CD	nummod
f.2d	CD	nummod
347	CD	pobj
,	,	punct
350	CD	appos
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.1992	LS	appos
)	-RRB-	punct
.	.	punct

consequently	RB	advmod
,	,	punct
court	NNS	nsubj
can	MD	aux
not	RB	neg
decide	VB	ROOT
the	DT	det
obviousness	JJ	pobj
or	CC	cc
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	dobj
of	IN	prep
a	DT	det
patent	NN	compound
claim	NN	pobj
by	IN	prep
proxy	NN	pobj
.	.	punct

undue	JJ	amod
dependence	NN	nsubj
on	IN	prep
mechanical	JJ	amod
application	NN	pobj
of	IN	prep
a	DT	det
few	JJ	amod
maxim	NNS	pobj
of	IN	prep
law	NN	pobj
,	,	punct
such	JJ	amod
as	IN	prep
"	``	punct
obvious	JJ	pobj
to	TO	aux
try	VB	xcomp
,	,	punct
"	''	punct
that	WDT	nsubj
have	VBP	relcl
no	DT	det
bearing	NN	dobj
on	IN	prep
the	DT	det
fact	NNS	pobj
certainly	RB	advmod
invite	VBZ	ROOT
error	NN	dobj
as	IN	mark
decision	NNS	nsubjpass
on	IN	prep
obviousness	NN	pobj
must	MD	aux
be	VB	auxpass
narrowly	RB	advmod
tailor	VBN	advcl
to	IN	prep
the	DT	det
fact	NNS	pobj
of	IN	prep
each	DT	det
individual	JJ	amod
case	NN	pobj
.	.	punct

As	IN	mark
-PRON-	PRP	nsubj
state	VBD	advcl
in	IN	prep
DyStar	NNP	pobj
,	,	punct

 	_SP	
Obviousness	NNP	nsubj
be	VBZ	ROOT
a	DT	det
complicated	JJ	amod
subject	NN	attr
require	VBG	acl
sophisticated	JJ	amod
analysis	NN	dobj
,	,	punct
and	CC	cc
no	DT	det
single	JJ	amod
case	NN	nsubj
lay	VBZ	conj
out	RP	prt
all	DT	det
facet	NNS	dobj
of	IN	prep
the	DT	det
legal	JJ	amod
test	NN	pobj
.	.	punct
[	-LRB-	punct
there	EX	expl
be	VBZ	conj
]	-RRB-	punct
danger	NN	attr
inherent	JJ	amod
in	IN	prep
focus	VBG	pcomp
on	IN	prep
isolate	VBN	amod
dictum	NNS	pobj
rather	RB	advmod
than	IN	cc
glean	VBG	pcomp
the	DT	det
law	NN	dobj
of	IN	prep
a	DT	det
particular	JJ	amod
area	NN	pobj
from	IN	prep
careful	JJ	amod
reading	NN	pobj
of	IN	prep
the	DT	det
full	JJ	amod
text	NN	pobj
of	IN	prep
a	DT	det
group	NN	pobj
of	IN	prep
related	JJ	amod
precedent	NNS	pobj
for	IN	prep
all	DT	pobj
-PRON-	PRP	nsubj
say	VBP	relcl
that	DT	nsubj
be	VBZ	ccomp
dispositive	JJ	acomp
and	CC	cc
for	IN	conj
what	WP	dobj
-PRON-	PRP	nsubj
hold	VBP	pcomp
.	.	punct

when	WRB	advmod
party	NNS	nsubj
...	NFP	punct
do	VB	aux
not	RB	neg
engage	VB	advcl
in	IN	prep
such	JJ	amod
careful	JJ	amod
,	,	punct
candid	JJ	conj
,	,	punct
and	CC	cc
complete	VB	conj
legal	JJ	amod
analysis	NN	pobj
,	,	punct
much	JJ	amod
confusion	NN	nsubj
about	IN	prep
the	DT	det
law	NN	pobj
arise	VBZ	ROOT
and	CC	cc
,	,	punct
through	IN	prep
time	NN	pobj
,	,	punct
can	MD	aux
be	VB	auxpass
compound	VBN	conj
.	.	punct

 	_SP	

464	CD	nummod
f.3d	CD	ROOT
at	IN	prep
1367	CD	pobj
.	.	punct

On	IN	prep
the	DT	det
fact	NNS	pobj
of	IN	prep
this	DT	det
case	NN	pobj
,	,	punct
however	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
be	VBP	ROOT
satisfied	JJ	acomp
that	IN	mark
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	nsubj
show	VBZ	ccomp
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
not	RB	neg
merely	RB	advmod
obvious	JJ	acomp
to	TO	aux
try	VB	xcomp
benzene	NN	compound
sulphonate	VB	dobj
,	,	punct
but	CC	cc
would	MD	aux
have	VB	aux
be	VBN	conj
indeed	RB	advmod
obvious	JJ	acomp
to	TO	aux
make	VB	xcomp
amlodipine	JJ	compound
besylate	NN	dobj
.	.	punct

 	_SP	

first	RB	advmod
,	,	punct
this	DT	nsubj
be	VBZ	ROOT
not	RB	neg
the	DT	det
case	NN	attr
where	WRB	advmod
there	EX	expl
be	VBP	relcl
"	``	punct
numerous	JJ	amod
parameter	NNS	attr
"	''	punct
to	TO	aux
try	VB	relcl
.	.	punct

rather	RB	advmod
,	,	punct
the	DT	det
only	JJ	amod
parameter	RBR	nsubj
to	TO	aux
be	VB	relcl
vary	VBN	acomp
be	VBZ	ROOT
the	DT	det
anion	NN	attr
with	IN	prep
which	WDT	pobj
to	TO	aux
make	VB	relcl
the	DT	det
amlodipine	NN	nsubj
acid	NN	compound
addition	NN	compound
salt	NN	ccomp
.	.	punct

Although	IN	mark
-PRON-	PRP	nsubj
recognize	VBP	advcl
some	DT	det
degree	NN	dobj
of	IN	prep
unpredictability	NN	pobj
of	IN	prep
salt	NN	compound
formation	NN	pobj
,	,	punct
see	VB	ROOT
,	,	punct
e.g.	RB	advmod
,	,	punct
Sanofi	NNP	compound
-	HYPH	punct
Synthelabo	NNP	npadvmod
v.	CC	prep
Apotex	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
470	CD	nummod
f.3d	CD	appos
1368	CD	nummod
,	,	punct
1379	CD	appos
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.2006	LS	appos
)	-RRB-	punct
,	,	punct

the	DT	det
mere	JJ	amod
possibility	NN	nsubj
that	IN	mark
some	DT	det
salt	NNS	nsubj
may	MD	aux
not	RB	neg
form	VB	acl
do	VBZ	aux
not	RB	neg
demand	VB	ROOT
a	DT	det
conclusion	NN	dobj
that	IN	mark
those	DT	nsubj
that	WDT	nsubj
do	VBP	relcl
be	VBP	acl
necessarily	RB	advmod
non	JJ	subtok
-	JJ	subtok
obvious	JJ	acomp
.	.	punct

This	DT	nsubj
be	VBZ	ccomp
especially	RB	advmod
true	JJ	acomp
here	RB	advmod
,	,	punct
where	WRB	advmod
(	-LRB-	punct
1	LS	meta
)	-RRB-	punct
as	IN	mark
note	VBN	advcl
above	RB	advmod
,	,	punct
the	DT	det
skilled	JJ	amod
artisan	NN	nsubj
have	VBD	ccomp
a	DT	advmod
reasonable	JJ	amod
(	-LRB-	punct
although	IN	mark
not	RB	neg
guarantee	VBN	parataxis
)	-RRB-	punct
expectation	NN	dobj
that	IN	mark
amlodipine	JJ	compound
besylate	NN	nsubj
would	MD	aux
form	VB	relcl
;	,	punct
(	-LRB-	punct
2	LS	meta
)	-RRB-	punct
Pfizer	NNP	nsubj
concede	VBD	ROOT
in	IN	prep
prior	JJ	amod
litigation	NN	pobj
that	IN	mark
the	DT	det
type	NN	nsubj
of	IN	prep
salt	NN	pobj
have	VBD	ccomp
no	DT	det
effect	NN	dobj
on	IN	prep
the	DT	det
therapeutic	JJ	amod
effect	NN	pobj
of	IN	prep
the	DT	det
active	JJ	amod
ingredient	NN	pobj
,	,	punct
amlodipine	NN	conj
,	,	punct
and	CC	cc
be	VBD	conj
practically	RB	advmod
interchangeable	JJ	acomp
,	,	punct
Pfizer	NNP	nsubj
v.	IN	prep
Dr.	NNP	compound
Reddy	NNP	poss
's	POS	case
Labs.	NNP	pobj
,	,	punct
359	CD	nummod
f.3d	CD	appos
at	IN	prep
1365	CD	pobj
-	SYM	punct
66	CD	prep
;	:	punct
and	CC	cc
(	-LRB-	punct
3	LS	meta
)	-RRB-	punct
numerous	JJ	amod
other	JJ	amod
publication	NNS	conj
(	-LRB-	punct
describe	VBN	acl
above	IN	advmod
)	-RRB-	punct
clearly	RB	advmod
direct	VBD	conj
the	DT	det
skilled	JJ	amod
artisan	NN	dobj
to	IN	prep
a	DT	det
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NN	pobj
make	VBN	acl
from	IN	prep
benzene	NN	compound
sulphonate	NN	pobj
,	,	punct
include	VBG	prep
,	,	punct
significantly	RB	advmod
,	,	punct
the	DT	det
Carabateas	NNP	compound
patent	NN	pobj
which	WDT	nsubj
teach	VBD	relcl
the	DT	det
besylate	NN	compound
acid	NN	compound
addition	NN	compound
salt	NN	compound
form	NN	dobj
of	IN	prep
another	DT	det
dihydropyridine	JJ	amod
pharmaceutical	NN	compound
compound	NN	pobj
.	.	punct

 	_SP	

second	JJ	advmod
,	,	punct
this	DT	nsubj
be	VBZ	ROOT
not	RB	neg
the	DT	det
case	NN	attr
where	WRB	advmod
the	DT	det
prior	JJ	amod
art	NN	nsubj
teach	VBZ	relcl
merely	RB	advmod
to	TO	aux
pursue	VB	xcomp
a	DT	det
"	``	punct
general	JJ	amod
approach	NN	dobj
that	WDT	nsubj
seem	VBD	relcl
to	TO	aux
be	VB	xcomp
a	DT	det
promising	JJ	amod
field	NN	attr
of	IN	prep
experimentation	NN	pobj
"	''	punct
or	CC	cc
"	``	punct
give	VBD	conj
only	RB	advmod
general	JJ	amod
guidance	NN	dobj
as	IN	prep
to	IN	prep
the	DT	det
particular	JJ	amod
form	NN	pobj
of	IN	prep
the	DT	det
claim	VBN	amod
invention	NN	pobj
or	CC	cc
how	WRB	advmod
to	TO	aux
achieve	VB	conj
-PRON-	PRP	dobj
"	''	punct
.	.	punct

O'Farrell	NNP	ROOT
,	,	punct
853	CD	nummod
f.2d	CD	appos
at	IN	prep
903	CD	pobj
;	:	punct
Medichem	NNP	appos
,	,	punct
437	CD	nummod
f.3d	CD	appos
at	IN	prep
1167	CD	pobj
.	.	punct

here	RB	advmod
,	,	punct
as	IN	mark
admit	VBN	advcl
by	IN	agent
Mr.	NNP	compound
Davison	NNP	pobj
,	,	punct
in	IN	prep
select	VBG	pcomp
an	DT	det
acid	NN	compound
addition	NN	compound
salt	NN	compound
formulation	NN	dobj
,	,	punct
one	CD	nsubj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
look	VBD	ROOT
to	IN	prep
pharmacopoeia	NNS	pobj
and	CC	cc
compendia	VB	conj
to	TO	aux
find	VB	advcl
a	DT	det
salt	NN	dobj
that	WDT	nsubjpass
be	VBD	auxpass
previously	RB	advmod
approve	VBN	relcl
by	IN	agent
the	DT	det
FDA	NNP	pobj
and	CC	cc
use	VBN	conj
successfully	RB	advmod
within	IN	prep
the	DT	det
pharmaceutical	NN	amod
industry	NN	pobj
.	.	punct

Berge	NNP	nsubj
clearly	RB	advmod
point	VBD	ROOT
the	DT	det
skilled	JJ	amod
artisan	NN	dobj
to	IN	prep
53	CD	nummod
anion	NNS	pobj
that	WDT	nsubj
,	,	punct
as	IN	prep
of	IN	prep
1974	CD	pobj
,	,	punct
be	VBD	relcl
pharmaceutically	RB	advmod
acceptable	JJ	acomp
.	.	punct

As	IN	mark
Dr.	NNP	compound
Wells	NNP	poss
'	POS	case
testimony	NN	nsubj
and	CC	cc
the	DT	det
Carabateas	NNP	compound
patent	NN	conj
demonstrate	VBD	advcl
,	,	punct
one	CD	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
be	VBD	ROOT
capable	JJ	acomp
of	IN	prep
further	JJ	advmod
narrowing	NN	pcomp
that	DT	det
list	NN	dobj
of	IN	prep
53	CD	nummod
anion	NNS	pobj
to	IN	prep
a	DT	det
much	RB	advmod
small	JJR	amod
group	NN	pobj
,	,	punct
include	VBG	prep
benzene	NN	compound
sulphonate	NN	pobj
,	,	punct
with	IN	prep
a	DT	det
reasonable	JJ	amod
expectation	NN	pobj
of	IN	prep
success	NN	pobj
.	.	punct

 	_SP	

finally	RB	advmod
,	,	punct
Pfizer	NNP	nsubj
protest	VBZ	ROOT
that	IN	dobj
a	DT	det
conclusion	NN	pobj
that	WDT	mark
amlodipine	JJ	compound
besylate	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	acl
obvious	JJ	amod
disregard	NNS	attr
-PRON-	PRP$	poss
"	``	punct
discovery	NN	attr
"	''	punct
because	IN	mark
-PRON-	PRP	nsubjpass
be	VBD	auxpass
obtain	VBN	advcl
through	IN	prep
the	DT	det
use	NN	pobj
of	IN	prep
trial	NN	nmod
and	CC	cc
error	NN	conj
procedure	NNS	pobj
.	.	punct

While	IN	mark
the	DT	det
pharmaceutical	NN	amod
industry	NN	nsubjpass
may	MD	aux
be	VB	auxpass
particularly	RB	advmod
adversely	RB	advmod
impact	VBN	ROOT
by	IN	agent
application	NN	pobj
of	IN	prep
an	DT	det
"	``	punct
obvious	JJ	pobj
to	TO	aux
try	VB	relcl
"	''	punct
analysis	NN	dobj
,	,	punct
see	VB	intj
,	,	punct
e.g.	RB	advmod
,	,	punct

In	IN	prep
re	NN	pobj
Merck	NNP	pobj
,	,	punct
800	CD	nummod
f.2d	CD	pobj
at	IN	prep
1100	CD	pobj
(	-LRB-	punct
Baldwin	NNP	appos
,	,	punct
J.	NNP	appos
,	,	punct
dissent	VBG	acl
)	-RRB-	punct
,	,	punct
that	IN	mark
Pfizer	NNP	nsubj
have	VBD	csubj
to	TO	aux
verify	VB	xcomp
through	IN	prep
test	VBG	pcomp
the	DT	det
expect	VBN	amod
trait	NNS	dobj
of	IN	prep
each	DT	det
acid	NN	compound
addition	NN	compound
salt	NN	pobj
be	VBZ	ROOT
of	IN	prep
no	DT	det
consequence	NN	pobj
because	IN	mark
-PRON-	PRP	nsubj
do	VBZ	aux
not	RB	neg
compel	VB	advcl
a	DT	det
conclusion	NN	dobj
of	IN	prep
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	pobj
here	RB	advmod
.	.	punct

In	IN	prep
come	VBG	pcomp
to	IN	prep
this	DT	det
conclusion	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
have	VBP	aux
not	RB	neg
ignore	VBN	ROOT
the	DT	det
fact	NN	dobj
that	IN	mark
"	``	punct
patentability	NN	nsubjpass
shall	MD	aux
not	RB	neg
be	VB	auxpass
negative	VBN	acl
by	IN	agent
the	DT	det
manner	NN	pobj
in	IN	prep
which	WDT	pobj
the	DT	det
invention	NN	nsubjpass
be	VBD	auxpass
make	VBN	relcl
"	''	punct
.	.	punct

35	CD	ROOT

u.s.c.	NN	subtok
¡±	NNP	ROOT
103(a	CD	npadvmod
)	-RRB-	punct
.	.	punct

nor	CC	cc
be	VBP	ROOT
-PRON-	PRP	nsubj
ignorant	JJ	acomp
of	IN	prep
the	DT	det
fact	NN	pobj
that	IN	mark
reference	NN	nsubjpass
to	IN	prep
"	``	punct
routine	JJ	amod
testing	NN	pobj
"	''	punct
or	CC	cc
"	``	punct
routine	JJ	amod
experimentation	NN	conj
"	''	punct
be	VBZ	auxpass
disfavor	VBN	acl
.	.	punct

see	VB	ROOT
,	,	punct

e.g.	RB	advmod
,	,	punct
In	IN	ROOT
re	IN	prep
Yates	NNP	pobj
,	,	punct
663	CD	nummod
f.2d	CD	pobj
1054	CD	nummod
,	,	punct
1056	CD	npadvmod

n.	NN	dep
4	CD	nummod
(	-LRB-	punct
C.C.P.A.1981	NNP	intj
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
the	DT	det
Solicitor	NNP	npadvmod
...	NFP	punct
argue	VBZ	ROOT
that	IN	mark
-PRON-	PRP	nsubj
be	VBZ	ccomp
'	``	punct
not	RB	neg
unobvious	JJ	acomp
to	TO	aux
discover	VB	xcomp
optimum	JJ	advmod
or	CC	cc
workable	JJ	conj
range	NNS	dobj
by	IN	prep
routine	JJ	amod
experimentation	NN	pobj
.	.	punct
'	''	punct
In	IN	prep
many	JJ	amod
instance	NNS	pobj
,	,	punct
this	DT	nsubj
may	MD	aux
be	VB	ccomp
true	JJ	acomp
.	.	punct
the	DT	det
problem	NN	nsubj
,	,	punct
however	RB	advmod
,	,	punct
with	IN	prep
such	JJ	amod
'	POS	punct
rule	NNS	pobj
of	IN	prep
patentability	NN	pobj
'	''	punct
(	-LRB-	punct
and	CC	cc
the	DT	det
ever	RB	advmod
-	HYPH	punct
lengthen	VBG	amod
list	NN	pobj
of	IN	prep
exception	NNS	pobj
which	WDT	dobj
-PRON-	PRP	nsubj
engender	VBP	relcl
)	-RRB-	punct
be	VBZ	ccomp
that	IN	mark
-PRON-	PRP	nsubj
tend	VBP	ccomp
to	TO	aux
becloud	VB	xcomp
the	DT	det
ultimate	JJ	amod
legal	JJ	amod
issue	NN	dobj
-	HYPH	punct
obviousness	NN	appos
-	:	punct
and	CC	cc
exalt	VB	conj
the	DT	det
formal	JJ	amod
exercise	NN	dobj
of	IN	prep
squeeze	VBG	pcomp
new	JJ	amod
factual	JJ	amod
situation	NNS	dobj
into	IN	prep
preestablished	JJ	amod
pigeonhole	NNS	pobj
.	.	punct

additionally	RB	advmod
,	,	punct
the	DT	det
emphasis	NN	nsubj
upon	IN	prep
routine	JJ	amod
experimentation	NN	pobj
be	VBZ	ccomp
contrary	JJ	acomp
to	IN	prep
the	DT	det
last	JJ	amod
sentence	NN	pobj
of	IN	prep
section	NN	pobj
103	CD	nummod
"	''	punct
.	.	punct
)	-RRB-	punct
(	-LRB-	punct
internal	JJ	amod
citation	NN	nsubj
omit	VBN	ccomp
)	-RRB-	punct
;	.	punct
In	IN	prep
re	NN	pobj
Saether	NNP	pobj
,	,	punct
492	CD	nsubj
f.2d	CD	compound
849	CD	nummod
,	,	punct
854	CD	appos
(	-LRB-	punct
c.c.p.a.1974	NN	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
In	IN	prep
-PRON-	PRP$	poss
argument	NN	pobj
that	IN	mark
'	``	punct
mere	JJ	amod
routine	JJ	amod
experimentation	NN	nsubjpass
'	''	punct
be	VBD	auxpass
involve	VBN	acl
in	IN	prep
determine	VBG	pcomp
the	DT	det
optimize	VBN	amod
set	NN	dobj
of	IN	prep
characteristic	NNS	pobj
,	,	punct
the	DT	det
solicitor	NN	nsubj
overlook	VBZ	ccomp
the	DT	det
last	JJ	amod
sentence	NN	dobj
of	IN	prep
35	CD	nummod
U.S.C.	NNP	pobj
¡±	CD	nummod
103	CD	nummod
....	.	punct
here	RB	advmod
-PRON-	PRP	nsubj
be	VBP	ccomp
concerned	JJ	acomp
with	IN	prep
the	DT	det
question	NN	pobj
of	IN	prep
whether	IN	mark
the	DT	det
claim	VBN	amod
invention	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	pcomp
obvious	JJ	acomp
at	IN	prep
the	DT	det
time	NN	pobj
-PRON-	PRP	nsubjpass
be	VBD	auxpass
make	VBN	relcl
to	IN	prep
a	DT	det
person	NN	pobj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
in	IN	prep
the	DT	det
art	NN	pobj
-	:	punct
not	RB	neg
how	WRB	advmod
-PRON-	PRP	nsubjpass
be	VBD	auxpass
achieve	VBN	conj
"	''	punct
.	.	punct
)	-RRB-	punct
(	-LRB-	punct
internal	JJ	amod
citation	NN	nsubj
omit	VBN	ccomp
)	-RRB-	punct
;	.	punct
In	IN	prep
re	IN	pobj
Fay	NNP	pobj
,	,	punct
52	CD	nummod
c.c.p.a.	NN	pobj
1483	CD	nummod
,	,	punct
347	CD	nummod
f.2d	CD	nummod
597	CD	appos
,	,	punct
602	CD	appos
(	-LRB-	punct
C.C.P.A.1965	NNP	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
-PRON-	PRP	nsubj
do	VBP	aux
not	RB	neg
agree	VB	ccomp
that	IN	mark
'	``	punct
routine	JJ	amod
experimentation	NN	poss
'	''	punct
negative	NNS	compound
patentability	NN	ccomp
.	.	punct
the	DT	det
last	JJ	amod
sentence	NN	nsubj
of	IN	prep
section	NN	pobj
103	CD	nummod
state	NNS	npadvmod
that	IN	mark
'	``	punct
patentability	NN	nsubjpass
shall	MD	aux
not	RB	neg
be	VB	auxpass
negative	VBN	ccomp
by	IN	agent
the	DT	det
manner	NN	pobj
in	IN	prep
which	WDT	pobj
the	DT	det
invention	NN	nsubjpass
be	VBD	auxpass
make	VBN	relcl
.	.	punct
'	''	punct
to	TO	aux
support	VB	csubj
the	DT	det
board	NN	poss
's	POS	case
decision	NN	dobj
that	IN	mark
'	``	punct
routine	JJ	amod
experimentation	NN	nsubj
within	IN	prep
the	DT	det
teaching	NNS	pobj
of	IN	prep
the	DT	det
art	NN	pobj
'	''	punct
will	MD	aux
defeat	VB	acl
patentability	NN	dobj
require	VBZ	ROOT
a	DT	det
primary	JJ	amod
determination	NN	dobj
of	IN	prep
whether	IN	mark
or	CC	cc
not	RB	neg
appellant	NNS	poss
'	POS	case
experimentation	NN	nsubj
come	VBZ	pcomp
within	IN	prep
the	DT	det
teaching	NNS	pobj
of	IN	prep
the	DT	det
art	NN	pobj
.	.	punct
Whether	IN	mark
the	DT	det
subsequent	JJ	amod
experimentation	NN	nsubjpass
be	VBZ	auxpass
term	VBN	advcl
'	``	punct
routine	JJ	oprd
'	''	punct
or	CC	cc
not	RB	neg
be	VBZ	conj
of	IN	prep
no	DT	det
consequence	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

 	_SP	

however	RB	advmod
,	,	punct
on	IN	prep
the	DT	det
particularized	JJ	amod
fact	NNS	pobj
of	IN	prep
this	DT	det
case	NN	pobj
,	,	punct
consideration	NN	nsubj
of	IN	prep
the	DT	det
"	``	punct
routine	JJ	amod
testing	NN	pobj
"	''	punct
perform	VBN	acl
by	IN	agent
Pfizer	NNP	pobj
be	VBZ	ROOT
appropriate	JJ	acomp
because	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
provide	VBD	advcl
not	RB	preconj
only	RB	advmod
the	DT	det
mean	NNS	dobj
of	IN	prep
create	VBG	pcomp
acid	JJ	compound
addition	NN	compound
salt	NNS	dobj
but	CC	cc
also	RB	advmod
predict	VBD	conj
the	DT	det
result	NNS	dobj
,	,	punct
which	WDT	dobj
Pfizer	NNP	nsubj
merely	RB	advmod
have	VBD	relcl
to	TO	aux
verify	VB	xcomp
through	IN	prep
routine	JJ	amod
testing	NN	pobj
.	.	punct

Merck	NNP	ROOT
,	,	punct
874	CD	nummod
f.2d	CD	appos
at	IN	prep
809	CD	pobj
.	.	punct

the	DT	det
evidence	NN	nsubj
show	VBZ	ROOT
that	IN	mark
,	,	punct
upon	IN	prep
make	VBG	pcomp
a	DT	det
new	JJ	amod
acid	NN	compound
addition	NN	compound
salt	NN	dobj
,	,	punct
-PRON-	PRP	nsubj
be	VBD	ccomp
routine	JJ	acomp
in	IN	prep
the	DT	det
art	NN	pobj
to	TO	aux
verify	VB	advcl
the	DT	det
expect	VBN	amod
physicochemical	JJ	amod
characteristic	NNS	nsubj
of	IN	prep
each	DT	det
salt	NN	pobj
,	,	punct
include	VBG	prep
solubility	NN	pobj
,	,	punct
pH	NNS	intj
,	,	punct
stability	NN	conj
,	,	punct
hygroscopicity	NN	conj
,	,	punct
and	CC	cc
stickiness	NN	conj
,	,	punct
and	CC	cc
Pfizer	NNP	poss
's	POS	case
scientist	NNS	conj
use	VBD	ccomp
standard	JJ	amod
technique	NNS	dobj
to	TO	aux
do	VB	xcomp
so	RB	advmod
.	.	punct

These	DT	det
type	NN	nsubj
of	IN	prep
experiment	NNS	pobj
use	VBN	acl
by	IN	agent
Pfizer	NNP	poss
's	POS	case
scientist	NNS	pobj
to	TO	aux
verify	VB	acl
the	DT	det
physicochemical	JJ	amod
characteristic	NNS	dobj
of	IN	prep
each	DT	det
salt	NN	pobj
be	VBP	ROOT
not	RB	neg
equivalent	JJ	acomp
to	IN	prep
the	DT	det
trial	NN	nmod
and	CC	cc
error	NN	conj
procedure	NNS	pobj
often	RB	advmod
employ	VBN	acl
to	TO	aux
discover	VB	xcomp
a	DT	det
new	JJ	amod
compound	NN	dobj
where	WRB	advmod
the	DT	det
prior	JJ	amod
art	NN	nsubj
give	VBD	relcl
no	DT	det
motivation	NN	dobj
or	CC	cc
suggestion	NN	conj
to	TO	aux
make	VB	advcl
the	DT	det
new	JJ	amod
compound	NN	dobj
nor	CC	cc
a	DT	det
reasonable	JJ	amod
expectation	NN	conj
of	IN	prep
success	NN	pobj
.	.	punct

This	DT	nsubj
be	VBZ	ROOT
not	RB	neg
to	TO	aux
say	VB	xcomp
that	IN	mark
the	DT	det
length	NN	nsubj
,	,	punct
expense	NN	conj
,	,	punct
and	CC	cc
difficulty	NN	conj
of	IN	prep
the	DT	det
technique	NNS	pobj
use	VBN	acl
be	VBP	ccomp
dispositive	JJ	acomp
since	IN	prep
many	JJ	amod
technique	NNS	pobj
that	WDT	nsubj
require	VBP	relcl
extensive	JJ	amod
time	NN	dobj
,	,	punct
money	NN	conj
,	,	punct
and	CC	cc
effort	NN	conj
to	TO	aux
carry	VB	xcomp
out	RP	prt

may	MD	aux
nevertheless	RB	advmod
be	VB	ROOT
arguably	RB	advmod
"	``	punct
routine	JJ	acomp
"	''	punct
to	IN	prep
one	CD	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
.	.	punct

rather	RB	advmod
,	,	punct
-PRON-	PRP$	poss
conclusion	NN	nsubj
here	RB	advmod
rely	VBZ	ROOT
on	IN	prep
the	DT	det
fact	NN	pobj
that	IN	mark
one	CD	nsubj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	aux
have	VBN	acl
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
the	DT	det
invention	NN	nsubjpass
be	VBD	auxpass
make	VBN	relcl
,	,	punct
and	CC	cc
merely	RB	advmod
have	VBD	conj
to	TO	aux
verify	VB	xcomp
that	DT	det
expectation	NN	dobj
.	.	punct

cf	UH	ROOT
.	.	punct

velander	NN	nsubj
v.	IN	prep
Garner	NNP	pobj
,	,	punct
348	CD	nummod
f.3d	CD	appos
1359	CD	nummod
,	,	punct
1368	CD	appos
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.2003	NFP	ROOT
)	-RRB-	punct
(	-LRB-	punct
that	IN	mark
one	CD	nsubj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
view	VB	ccomp
variability	NN	dobj
in	IN	prep
produce	VBG	pcomp
fibrinogen	NN	dobj
in	IN	prep
transgenic	JJ	amod
mammal	NNS	pobj
as	IN	prep
evidence	NN	pobj
that	IN	mark
"	``	punct
expense	NN	nsubjpass
,	,	punct
time	NN	conj
and	CC	cc
effort	NN	conj
"	''	punct
would	MD	aux
be	VB	auxpass
involve	VBN	acl
do	VBD	aux
not	RB	neg
equate	VB	ccomp
to	IN	prep
a	DT	det
conclusion	NN	pobj
that	DT	mark
success	NN	nsubj
be	VBD	acl
unlikely	JJ	acomp
)	-RRB-	punct
.	.	punct

simply	RB	advmod
put	VBN	advcl
,	,	punct
to	TO	aux
conclude	VB	advcl
that	DT	mark
amlodipine	JJ	compound
besylate	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
,	,	punct
"	''	punct
the	DT	det
prior	JJ	amod
art	NN	nsubj
,	,	punct
common	JJ	amod
knowledge	NN	conj
,	,	punct
or	CC	cc
the	DT	det
nature	NN	conj
of	IN	prep
the	DT	det
problem	NN	pobj
,	,	punct
view	VBD	advcl
through	IN	prep
the	DT	det
eye	NNS	pobj
of	IN	prep
an	DT	det
ordinary	JJ	amod
artisan	NN	pobj
"	''	punct
merely	RB	advmod
have	VBD	ROOT
to	TO	aux
suggest	VB	xcomp
react	VBG	amod
amlodipine	NN	compound
base	NN	dobj
with	IN	prep
benzene	NN	amod
sulphonic	JJ	amod
acid	NN	pobj
to	TO	aux
form	VB	advcl
the	DT	det
besylate	NN	compound
acid	NN	compound
addition	NN	compound
salt	NN	dobj
,	,	punct
and	CC	cc
that	IN	mark
that	DT	mark
acid	NN	compound
addition	NN	compound
salt	NN	compound
form	NN	nsubj
would	MD	aux
work	VB	conj
for	IN	prep
-PRON-	PRP$	poss
intended	JJ	amod
purpose	NN	pobj
.	.	punct

DyStar	NNP	ROOT
,	,	punct
464	CD	nummod
f.3d	CD	appos
at	IN	prep
1361	CD	pobj
.	.	punct

-PRON-	PRP	nsubj
do	VBD	ROOT
.	.	punct

see	VB	ROOT
O'Farrell	NNP	dobj
,	,	punct
853	CD	nummod
f.2d	CD	appos
at	IN	prep
904	CD	pobj
.	.	punct

 	_SP	

-PRON-	PRP	nsubj
find	VBP	ROOT
this	DT	det
case	NN	nsubj
analogous	JJ	ccomp
to	IN	prep
the	DT	det
optimization	NN	pobj
of	IN	prep
a	DT	det
range	NN	pobj
or	CC	cc
other	JJ	amod
variable	NN	conj
within	IN	prep
the	DT	det
claim	NNS	pobj
that	WDT	nsubj
flow	VBZ	relcl
from	IN	prep
the	DT	det
"	``	punct
normal	JJ	amod
desire	NN	pobj
of	IN	prep
scientist	NNS	pobj
or	CC	cc
artisan	VBZ	conj
to	TO	aux
improve	VB	acl
upon	IN	prep
what	WP	nsubjpass
be	VBZ	auxpass
already	RB	advmod
generally	RB	advmod
know	VBN	pcomp
"	''	punct
.	.	punct

In	IN	prep
re	NN	pobj
Peterson	NNP	pobj
,	,	punct
315	CD	nummod
f.3d	CD	nummod
1325	CD	nummod
,	,	punct
1330	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2003	NFP	ROOT
)	-RRB-	punct
(	-LRB-	punct
determine	VBG	advcl
where	WRB	advmod
in	IN	prep
a	DT	det
disclose	VBN	amod
set	NN	pobj
of	IN	prep
percentage	NN	pobj
range	VBZ	ccomp
the	DT	det
optimum	JJ	amod
combination	NN	nsubj
of	IN	prep
percentage	NNS	pobj
lie	VBZ	ccomp
be	VBZ	ccomp
prima	NN	amod
facie	NN	attr
obvious	JJ	amod
)	-RRB-	punct
.	.	punct

In	IN	prep
In	IN	pobj
re	NN	compound
Aller	NNP	pobj
,	,	punct
42	CD	nummod
c.c.p.a.	NN	pobj
824	CD	nummod
,	,	punct
220	CD	npadvmod
f.2d	CD	nummod
454	CD	nummod
,	,	punct
456	CD	appos
(	-LRB-	punct
1955	CD	appos
)	-RRB-	punct
,	,	punct
-PRON-	PRP$	poss
predecessor	NN	compound
court	NN	nsubj
set	VBD	ROOT
forth	RP	prt
the	DT	det
rule	NN	dobj
that	IN	mark
the	DT	det
discovery	NN	nsubj
of	IN	prep
an	DT	det
optimum	JJ	amod
value	NN	pobj
of	IN	prep
a	DT	det
variable	NN	pobj
in	IN	prep
a	DT	det
know	VBN	amod
process	NN	pobj
be	VBZ	acl
usually	RB	advmod
obvious	JJ	acomp
.	.	punct

see	VB	ROOT
also	RB	advmod
In	IN	prep
re	IN	compound
Boesch	NNP	pobj
,	,	punct
617	CD	nummod
f.2d	CD	nummod
272	CD	nummod
,	,	punct
276	CD	nummod
(	-LRB-	punct
C.C.P.A.1980	NNP	ccomp
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
Discovery	NNP	nsubj
of	IN	prep
an	DT	det
optimum	JJ	amod
value	NN	pobj
of	IN	prep
a	DT	det
result	NN	nmod
effective	JJ	amod
variable	NN	pobj
in	IN	prep
a	DT	det
know	VBN	amod
process	NN	pobj
be	VBZ	ccomp
ordinarily	RB	advmod
within	IN	prep
the	DT	det
skill	NN	pobj
of	IN	prep
the	DT	det
art	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

similarly	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
hold	VBP	ROOT
that	IN	mark
the	DT	det
optimization	NN	nsubj
of	IN	prep
the	DT	det
acid	JJ	compound
addition	NN	compound
salt	NN	compound
formulation	NN	pobj
for	IN	prep
an	DT	det
active	JJ	amod
pharmaceutical	NN	amod
ingredient	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
where	WRB	advmod
as	IN	prep
here	RB	pcomp
the	DT	det
acid	NN	compound
addition	NN	compound
salt	NN	compound
formulation	NN	nsubj
have	VBZ	advcl
no	DT	det
effect	NN	dobj
on	IN	prep
the	DT	det
therapeutic	JJ	amod
effectiveness	NN	pobj
of	IN	prep
the	DT	det
active	JJ	amod
ingredient	NN	pobj
and	CC	cc
the	DT	det
prior	JJ	amod
art	NN	nsubj
heavily	RB	advmod
suggest	VBZ	conj
the	DT	det
particular	JJ	amod
anion	NN	dobj
use	VBN	acl
to	TO	aux
form	VB	xcomp
the	DT	det
salt	NN	dobj
.	.	punct

cf	UH	ROOT
.	.	punct

In	IN	prep
re	NN	pobj
Geisler	NNP	pobj
,	,	punct
116	CD	nummod
F.3d	NNP	appos
1465	CD	nummod
,	,	punct
1470	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1997	ADD	pobj
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
'	``	punct
-PRON-	PRP	nsubj
be	VBZ	ROOT
not	RB	neg
inventive	JJ	acomp
to	TO	aux
discover	VB	xcomp
the	DT	det
optimum	JJ	amod
or	CC	cc
workable	JJ	conj
range	NNS	dobj
by	IN	prep
routine	JJ	amod
experimentation	NN	pobj
.	.	punct
'	''	punct
"	''	punct
(	-LRB-	punct
quote	VBG	ccomp
Aller	NNP	dobj
,	,	punct
220	CD	nummod
f.2d	CD	appos
at	IN	prep
456	CD	pobj
)	-RRB-	punct
)	-RRB-	punct
;	.	punct
In	IN	prep
re	IN	pobj
Kulling	NNP	pobj
,	,	punct
897	CD	nummod
f.2d	CD	nummod
1147	CD	nummod
,	,	punct
1149	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1990	LS	appos
)	-RRB-	punct
(	-LRB-	punct
find	VBG	acl
no	DT	det
clear	JJ	amod
error	NN	dobj
in	IN	prep
Board	NNP	pobj
of	IN	prep
Patent	NNP	compound
Appeals	NNPS	pobj
and	CC	cc
Interferences	NNPS	poss
'	POS	case
conclusion	NN	dobj
that	IN	mark
the	DT	det
amount	NN	nsubj
of	IN	prep
eluent	NN	pobj
to	TO	aux
be	VB	auxpass
use	VBN	relcl
in	IN	prep
a	DT	det
washing	NN	amod
sequence	NN	pobj
be	VBD	acl
a	DT	det
matter	NN	attr
of	IN	prep
routine	JJ	amod
optimization	NN	pobj
know	VBN	acl
in	IN	prep
the	DT	det
pertinent	JJ	amod
prior	JJ	amod
art	NN	pobj
and	CC	cc
therefore	RB	advmod
obvious	JJ	conj
)	-RRB-	punct
.	.	punct

indeed	RB	advmod
,	,	punct
the	DT	det
logical	JJ	amod
line	NN	nsubj
of	IN	prep
testing	NN	pobj
be	VBD	ROOT
to	TO	aux
react	VB	xcomp
benzene	NN	compound
sulphonate	JJ	dobj
with	IN	prep
amlodipine	NN	pobj
to	TO	aux
confirm	VB	advcl
the	DT	det
presence	NN	dobj
of	IN	prep
a	DT	det
salt	NN	pobj
,	,	punct
and	CC	cc
then	RB	advmod
to	TO	aux
verify	VB	conj
that	IN	mark
the	DT	det
physicochemical	JJ	amod
property	NNS	nsubj
of	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
be	VBD	ccomp
adequate	JJ	acomp
,	,	punct
particularly	RB	advmod
the	DT	det
trait	NN	appos
of	IN	prep
sufficient	JJ	amod
non	JJ	subtok
-	JJ	subtok
stickiness	NN	pobj
.	.	punct

the	DT	det
experimentation	NN	nsubj
need	VBD	ccomp
,	,	punct
then	RB	advmod
,	,	punct
to	TO	aux
arrive	VB	csubj
at	IN	prep
the	DT	det
subject	JJ	amod
matter	NN	pobj
claim	VBD	acl
in	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
be	VBD	ROOT
"	``	punct
nothing	NN	attr
more	JJR	amod
than	IN	prep
routine	JJ	amod
"	''	punct
application	NN	pobj
of	IN	prep
a	DT	det
well	RB	advmod
-	HYPH	punct
know	VBN	amod
problem	NN	npadvmod
-	HYPH	punct
solve	VBG	amod
strategy	NN	pobj
,	,	punct
Merck	NNP	appos
,	,	punct
874	CD	nummod
f.2d	CD	appos
at	IN	prep
809	CD	pobj
,	,	punct
and	CC	cc
-PRON-	PRP	nsubj
conclude	VBP	conj
,	,	punct
"	''	punct
the	DT	det
work	NN	dobj
of	IN	prep
a	DT	det
skilled	JJ	amod
[	-LRB-	punct
artisan	NN	pobj
]	-RRB-	punct
,	,	punct
not	RB	neg
of	IN	prep
an	DT	det
inventor	NN	pobj
"	''	punct
.	.	punct

DyStar	NNP	nsubj
,	,	punct
464	CD	nummod
f.3d	CD	appos
at	IN	prep
1371	CD	pobj
;	:	punct
see	VB	ROOT
also	RB	advmod
In	IN	prep
re	IN	pobj
Luck	NNP	pobj
,	,	punct
476	CD	nummod
f.2d	CD	nummod
650	CD	appos
,	,	punct
652	CD	nummod
-	SYM	punct
53	CD	prep
(	-LRB-	punct
c.c.p.a.1973	UH	appos
)	-RRB-	punct
(	-LRB-	punct
use	NN	nsubj
of	IN	prep
routine	JJ	amod
testing	NN	pobj
to	TO	aux
identify	VB	acl
optimum	JJ	amod
amount	NNS	dobj
of	IN	prep
silane	NN	pobj
to	TO	aux
be	VB	auxpass
employ	VBN	relcl
in	IN	prep
a	DT	det
lamp	NN	compound
coating	NN	pobj
,	,	punct
without	IN	prep
establish	VBG	pcomp
a	DT	det
critical	JJ	amod
upper	JJ	amod
limit	NN	dobj
or	CC	cc
demonstrate	VBG	conj
any	DT	det
unexpected	JJ	amod
result	NN	dobj
,	,	punct
lie	VBZ	ccomp
within	IN	prep
the	DT	det
ambit	NN	pobj
of	IN	prep
the	DT	det
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
)	-RRB-	punct
;	.	punct
In	IN	prep
re	IN	pobj
Esterhoy	NNP	pobj
,	,	punct
58	CD	nummod
c.c.p.a.	NN	pobj
1116	CD	nummod
,	,	punct
440	CD	nummod
f.2d	CD	nummod
1386	CD	nummod
,	,	punct
1389	CD	npadvmod
(	-LRB-	punct
1971	CD	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
one	CD	nsubj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
thus	RB	advmod
manifestly	RB	advmod
operate	VB	conj
the	DT	det
Switzer	NNP	nmod
et	NNP	nmod
al	NNP	nmod
.	.	punct
process	NN	dobj
under	IN	prep
condition	NNS	pobj
most	RBS	advmod
desirable	JJ	amod
for	IN	prep
maximum	JJ	amod
and	CC	cc
efficient	JJ	conj
concentration	NN	pobj
of	IN	prep
the	DT	det
acid	NN	pobj
.	.	punct
the	DT	det
condition	NNS	nsubj
recite	VBN	acl
in	IN	prep
the	DT	det
claim	NNS	pobj
appear	VBP	ccomp
to	IN	prep
-PRON-	PRP	pobj
to	TO	aux
be	VB	xcomp
only	RB	advmod
optimum	JJ	acomp
and	CC	cc
easily	RB	advmod
ascertain	VBN	conj
by	IN	agent
routine	JJ	amod
experimentation	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct

;	.	punct
In	IN	prep
re	IN	pobj
Swentzel	NNP	pobj
,	,	punct
42	CD	nummod
C.C.P.A.	NNP	dep
757	CD	nummod
,	,	punct
219	CD	quantmod
f.2d	CD	nummod
216	CD	nummod
,	,	punct
219	CD	nummod
(	-LRB-	punct
1955	CD	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
-PRON-	PRP	nsubj
may	MD	aux
well	RB	advmod
be	VB	ccomp
that	IN	mark
the	DT	det
size	NN	nsubj
represent	VBZ	ccomp
the	DT	det
large	JJS	amod
particle	NNS	dobj
suitable	JJ	amod
for	IN	prep
appellant	NN	poss
's	POS	case
purpose	NN	pobj
,	,	punct
but	CC	cc
the	DT	det
determination	NN	nsubj
of	IN	prep
that	DT	det
desire	VBN	amod
size	NN	pobj
under	IN	prep
the	DT	det
present	JJ	amod
circumstance	NNS	pobj
involve	VBZ	conj
nothing	NN	dobj
more	JJR	amod
than	IN	prep
routine	JJ	amod
experimentation	NN	pobj
and	CC	cc
exercise	NN	conj
of	IN	prep
the	DT	det
judgment	NN	pobj
of	IN	prep
one	CD	pobj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
;	.	punct
In	IN	prep
re	IN	pobj
Swain	NNP	pobj
,	,	punct
33	CD	nummod
c.c.p.a.	NN	appos
1266	CD	nummod
,	,	punct
156	CD	nummod
f.2d	CD	nummod
246	CD	nummod
,	,	punct
247	CD	nummod
-	SYM	punct
48	CD	prep
(	-LRB-	punct
1946	CD	meta
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
In	IN	prep
the	DT	det
absence	NN	pobj
of	IN	prep
a	DT	det
proper	JJ	amod
showing	NN	pobj
of	IN	prep
an	DT	det
unexpected	JJ	amod
and	CC	cc
superior	JJ	conj
result	NN	pobj
over	IN	prep
the	DT	det
disclosure	NN	pobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
no	DT	det
invention	NN	nsubjpass
be	VBZ	auxpass
involve	VBN	ROOT
in	IN	prep
a	DT	det
result	NN	pobj
obtain	VBN	acl
by	IN	agent
experimentation	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

 	_SP	

thus	RB	advmod
,	,	punct
while	IN	mark
patentability	NN	nsubjpass
of	IN	prep
an	DT	det
invention	NN	pobj
be	VBZ	auxpass
not	RB	neg
negate	VBN	advcl
by	IN	agent
the	DT	det
manner	NN	pobj
in	IN	prep
which	WDT	pobj
-PRON-	PRP	nsubjpass
be	VBD	auxpass
make	VBN	relcl
,	,	punct
"	''	punct
the	DT	det
converse	NN	nsubj
be	VBZ	ccomp
equally	RB	advmod
true	JJ	acomp
:	:	punct
patentability	NN	nsubjpass
be	VBZ	auxpass
not	RB	neg
impart	VBN	ROOT
where	WRB	advmod
'	``	punct
the	DT	det
prior	JJ	amod
art	NN	nsubj
would	MD	aux
have	VB	aux
suggest	VBN	ccomp
to	IN	prep
one	CD	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
that	WDT	mark
this	DT	det
process	NN	nsubjpass
should	MD	aux
be	VB	auxpass
carry	VBN	ccomp
out	RP	prt
and	CC	cc
would	MD	aux
have	VB	conj
a	DT	det
reasonable	JJ	amod
likelihood	NN	dobj
of	IN	prep
success	NN	pobj
.	.	punct
'	''	punct
"	``	punct

Merck	NNP	dep
,	,	punct
874	CD	nummod
f.2d	CD	appos
at	IN	prep
809	CD	pobj
(	-LRB-	punct
quote	VBG	pobj
in	RP	prep
re	IN	compound
Dow	NNP	compound
Chem	NNP	pobj
.	.	punct
Co.	NNP	ROOT
,	,	punct
837	CD	nummod
f.2d	CD	appos
469	CD	nummod
,	,	punct
473	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1988	CD	appos
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

For	IN	prep
these	DT	det
reason	NNS	pobj
,	,	punct
-PRON-	PRP	nsubj
hold	VBP	ROOT
that	IN	mark
Apotex	NNP	nsubj
introduce	VBD	ccomp
clear	JJ	advmod
and	CC	cc
convincing	JJ	conj
evidence	NN	dobj
that	IN	mark
a	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
have	VB	aux
have	VBN	acl
a	DT	det
reasonable	JJ	amod
expectation	NN	dobj
of	IN	prep
success	NN	pobj
with	IN	prep
the	DT	det
besylate	NN	compound
salt	NN	compound
form	NN	pobj
of	IN	prep
amlodipine	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
the	DT	det
invention	NN	nsubjpass
be	VBD	auxpass
make	VBN	relcl
.	.	punct

accordingly	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
agree	VBP	ROOT
with	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
that	IN	mark
a	DT	det
prima	NN	amod
facie	NN	compound
case	NN	nsubjpass
of	IN	prep
obviousness	JJ	pobj
be	VBD	auxpass
establish	VBN	ccomp
with	IN	prep
regard	NN	pobj
to	IN	prep
the	DT	det
claim	NNS	pobj
of	IN	prep
the	DT	det
¡¬303	JJ	nummod
patent	NN	pobj
,	,	punct
albeit	IN	advmod
for	IN	prep
different	JJ	amod
reason	NNS	pobj
.	.	punct

 	_SP	

secondary	JJ	compound
Considerations	NNPS	ROOT

  	_SP	

Before	IN	mark
-PRON-	PRP	nsubj
turn	VBP	advcl
to	IN	prep
the	DT	det
remain	VBG	amod
conflict	NN	pobj
between	IN	prep
the	DT	det
party	NNS	pobj
-	:	punct
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
consideration	NN	pobj
of	IN	prep
the	DT	det
objective	JJ	amod
indicia	NN	pobj
of	IN	prep
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	pobj
-	:	punct
-PRON-	PRP	nsubj
must	MD	aux
first	RB	advmod
address	VB	ROOT
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
reference	NN	dobj
in	IN	prep
-PRON-	PRP$	poss
bench	JJ	compound
opinion	NN	pobj
to	IN	prep
Pfizer	NNP	poss
's	POS	case
business	NN	compound
decision	NN	pobj
to	TO	aux
switch	VB	acl
-PRON-	PRP$	poss
commercial	JJ	amod
product	NN	dobj
from	IN	prep
an	DT	det
amlodipine	JJ	amod
maleate	JJ	compound
formulation	NN	pobj
to	IN	prep
an	DT	det
amlodipine	JJ	compound
besylate	NN	compound
formulation	NN	pobj
,	,	punct
apparently	RB	advmod
as	IN	prep
evidence	NN	pobj
of	IN	prep
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	pobj
.	.	punct

see	VB	advcl
Bench	NNP	compound
order	NN	compound
tr	UH	dobj
.	.	punct
at	IN	prep
6:21	CD	compound
-	HYPH	punct
7:1	CD	punct
(	-LRB-	punct
"	``	punct
pfizer	NN	nsubj
be	VBZ	ccomp
a	DT	det
big	JJ	amod
company	NN	attr
,	,	punct
which	WDT	nsubj
by	IN	prep
this	DT	det
time	NN	pobj
have	VBD	relcl
a	DT	det
large	JJ	amod
investment	NN	dobj
in	IN	prep
amlodipine	NN	compound
maleate	NN	pobj
....	.	punct
a	DT	det
decision	NN	nsubj
to	TO	aux
switch	VB	acl
to	IN	prep
some	DT	det
other	JJ	amod
product	NN	pobj
,	,	punct
or	CC	cc
even	RB	advmod
to	TO	aux
abandon	VB	conj
the	DT	det
entire	JJ	amod
product	NN	dobj
,	,	punct
be	VBZ	ROOT
the	DT	det
corporate	JJ	amod
equivalent	NN	attr
of	IN	prep
turn	VBG	pcomp
the	DT	det
Queen	NNP	compound
Mary	NNP	dobj
"	''	punct
.	.	punct
)	-RRB-	punct
;	:	punct

Bench	NNP	compound
Order	NNP	compound
tr	UH	nsubj
.	.	punct
at	IN	prep
18:17	CD	pobj
-	SYM	punct
21	CD	prep
(	-LRB-	punct
"	``	punct
pfizer	NN	nsubj
would	MD	aux
not	RB	neg
have	VB	aux
change	VBN	ROOT
from	IN	prep
the	DT	det
maleate	NN	pobj
,	,	punct
into	IN	prep
which	WDT	pobj
-PRON-	PRP	nsubj
have	VBD	aux
invest	VBN	relcl
both	DT	det
time	NN	dobj
and	CC	cc
research	NN	compound
dollar	NNS	conj
,	,	punct
to	TO	aux
seek	VB	advcl
out	RP	prt
a	DT	det
very	RB	advmod
strange	JJ	amod
and	CC	cc
rare	JJ	conj
besylate	NN	compound
salt	NN	dobj
,	,	punct
absent	JJ	amod
an	DT	det
extremely	RB	advmod
good	JJ	amod
reason	NN	dobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
reliance	NN	nsubj
on	IN	prep
this	DT	det
"	``	punct
objective	JJ	amod
consideration	NN	pobj
"	''	punct
seem	VBZ	ROOT
suspect	JJ	oprd
as	IN	mark
there	EX	expl
be	VBZ	advcl
no	DT	det
evidence	NN	attr
in	IN	prep
the	DT	det
appellate	JJ	amod
record	NN	pobj
to	TO	aux
support	VB	relcl
the	DT	det
implicit	JJ	amod
find	VBG	dobj
that	IN	mark
Pfizer	NNP	nsubj
ever	RB	advmod
consider	VBD	acl
abandon	VBG	xcomp
amlodipine	NN	dobj
or	CC	cc
stand	VBD	conj
to	TO	aux
lose	VB	advcl
significant	JJ	amod
time	NN	dobj
and	CC	cc
investment	NN	compound
dollar	NNS	conj
.	.	punct

indeed	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
be	VBP	ROOT
not	RB	neg
ignorant	JJ	acomp
of	IN	prep
the	DT	det
fact	NN	pobj
that	IN	mark
pharmaceutical	NN	amod
company	NNS	nsubj
be	VBP	acl
in	IN	prep
the	DT	det
business	NN	pobj
of	IN	prep
research	NN	pobj
and	CC	cc
development	NN	conj
.	.	punct

-PRON-	PRP	nsubj
therefore	RB	advmod
disregard	VBP	ROOT
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
finding	NNS	dobj
on	IN	prep
this	DT	det
point	NN	pobj
as	IN	prep
clearly	RB	advmod
erroneous	JJ	amod
,	,	punct
or	CC	cc
in	IN	conj
any	DT	det
event	NN	pobj
insufficiently	RB	advmod
probative	JJ	amod
of	IN	prep
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	pobj
to	TO	aux
overcome	VB	advcl
the	DT	det
evidence	NN	dobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	compound
teaching	NNS	pobj
.	.	punct

  	_SP	

evidence	NN	nsubjpass
of	IN	prep
unexpected	JJ	amod
result	NNS	pobj
can	MD	aux
be	VB	auxpass
use	VBN	ROOT
to	TO	aux
rebut	VB	xcomp
a	DT	det
prima	NN	amod
facie	NN	compound
case	NN	dobj
of	IN	prep
obviousness	JJ	pobj
.	.	punct

Peterson	NNP	ROOT
,	,	punct
315	CD	nummod
f.3d	CD	appos
at	IN	prep
1330	CD	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
,	,	punct
while	IN	mark
amlodipine	JJ	compound
besylate	NN	nsubj
be	VBD	advcl
not	RB	neg
superior	JJ	acomp
to	TO	aux
amlodipine	VB	xcomp
maleate	NN	dobj
in	IN	prep
every	DT	det
category	NN	pobj
of	IN	prep
physicochemical	JJ	amod
property	NNS	pobj
,	,	punct
-PRON-	PRP	nsubj
nonetheless	RB	advmod
"	``	punct
clearly	RB	advmod
and	CC	cc
unexpectedly	RB	conj
illustrate	VBZ	ccomp
a	DT	det
superior	JJ	amod
combination	NN	dobj
of	IN	prep
property	NNS	pobj
when	WRB	advmod
compare	VBN	advcl
to	IN	aux
"	``	punct
amlodipine	VB	pcomp
maleate.6	XX	dobj
With	IN	prep
regard	NN	pobj
to	IN	prep
solubility	NN	pobj
,	,	punct
the	DT	det
¡¬303	JJ	nummod
patent	NN	compound
disclose	VBZ	appos
that	WDT	mark
amlodipine	VBP	compound
besylate	NN	nsubj
have	VBZ	relcl
a	DT	det
solubility	NN	dobj
of	IN	prep
4.6	CD	nummod
mg	NN	nmod
/	SYM	punct
ml	NN	pobj
at	IN	prep
pH	NNP	pobj
6.6	CD	nummod
,	,	punct
whereas	IN	mark
amlodipine	VBP	amod
maleate	NN	nsubj
have	VBZ	advcl
a	DT	det
solubility	NN	dobj
of	IN	prep
4.5	CD	nummod
mg	NN	nmod
/	SYM	punct
ml	NN	pobj
at	IN	prep
pH	NNP	pobj
4.8	CD	nummod
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
state	VBD	ROOT
that	IN	mark
any	DT	det
product	NN	nsubj
have	VBG	acl
a	DT	det
solubility	NN	dobj
great	JJR	amod
than	IN	prep
1.0	CD	nummod
mg	NN	nmod
/	SYM	punct
ml	NNP	nsubj
be	VBZ	ccomp
acceptable	JJ	acomp
,	,	punct
and	CC	cc
that	IN	mark
"	``	punct
the	DT	det
rest	NN	nsubj
be	VBZ	conj
sound	JJ	acomp
and	CC	cc
fury	NN	conj
"	''	punct
.	.	punct

Bench	NNP	compound
order	NN	compound
tr	UH	ROOT
.	.	punct
at	IN	prep
11:10	CD	pobj
.	.	punct

-PRON-	PRP	nsubj
conclude	VBP	ROOT
from	IN	prep
this	DT	det
statement	NN	pobj
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
find	VB	ccomp
that	IN	mark
the	DT	det
solubility	NN	nsubj
of	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
be	VBD	ccomp
materially	RB	advmod
superior	JJ	amod
,	,	punct
much	RB	advmod
less	JJR	advmod
"	``	punct
unexpectedly	RB	advmod
superior	JJ	acomp
"	''	punct
to	IN	prep
the	DT	det
solubility	NN	pobj
of	IN	prep
amlodipine	JJ	compound
maleate	NN	pobj
.	.	punct

similarly	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
also	RB	advmod
conclude	VBP	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
rely	VB	ccomp
on	IN	prep
non	JJ	subtok
-	JJ	subtok
hygroscopicity	NN	pobj
as	IN	prep
a	DT	det
secondary	JJ	amod
consideration	NN	pobj
.	.	punct

thus	RB	advmod
,	,	punct
the	DT	det
two	CD	nummod
allegedly	RB	advmod
unexpected	JJ	amod
and	CC	cc
superior	JJ	conj
property	NNS	nsubj
remain	VBG	acl
be	VBP	ROOT
drug	NN	compound
stability	NN	attr
and	CC	cc
tablet	NN	compound
processing	NN	conj
.	.	punct

 	_SP	

With	IN	prep
respect	NN	pobj
to	IN	prep
stability	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ROOT
that	IN	mark
the	DT	det
¡¬303	JJ	compound
patent	NN	nsubj
provide	VBD	ccomp
an	DT	det
ordinal	JJ	amod
listing	NN	dobj
of	IN	prep
several	JJ	amod
test	VBN	amod
salt	NNS	pobj
descend	VBG	acl
in	IN	prep
rank	NN	compound
order	NN	pobj
from	IN	prep
the	DT	det
most	RBS	advmod
stable	JJ	pobj
to	IN	prep
the	DT	det
least	JJS	advmod
stable	JJ	pobj
,	,	punct
where	WRB	advmod
the	DT	det
besylate	NN	compound
salt	NN	nsubj
be	VBD	relcl
the	DT	det
most	RBS	advmod
stable	JJ	attr
of	IN	prep
the	DT	det
eight	CD	nummod
salt	NNS	pobj
test	VBN	acl
,	,	punct
and	CC	cc
the	DT	det
maleate	JJ	compound
salt	NN	nsubj
be	VBD	conj
the	DT	det
sixth	JJ	amod
most	RBS	advmod
stable	JJ	amod
salt	NN	attr
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
also	RB	advmod
find	VBD	ROOT
that	IN	mark
amlodipine	JJ	compound
besylate	NN	nsubj
be	VBD	ccomp
"	``	punct
sufficiently	RB	advmod
nonsticky	JJ	acomp
to	TO	aux
obtain	VB	xcomp
commercial	JJ	amod
processability	NN	dobj
"	''	punct
.	.	punct

pfizer	NN	nsubj
assert	VBZ	ROOT
that	IN	mark
these	DT	det
improvement	NNS	nsubj
have	VBP	ccomp
significant	JJ	amod
practical	JJ	amod
value	NN	dobj
and	CC	cc
be	VBP	conj
indicative	JJ	acomp
of	IN	prep
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	pobj
.	.	punct

 	_SP	

In	IN	prep
contrast	NN	pobj
,	,	punct
Apotex	NNP	nsubj
assert	VBZ	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
commit	VBD	ccomp
several	JJ	amod
error	NNS	dobj
when	WRB	advmod
assess	VBG	advcl
secondary	JJ	amod
consideration	NNS	dobj
.	.	punct

specifically	RB	advmod
,	,	punct
Apotex	NNP	nsubj
assert	VBZ	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
err	VBN	acl
by	IN	agent
compare	VBG	pcomp
amlodipine	JJ	compound
besylate	NN	dobj
only	RB	advmod
to	IN	prep
the	DT	det
maleate	JJ	nmod
preferred	JJ	amod
embodiment	NN	pobj
disclose	VBN	acl
in	IN	prep
the	DT	det
¡¬909	JJR	nummod
patent	NN	pobj
rather	RB	advmod
than	IN	cc
the	DT	det
entire	JJ	amod
genus	NN	pobj
of	IN	prep
amlodipine	JJ	compound
salt	NNS	pobj
claim	VBD	ccomp
therein	RB	advmod
.	.	punct

Apotex	NNP	nsubj
also	RB	advmod
ask	VBZ	ROOT
this	DT	det
court	NN	dobj
to	TO	aux
discount	VB	xcomp
Pfizer	NNP	poss
's	POS	case
evidence	NN	dobj
of	IN	prep
unexpectedly	RB	advmod
superior	JJ	amod
property	NNS	pobj
because	IN	mark
the	DT	det
stability	NN	nmod
and	CC	cc
drug	NN	conj
processing	NN	conj
property	NNS	nsubj
of	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
be	VBP	advcl
neither	CC	preconj
"	``	punct
unexpected	JJ	acomp
"	''	punct
nor	CC	cc
"	``	punct
surprising	JJ	conj
"	''	punct
.	.	punct

finally	RB	advmod
,	,	punct
Apotex	NNP	nsubj
assert	VBZ	ROOT
that	IN	mark
even	RB	advmod
if	IN	mark
amlodipine	JJ	nsubj
besylate	NN	nsubj
exhibit	VBZ	ccomp
a	DT	det
well	JJR	amod
combination	NN	dobj
of	IN	prep
solubility	NN	pobj
,	,	punct
pH	NNS	intj
,	,	punct
stability	NN	nmod
,	,	punct
non	JJ	subtok
-	JJ	subtok
hygroscopicity	JJ	amod
,	,	punct
and	CC	cc
non	JJ	subtok
-	JJ	subtok
stickiness	JJ	amod
property	NNS	conj
than	IN	prep
other	JJ	amod
member	NNS	pobj
of	IN	prep
the	DT	det
genus	NN	pobj
of	IN	prep
amlodipine	JJ	compound
salt	NNS	pobj
,	,	punct
this	DT	det
purported	JJ	amod
superiority	NN	nsubj
of	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
be	VBZ	ccomp
not	RB	neg
significant	JJ	acomp
enough	RB	advmod
as	IN	prep
a	DT	det
matter	NN	pobj
of	IN	prep
law	NN	pobj
to	TO	aux
make	VB	xcomp
-PRON-	PRP	nsubj
non	JJ	subtok
-	JJ	subtok
obvious	JJ	ccomp
.	.	punct

Apotex	NNP	nsubj
argue	VBZ	ROOT
that	IN	mark
amlodipine	NN	nsubj
be	VBZ	ccomp
the	DT	det
active	JJ	amod
ingredient	NN	attr
and	CC	cc
the	DT	det
sole	JJ	amod
source	NN	conj
of	IN	prep
therapeutic	JJ	amod
effect	NNS	pobj
of	IN	prep
amlodipine	JJ	compound
besylate	NN	pobj
,	,	punct
whereas	IN	mark
the	DT	det
besylate	NN	nsubj
be	VBZ	advcl
merely	RB	advmod
a	DT	det
means	NN	attr
of	IN	prep
deliver	VBG	pcomp
the	DT	det
amlodipine	JJ	compound
part	NN	dobj
of	IN	prep
the	DT	det
molecule	NN	pobj
.	.	punct

thus	RB	advmod
,	,	punct
Apotex	NNP	nsubj
assert	VBZ	parataxis
,	,	punct
any	DT	det
salt	NN	nsubj
need	VBP	aux
only	RB	advmod
exhibit	VB	ROOT
adequate	JJ	amod
physicochemical	JJ	amod
characteristic	NNS	dobj
in	IN	prep
order	NN	pobj
to	TO	aux
serve	VB	acl
-PRON-	PRP$	poss
purpose	NN	dobj
of	IN	prep
deliver	VBG	pcomp
the	DT	det
amlodipine	NN	dobj
.	.	punct

Apotex	NNP	nsubj
contend	VBZ	ROOT
that	IN	mark
the	DT	det
record	NN	nsubj
here	RB	advmod
demonstrate	VBZ	ccomp
that	IN	mark
the	DT	det
amlodipine	JJ	compound
maleate	JJ	compound
tablet	NN	nsubj
also	RB	advmod
perform	VBZ	ccomp
these	DT	det
same	JJ	amod
function	NNS	dobj
.	.	punct

the	DT	det
issue	NN	nsubj
before	IN	prep
-PRON-	PRP	pobj
be	VBZ	ROOT
whether	IN	mark
,	,	punct
base	VBN	prep
upon	IN	prep
the	DT	det
evidence	NN	pobj
as	IN	prep
a	DT	det
whole	NN	pobj
,	,	punct
Pfizer	NNP	poss
's	POS	case
showing	NN	nsubj
of	IN	prep
superior	JJ	amod
result	NNS	pobj
be	VBD	ccomp
sufficiently	RB	advmod
unexpected	JJ	acomp
so	IN	mark
as	IN	mark
to	TO	aux
rebut	VB	advcl
Apotex	NNP	poss
's	POS	case
showing	NN	dobj
of	IN	prep
a	DT	det
prima	NN	amod
facie	NN	compound
case	NN	pobj
of	IN	prep
obviousness	JJ	pobj
.	.	punct

  	_SP	

While	IN	mark
-PRON-	PRP	nsubj
agree	VBP	advcl
that	IN	mark
the	DT	det
teaching	NN	nsubjpass
of	IN	prep
a	DT	det
prior	JJ	amod
art	NN	compound
patent	NN	pobj
be	VBZ	auxpass
not	RB	neg
limit	VBN	ccomp
to	IN	prep
-PRON-	PRP$	poss
preferred	JJ	amod
embodiment	NN	pobj
,	,	punct
see	VB	ROOT
Merck	NNP	dobj
,	,	punct
874	CD	nummod
f.2d	CD	appos
at	IN	prep
807	CD	pobj
(	-LRB-	punct
"	``	punct
the	DT	det
fact	NN	nsubj
that	IN	mark
a	DT	det
specific	JJ	amod
[	-LRB-	punct
embodiment	NN	nsubjpass
]	-RRB-	punct
be	VBZ	auxpass
teach	VBN	acl
to	TO	aux
be	VB	auxpass
prefer	VBN	xcomp
be	VBZ	aux
not	RB	neg
control	VBG	ccomp
,	,	punct
since	IN	mark
all	DT	det
disclosure	NNS	pobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
include	VBG	prep
unpreferred	JJ	amod
embodiment	NNS	pobj
,	,	punct
must	MD	aux
be	VB	auxpass
consider	VBN	advcl
"	''	punct
)	-RRB-	punct
,	,	punct
the	DT	det
other	JJ	amod
amlodipine	JJ	compound
salt	NNS	nsubjpass
of	IN	prep
which	WDT	pobj
Apotex	NNP	nsubj
complain	VBZ	relcl
(	-LRB-	punct
i.e.	FW	advmod
,	,	punct
amlodipine	JJ	nmod
tosylate	NN	dobj
and	CC	cc
amlodipine	VB	conj
mesylate	NN	conj
)	-RRB-	punct
be	VBD	auxpass
not	RB	neg
expressly	RB	advmod
recite	VBN	conj
in	IN	prep
the	DT	det
¡¬909	JJR	nummod
patent	NN	pobj
or	CC	cc
elsewhere	RB	conj
in	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

thus	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
obligation	NN	nsubj
to	TO	aux
consider	VB	acl
the	DT	det
entire	JJ	amod
range	NN	dobj
of	IN	prep
prior	JJ	amod
art	NN	compound
compound	NNS	pobj
would	MD	aux
have	VB	aux
be	VBN	ROOT
satisfy	VBN	acomp
here	RB	advmod
by	IN	agent
-PRON-	PRP$	poss
comparison	NN	pobj
of	IN	prep
the	DT	det
close	JJS	amod
prior	JJ	amod
art	NN	compound
compound	NN	pobj
to	TO	aux
amlodipine	JJ	relcl
besylate	NN	dobj
.	.	punct

Kao	NNP	compound
Corp.	NNP	nsubjpass
v.	IN	prep
Unilever	NNP	compound
United	NNP	compound
States	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
441	CD	nummod
F.3d	NNP	appos
963	CD	nummod
,	,	punct
970	CD	nummod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.2006	ADD	appos
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
'	``	punct
when	WRB	advmod
unexpected	JJ	amod
result	NNS	nsubjpass
be	VBP	auxpass
use	VBN	advcl
as	IN	prep
evidence	NN	pobj
of	IN	prep
nonobviousness	NN	pobj
,	,	punct
the	DT	det
result	NNS	nsubjpass
must	MD	aux
be	VB	auxpass
show	VBN	ROOT
to	TO	aux
be	VB	xcomp
unexpected	JJ	acomp
compare	VBN	prep
with	IN	prep
the	DT	det
close	JJS	amod
prior	JJ	amod
art	NN	pobj
.	.	punct
'	''	punct
"	punct	punct
-RRB-	punct	punct
(	-LRB-	punct
quote	VBG	advcl
In	IN	prep
re	IN	pobj
Baxter	NNP	compound
Travenol	NNP	compound
Labs.	NNP	pobj
,	,	punct
952	CD	nummod
f.2d	CD	nummod
388	CD	appos
,	,	punct
392	CD	nummod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1991	LS	appos
)	-RRB-	punct
)	-RRB-	punct
.	.	punct

however	RB	advmod
,	,	punct
there	EX	expl
be	VBZ	ROOT
precious	JJ	acomp
little	JJ	amod
(	-LRB-	punct
if	IN	intj
any	DT	det
)	-RRB-	punct
evidence	NN	attr
to	TO	aux
support	VB	relcl
any	DT	det
implicit	JJ	amod
finding	NN	dobj
by	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
that	WDT	nsubj
amlodipine	VBP	relcl
maleate	NN	nsubj
be	VBZ	ccomp
actually	RB	advmod
the	DT	det
close	JJS	amod
prior	JJ	amod
art	NN	compound
compound	NN	attr
to	TO	aux
amlodipine	JJ	relcl
besylate	NN	dobj
.	.	punct

indeed	RB	advmod
,	,	punct
the	DT	det
prior	JJ	amod
art	NN	nsubj
of	IN	prep
Schmidt	NNP	pobj
,	,	punct
Spiegel	NNP	conj
,	,	punct
Carabateas	NNP	conj
,	,	punct
and	CC	cc
Barth	NNP	conj
,	,	punct
discuss	VBN	acl
above	RB	advmod
,	,	punct
evidence	VBZ	ROOT
that	IN	mark
one	CD	nsubj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
expect	VB	ccomp
an	DT	det
acid	NN	compound
addition	NN	compound
salt	NN	nsubj
make	VBN	acl
from	IN	prep
benzene	NN	compound
sulphonate	JJ	pobj
to	TO	aux
have	VB	ccomp
good	JJ	amod
physicochemical	JJ	amod
property	NNS	dobj
.	.	punct

 	_SP	

another	DT	det
defect	NN	nsubj
in	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
reasoning	NN	pobj
be	VBZ	ROOT
-PRON-	PRP$	poss
failure	NN	attr
to	TO	aux
recognize	VB	acl
that	DT	mark
by	IN	prep
definition	NN	pobj
,	,	punct
any	DT	det
superior	JJ	amod
property	NN	nsubj
must	MD	aux
be	VB	ccomp
unexpected	JJ	acomp
to	TO	aux
be	VB	auxpass
consider	VBN	xcomp
as	IN	prep
evidence	NN	pobj
of	IN	prep
non	JJ	subtok
-	JJ	subtok
obviousness	JJ	pobj
.	.	punct

In	IN	ROOT
re	IN	compound
Chupp	NNP	pobj
,	,	punct
816	CD	nummod
f.2d	CD	compound
643	CD	nummod
,	,	punct
646	CD	appos
(	-LRB-	punct
Fed	NNP	compound
.	.	punct
Cir.1987	NNS	appos
)	-RRB-	punct
.	.	punct

thus	RB	advmod
,	,	punct
in	IN	prep
order	NN	pobj
to	TO	aux
properly	RB	advmod
evaluate	VB	acl
whether	IN	mark
a	DT	det
superior	JJ	amod
property	NN	nsubj
be	VBD	ccomp
unexpected	JJ	acomp
,	,	punct
the	DT	det
court	NN	nsubj
should	MD	aux
have	VB	aux
consider	VBN	ROOT
what	WDT	dobj
property	NNS	nsubjpass
be	VBD	auxpass
expect	VBN	ccomp
.	.	punct

Merck	NNP	ROOT
,	,	punct
874	CD	nummod
f.2d	CD	appos
at	IN	prep
808	CD	pobj
.	.	punct

here	RB	advmod
,	,	punct
Pfizer	NNP	poss
's	POS	case
evidence	NN	nsubj
must	MD	aux
fail	VB	ROOT
because	IN	mark
the	DT	det
record	NN	nsubj
be	VBZ	advcl
devoid	JJ	acomp
of	IN	prep
any	DT	det
evidence	NN	pobj
of	IN	prep
what	WP	dobj
the	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
have	VB	aux
expect	VBN	pcomp
.	.	punct

-PRON-	PRP	nsubj
will	MD	aux
not	RB	neg
simply	RB	advmod
presume	VB	ROOT
that	IN	mark
the	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
have	VB	aux
expect	VBN	ccomp
that	DT	mark
amlodipine	JJ	compound
besylate	NN	nsubj
would	MD	aux
have	VB	ccomp
the	DT	det
same	JJ	amod
characteristic	NNS	dobj
as	IN	prep
amlodipine	NN	compound
maleate	NN	pobj
,	,	punct
because	IN	mark
as	IN	mark
Pfizer	NNP	nsubj
assert	VBZ	advcl
,	,	punct
-PRON-	PRP$	poss
property	NNS	nsubj
be	VBP	advcl
not	RB	neg
absolutely	RB	advmod
predictable	JJ	acomp
.	.	punct

further	RB	advmod
,	,	punct
Dr.	NNP	compound
Wells	NNP	poss
'	POS	case
testimony	NN	nsubj
reflect	VBZ	ROOT
the	DT	det
fact	NN	dobj
that	IN	mark
-PRON-	PRP	nsubj
believe	VBD	acl
that	IN	mark
amlodipine	JJ	compound
besylate	NN	nsubj
would	MD	aux
solve	VB	ccomp
the	DT	det
problem	NNS	dobj
of	IN	prep
amlodipine	JJ	compound
maleate	NN	pobj
.	.	punct

unrebutted	JJ	amod
testimony	NN	nsubj
from	IN	prep
Apotex	NNP	poss
's	POS	case
expert	NN	pobj
evidence	NNS	ROOT
that	WDT	mark
,	,	punct
give	VBN	prep
the	DT	det
range	NN	pobj
of	IN	prep
53	CD	nummod
anion	NNS	pobj
disclose	VBN	acl
by	IN	agent
Berge	NNP	pobj
,	,	punct
one	CD	appos
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
expect	VB	ccomp
those	DT	det
anion	NNS	nsubj
to	TO	aux
provide	VB	ccomp
salt	NNS	dobj
have	VBG	acl
a	DT	det
range	NN	dobj
of	IN	prep
property	NNS	pobj
,	,	punct
some	DT	nsubj
of	IN	prep
which	WDT	pobj
would	MD	aux
be	VB	relcl
superior	JJ	acomp
,	,	punct
and	CC	cc
some	DT	nsubj
of	IN	prep
which	WDT	pobj
would	MD	aux
be	VB	conj
inferior	JJ	acomp
,	,	punct
to	TO	aux
amlodipine	VB	xcomp
maleate	NN	dobj
.	.	punct

Pfizer	NNP	nsubj
have	VBZ	aux
simply	RB	advmod
fail	VBN	ROOT
to	TO	aux
prove	VB	xcomp
that	IN	mark
the	DT	det
result	NNS	nsubj
be	VBP	ccomp
unexpected	JJ	acomp
.	.	punct

Boesch	NNP	ROOT
,	,	punct
617	CD	nummod
f.2d	CD	appos
at	IN	prep
278	CD	pobj
.	.	punct

 	_SP	

finally	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
do	VBP	aux
not	RB	neg
see	VB	ROOT
the	DT	det
trial	NN	compound
court	NN	poss
's	POS	case
finding	NN	dobj
that	DT	mark
amlodipine	JJ	compound
besylate	NN	nsubj
have	VBD	acl
adequate	JJ	amod
physicochemical	JJ	amod
characteristic	NNS	dobj
as	IN	prep
sufficient	JJ	amod
to	TO	aux
uphold	VB	xcomp
the	DT	det
court	NN	poss
's	POS	case
ultimate	JJ	amod
holding	NN	dobj
of	IN	prep
unexpected	JJ	amod
superiority	NN	pobj
.	.	punct

pfizer	NN	nsubj
reject	VBD	ROOT
amlodipine	NN	compound
maleate	NN	dobj
not	RB	neg
because	IN	mark
-PRON-	PRP	nsubj
fail	VBD	advcl
to	TO	aux
exhibit	VB	xcomp
an	DT	det
adequate	JJ	amod
combination	NN	dobj
of	IN	prep
solubility	NN	pobj
,	,	punct
pH	NNS	intj
,	,	punct
stability	NN	conj
in	IN	prep
capsule	NN	compound
form	NN	pobj
,	,	punct
and	CC	cc
non	JJ	subtok
-	JJ	subtok
hygroscopicity	JJ	punct
,	,	punct
but	CC	cc
because	IN	mark
-PRON-	PRP	nsubjpass
could	MD	aux
not	RB	neg
be	VB	auxpass
easily	RB	advmod
manufacture	VBN	conj
because	IN	prep
of	IN	pcomp
stickiness	NN	pobj
and	CC	cc
limited	JJ	amod
stability	NN	conj
of	IN	prep
amlodipine	JJ	compound
maleate	NN	pobj
in	IN	prep
the	DT	det
preferred	JJ	amod
commercial	JJ	amod
form	NN	pobj
of	IN	prep
a	DT	det
tablet	NN	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
wrongly	RB	advmod
rely	VBN	ROOT
on	IN	prep
the	DT	det
fact	NN	pobj
that	IN	mark
the	DT	det
"	``	punct
besylate	NN	compound
salt	NN	compound
work	NNS	nsubj
"	''	punct
because	IN	mark
considerable	JJ	amod
evidence	NN	nsubj
show	VBZ	acl
that	IN	mark
amlodipine	NN	compound
maleate	NN	nsubj
also	RB	advmod
work	VBD	ccomp
for	IN	prep
-PRON-	PRP$	poss
intended	JJ	amod
purpose	NN	pobj
and	CC	cc
even	RB	advmod
do	VBD	conj
so	RB	advmod
in	IN	prep
human	JJ	amod
clinical	JJ	amod
trial	NNS	pobj
,	,	punct
even	RB	advmod
though	IN	mark
somewhat	RB	advmod
inferior	JJ	advcl
in	IN	prep
ease	NN	pobj
of	IN	prep
tablete	VBG	pcomp
and	CC	cc
project	VBN	conj
shelf	NN	compound
-	HYPH	punct
life	NN	dobj
.	.	punct

At	IN	advmod
most	RBS	advmod
,	,	punct
then	RB	advmod
,	,	punct
Pfizer	NNP	nsubj
engage	VBD	ROOT
in	IN	prep
routine	JJ	pobj
,	,	punct
verification	NN	compound
testing	NN	npadvmod
to	TO	aux
optimize	VB	relcl
selection	NN	dobj
of	IN	prep
one	CD	pobj
of	IN	prep
several	JJ	amod
know	VBN	pobj
and	CC	cc
clearly	RB	advmod
suggest	VBN	conj
pharmaceutically	RB	advmod
-	HYPH	punct
acceptable	JJ	amod
salt	NNS	dobj
to	TO	aux
ease	VB	xcomp
-PRON-	PRP$	poss
commercial	JJ	amod
manufacturing	NN	dobj
and	CC	cc
marketing	NN	conj
of	IN	prep
the	DT	det
tablet	NN	compound
form	NN	pobj
of	IN	prep
the	DT	det
therapeutic	JJ	amod
amlodipine	NN	pobj
.	.	punct

create	VBG	csubj
a	DT	det
"	``	punct
product	NN	dobj
or	CC	cc
process	NN	conj
that	WDT	nsubj
be	VBZ	relcl
more	RBR	advmod
desirable	JJ	acomp
,	,	punct
for	IN	prep
example	NN	pobj
because	IN	mark
-PRON-	PRP	nsubj
be	VBZ	advcl
strong	JJR	acomp
,	,	punct
cheap	JJR	conj
,	,	punct
clean	JJR	conj
,	,	punct
faster	RBR	advmod
,	,	punct
light	JJR	conj
,	,	punct
small	JJR	amod
,	,	punct
more	RBR	advmod
durable	JJ	conj
,	,	punct
or	CC	cc
more	RBR	advmod
efficient	JJ	conj
...	:	punct
to	TO	aux
enhance	VB	xcomp
commercial	JJ	amod
opportunity	NNS	dobj
...	NFP	punct
be	VBZ	ROOT
universal	JJ	acomp
-	:	punct
and	CC	cc
even	RB	advmod
common	JJ	amod
-	HYPH	punct
sensical	JJ	conj
"	''	punct
.	.	punct

DyStar	NNP	ROOT
,	,	punct
464	CD	nummod
f.3d	CD	appos
at	IN	prep
1368	CD	pobj
.	.	punct

amlodipine	JJ	amod
besylate	NN	nsubj
be	VBZ	ROOT
obvious	JJ	acomp
on	IN	prep
the	DT	det
fact	NNS	pobj
of	IN	prep
this	DT	det
case	NN	pobj
because	IN	mark
the	DT	det
¡¬909	JJR	nummod
patent	NN	nsubj
suggest	VBN	advcl
-	:	punct
and	CC	cc
Dr.	NNP	compound
Wells	NNP	nsubj
expect	VBD	conj
-	:	punct
that	IN	mark
every	DT	det
other	JJ	amod
potential	JJ	amod
salt	NN	compound
form	NN	nsubj
of	IN	prep
amlodipine	NN	pobj
would	MD	aux
be	VB	ccomp
adequate	JJ	acomp
for	IN	prep
-PRON-	PRP$	poss
intended	JJ	amod
purpose	NN	pobj
,	,	punct
i.e.	FW	advmod
,	,	punct
to	TO	aux
increase	VB	advcl
bioavailability	NN	dobj
of	IN	prep
amlodipine	NN	pobj
,	,	punct
and	CC	cc
would	MD	aux
solve	VB	conj
the	DT	det
stickiness	NN	compound
problem	NN	dobj
of	IN	prep
the	DT	det
maleate	JJ	compound
salt	NN	pobj
.	.	punct

the	DT	det
fact	NN	nsubj
that	IN	mark
amlodipine	JJ	compound
besylate	NN	nsubj
be	VBD	acl
the	DT	det
good	JJS	attr
of	IN	prep
the	DT	det
seven	CD	nummod
acid	NN	compound
addition	NN	compound
salt	NNS	pobj
actually	RB	advmod
test	VBD	acl
prove	VBZ	ROOT
nothing	NN	dobj
more	JJR	amod
than	IN	prep
routine	JJ	amod
optimization	NN	pobj
that	WDT	nsubj
would	MD	aux
have	VB	aux
be	VBN	relcl
obvious	JJ	acomp
to	IN	prep
one	CD	pobj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
.	.	punct

see	VB	ROOT
Aller	NNP	dobj
,	,	punct
220	CD	nummod
f.2d	CD	appos
at	IN	prep
456	CD	pobj
(	-LRB-	punct
"	``	punct
even	RB	advmod
though	IN	mark
applicant	NN	poss
's	POS	case
modification	NN	compound
result	NNS	pobj
in	IN	prep
great	JJ	amod
improvement	NN	pobj
and	CC	cc
utility	NN	conj
over	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
may	MD	aux
still	RB	advmod
not	RB	neg
be	VB	advcl
patentable	JJ	acomp
if	IN	mark
the	DT	det
modification	NN	nsubj
be	VBD	advcl
within	IN	prep
the	DT	det
capability	NNS	pobj
of	IN	prep
one	CD	pobj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

These	DT	det
fact	NNS	nsubj
lead	VBP	ROOT
-PRON-	PRP	dobj
to	TO	aux
conclude	VB	xcomp
that	IN	mark
the	DT	det
result	VBG	amod
commercial	JJ	amod
embodiment	NN	nsubj
claim	VBN	ccomp
in	IN	prep
the	DT	det
¡¬303	JJ	nummod
patent	NN	pobj
,	,	punct
amlodipine	JJ	compound
besylate	NN	appos
,	,	punct
do	VBZ	aux
not	RB	neg
satisfy	VB	conj
the	DT	det
standard	NNS	dobj
of	IN	prep
patentability	NN	pobj
.	.	punct

  	_SP	

alternatively	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
hold	VBP	ROOT
that	IN	mark
even	RB	advmod
if	IN	mark
Pfizer	NNP	nsubj
show	VBD	advcl
that	IN	mark
amlodipine	JJ	compound
besylate	NN	compound
exhibit	VBZ	nsubj
unexpectedly	RB	advmod
superior	JJ	amod
result	NNS	ccomp
,	,	punct
this	DT	det
secondary	JJ	amod
consideration	NN	nsubj
do	VBZ	aux
not	RB	neg
overcome	VB	ccomp
the	DT	det
strong	JJ	amod
showing	NN	dobj
of	IN	prep
obviousness	JJ	pobj
in	IN	prep
this	DT	det
case	NN	pobj
.	.	punct

Although	IN	mark
secondary	JJ	amod
consideration	NNS	nsubjpass
must	MD	aux
be	VB	auxpass
take	VBN	advcl
into	IN	prep
account	NN	pobj
,	,	punct
-PRON-	PRP	nsubj
do	VBP	aux
not	RB	neg
necessarily	RB	advmod
control	VB	ROOT
the	DT	det
obviousness	JJ	amod
conclusion	NN	dobj
.	.	punct

Newell	NNP	compound
Cos	NNP	subtok
.	NNP	ROOT
,	,	punct
Inc.	NNP	npadvmod
v.	CC	prep

Kenney	NNP	compound
Mfg	NNP	nmod
.	.	punct
Co.	NNP	ROOT
,	,	punct
864	CD	npadvmod
f.2d	CD	nummod
757	CD	nummod
,	,	punct

768	CD	nummod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.1988	CD	ROOT
)	-RRB-	punct
.	.	punct

here	RB	advmod
,	,	punct
the	DT	det
record	NN	nsubj
establish	VBZ	ROOT
such	PDT	predet
a	DT	det
strong	JJ	amod
case	NN	dobj
of	IN	prep
obviousness	JJ	pobj
that	WDT	mark
Pfizer	NNP	poss
's	POS	case
allege	VBN	amod
unexpectedly	RB	advmod
superior	JJ	amod
result	NNS	nsubj
be	VBP	acl
ultimately	RB	advmod
insufficient	JJ	acomp
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
769	CD	pobj
.	.	punct

 	_SP	

From	IN	prep
-PRON-	PRP$	poss
de	FW	nmod
novo	NN	compound
assessment	NN	pobj
of	IN	prep
the	DT	det
determination	NN	pobj
below	RB	advmod
on	IN	prep
obviousness	JJ	pobj
in	IN	prep
view	NN	pobj
of	IN	prep
all	DT	pobj
of	IN	prep
the	DT	det
evidence	NN	pobj
and	CC	cc
for	IN	prep
the	DT	det
reason	NNS	pobj
articulate	VBN	acl
above	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
conclude	VBP	ROOT
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
err	VBD	ccomp
in	IN	prep
hold	VBG	pcomp
that	IN	mark
the	DT	det
claim	NNS	nsubj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
would	MD	aux
not	RB	neg
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
.	.	punct

 	_SP	

III	NNP	nmod
.	.	punct
conclusion	NN	ROOT

 	_SP	

Because	IN	mark
-PRON-	PRP	nsubj
find	VBP	advcl
claim	NNS	dobj
1	CD	npadvmod
-	SYM	punct
3	CD	prep
of	IN	prep
the	DT	det
¡¬303	JJ	nummod
patent	NN	compound
invalid	JJ	pobj
for	IN	prep
obviousness	JJ	pobj
,	,	punct
-PRON-	PRP	nsubj
find	VBP	ROOT
-PRON-	PRP	nsubj
unnecessary	JJ	ccomp
to	TO	aux
address	VB	advcl
Apotex	NNP	poss
's	POS	case
assertion	NN	dobj
that	IN	mark
Pfizer	NNP	nsubj
engage	VBD	acl
in	IN	prep
inequitable	JJ	amod
conduct	NN	pobj
during	IN	prep
prosecution	NN	pobj
of	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
and	CC	cc
that	IN	mark
-PRON-	PRP$	poss
patent	NN	nsubjpass
should	MD	aux
therefore	RB	advmod
be	VB	auxpass
declare	VBN	conj
unenforceable	JJ	oprd
.	.	punct

For	IN	prep
the	DT	det
aforementioned	JJ	amod
reason	NNS	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
judgment	NN	nsubjpass
be	VBZ	auxpass
reverse	VBN	ROOT
.	.	punct

 	_SP	

LINN	NNP	nsubj
,	,	punct
Circuit	NNP	compound
Judge	NNP	npadvmod
,	,	punct
concur	NNS	ROOT
in	IN	prep
the	DT	det
result	NN	pobj
.	.	punct

 	_SP	

all	DT	det
Citations	NNPS	ROOT

 	_SP	
480	CD	nummod
f.3d	CD	appos
1348	CD	appos
,	,	punct
82	CD	nummod
U.S.P.Q.2d	NNP	appos
1321	CD	nummod

 	_SP	

Footnotes	NNP	ROOT

 	_SP	

Besylate	NNP	nsubjpass
be	VBZ	auxpass
refer	VBN	ROOT
to	IN	prep
in	IN	prep
the	DT	det
art	NN	pobj
interchangeably	RB	advmod
as	IN	prep
benzene	NN	compound
sulphonate	JJ	pobj
,	,	punct
benzenesulphonate	VBP	conj
,	,	punct
or	CC	cc
benzene	VB	compound
sulfonate	NN	conj
.	.	punct

 	_SP	

the	DT	det
¡¬909	NN	nummod
patent	NN	nsubj
be	VBD	ROOT
subject	JJ	acomp
to	IN	prep
an	DT	det
appeal	NN	pobj
before	IN	prep
this	DT	det
court	NN	pobj
in	IN	prep
Pfizer	NNP	compound
Inc.	NNP	pobj
v.	CC	prep
Dr.	NNP	compound
Reddy	NNP	poss
's	POS	case
Labs.	NNP	nmod
,	,	punct
Ltd.	NNP	pobj
,	,	punct
359	CD	nummod
f.3d	CD	npadvmod
1361	CD	nummod
(	-LRB-	punct
Fed	NNP	pobj
.	.	punct
Cir.2004	LS	npadvmod
)	-RRB-	punct
.	.	punct

there	RB	advmod
,	,	punct
this	DT	det
court	NN	nsubj
hold	VBD	ROOT
that	IN	mark
the	DT	det
term	NN	nsubj
of	IN	prep
the	DT	det
¡¬909	JJR	nummod
patent	NN	pobj
as	IN	mark
extend	VBN	advcl
under	IN	prep
the	DT	det
patent	NN	compound
term	NN	compound
restoration	NN	compound
provision	NN	pobj
of	IN	prep
the	DT	det
Hatch	NNP	compound
-	HYPH	punct
Waxman	NNP	compound
Act	NNP	pobj
cover	VBZ	ccomp
amlodipine	NN	dobj
and	CC	cc
any	DT	det
salt	NN	conj
or	CC	cc
ester	NN	conj
as	IN	mark
claim	VBN	advcl
in	IN	prep
claim	NNS	pobj
1	CD	nummod
,	,	punct
7	CD	nummod
,	,	punct
and	CC	cc
8	CD	conj
.	.	punct

Idaho	NNS	ROOT
at	IN	prep
1367	CD	pobj
.	.	punct

 	_SP	

-PRON-	PRP	nsubj
recognize	VBP	ROOT
that	DT	det
hydrochloride	NN	nsubj
and	CC	cc
hydrobromide	NN	conj
be	VBP	ccomp
not	RB	neg
technically	RB	advmod
anion	NNS	attr
.	.	punct

however	RB	advmod
,	,	punct
since	IN	mark
the	DT	det
patentee	NN	nsubj
choose	VBD	advcl
to	TO	aux
be	VB	xcomp
-PRON-	PRP$	poss
own	JJ	amod
lexicographer	NN	attr
,	,	punct
-PRON-	PRP	nsubj
will	MD	aux
refer	VB	ROOT
to	IN	prep
these	DT	det
two	CD	nummod
acid	NNS	pobj
as	IN	prep
anion	NNS	pobj
for	IN	prep
purpose	NNS	pobj
of	IN	prep
this	DT	det
opinion	NN	pobj
.	.	punct

phillip	NNS	ROOT
v.	IN	prep
AWH	NNP	compound
Corp.	NNP	pobj
,	,	punct
415	CD	nummod
f.3d	CD	appos
1303	CD	nummod
,	,	punct
1316	CD	appos
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.2005	LS	dobj
)	-RRB-	punct
(	-LRB-	punct
en	IN	prep
banc	NN	npadvmod
)	-RRB-	punct
.	.	punct

 	_SP	

the	DT	det
trial	NN	compound
transcript	NN	nsubj
read	VBZ	ROOT
,	,	punct
"	``	punct
the	DT	det
patent	NN	compound
examiner	NN	nsubj
can	MD	aux
not	RB	neg
[	-LRB-	punct
sic	JJ	ccomp
]	-RRB-	punct
have	VBP	aux
be	VBN	ccomp
aware	JJ	acomp
of	IN	prep
the	DT	det
Berge	NNP	compound
article	NN	pobj
as	IN	mark
-PRON-	PRP	nsubjpass
be	VBD	auxpass
specifically	RB	advmod
note	VBN	advcl
and	CC	cc
cite	VBN	conj
in	IN	prep
the	DT	det
¡¬303	JJ	compound
patent	NN	pobj
-PRON-	PRP	appos
.	.	punct

As	IN	prep
such	JJ	amod
,	,	punct
the	DT	det
Court	NNP	nsubj
could	MD	aux
not	RB	neg
possibly	RB	advmod
find	VB	ROOT
by	IN	prep
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
evidence	NN	pobj
that	IN	mark
the	DT	det
article	NN	nsubjpass
and	CC	cc
-PRON-	PRP$	poss
teaching	NNS	conj
could	MD	aux
not	RB	neg
have	VB	aux
be	VBN	auxpass
consider	VBN	ccomp
by	IN	agent
the	DT	det
patent	NN	pobj
[	-LRB-	punct
sic	NN	oprd
]	-RRB-	punct
when	WRB	advmod
ultimately	RB	advmod
determine	VBG	advcl
whether	IN	mark
the	DT	det
¡¬303	JJ	compound
patent	NN	nsubj
be	VBD	ccomp
obvious	JJ	acomp
....	.	punct
"	''	punct
bench	JJ	compound
order	NN	compound
tr	UH	subtok
.	.	punct

22:16	CD	ROOT
-	SYM	punct
22	CD	prep
.	.	punct

-PRON-	PRP	nsubj
interpret	VBP	ROOT
this	DT	det
passage	NN	dobj
in	IN	prep
the	DT	det
only	JJ	amod
way	NN	pobj
that	WDT	nsubj
make	VBZ	relcl
sense	NN	dobj
-	:	punct
that	IN	mark
the	DT	det
Examiner	NNP	nsubj
do	VBD	aux
consider	VB	ccomp
the	DT	det
Berge	NNP	compound
reference	NN	dobj
during	IN	prep
prosecution	NN	pobj
.	.	punct

While	IN	mark
oral	JJ	amod
bench	NN	compound
ruling	NNS	nsubjpass
be	VBP	auxpass
certainly	RB	advmod
authorize	VBN	advcl
,	,	punct
-PRON-	PRP	nsubj
may	MD	aux
be	VB	ROOT
ill	RB	advmod
-	HYPH	punct
advise	VBN	acomp
in	IN	prep
a	DT	det
case	NN	pobj
of	IN	prep
this	DT	det
complexity	NN	pobj
.	.	punct

 	_SP	

the	DT	det
"	``	punct
clear	JJ	amod
and	CC	cc
convincing	JJ	conj
"	``	punct
standard	NN	nsubj
be	VBZ	ROOT
an	DT	det
intermediate	JJ	amod
standard	NN	attr
which	WDT	nsubj
lie	VBZ	relcl
somewhere	RB	advmod
in	IN	prep
between	IN	prep
the	DT	pobj
"	``	punct
beyond	IN	prep
a	DT	det
reasonable	JJ	amod
doubt	NN	pobj
"	''	punct
and	CC	cc
the	DT	det
"	``	punct
preponderance	NN	conj
of	IN	prep
the	DT	det
evidence	NN	pobj
"	''	punct
standard	NNS	appos
of	IN	prep
proof	NN	pobj
.	.	punct

Addington	NNP	ROOT
v.	CC	prep
Texas	NNP	pobj
,	,	punct
441	CD	nummod
U.S.	NNP	appos
418	CD	nummod
,	,	punct
425	CD	appos
,	,	punct

99	CD	nummod
s.ct	NN	subtok
.	.	ROOT

1804	CD	ROOT
,	,	punct
60	CD	nummod
l.ed.2d	NN	pobj
323	CD	nummod
(	-LRB-	punct
1979	CD	appos
)	-RRB-	punct
;	:	punct
see	VB	conj
also	RB	advmod
SSIH	NNP	compound
Equip	NNP	dobj
.	.	punct

S.A.	NNP	nmod
v.	IN	prep
United	NNP	compound
States	NNP	pobj
Int'l	NNP	compound
Trade	NNP	compound
Comm'n	NNPS	ROOT
,	,	punct
718	CD	nummod
f.2d	CD	nummod
365	CD	appos
,	,	punct
380	CD	nummod
-	SYM	punct
81	CD	prep
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1983	LS	appos
)	-RRB-	punct
(	-LRB-	punct
Nies	NNP	appos
,	,	punct
J.	NNP	appos
,	,	punct
additional	JJ	amod
view	NNS	appos
)	-RRB-	punct
.	.	punct

Although	IN	mark
an	DT	det
exact	JJ	amod
definition	NN	nsubj
be	VBZ	advcl
elusive	JJ	acomp
,	,	punct
"	``	punct
clear	JJ	nsubjpass
and	CC	cc
convincing	JJ	conj
evidence	NN	dobj
"	''	punct
have	VBZ	aux
be	VBN	auxpass
describe	VBN	ROOT
as	IN	prep
evidence	NN	pobj
that	IN	mark
"	``	punct
place	NNS	nsubj
in	IN	prep
the	DT	det
ultimate	JJ	amod
factfinder	NN	pobj
an	DT	det
abide	VBG	amod
conviction	NN	pobj
that	IN	mark
the	DT	det
truth	NN	nsubj
of	IN	prep
-PRON-	PRP$	poss
factual	JJ	amod
contention	NNS	pobj
be	VBP	acl
highly	RB	advmod
probable	JJ	acomp
"	''	punct
.	.	punct

Colorado	NNP	npadvmod
v.	IN	prep
New	NNP	compound
Mexico	NNP	pobj
,	,	punct
467	CD	nummod
U.S.	NNP	appos
310	CD	nummod
,	,	punct
316	CD	nummod
,	,	punct
104	CD	nummod
S.Ct	NNP	subtok
.	.	punct
2433	CD	appos
,	,	punct
81	CD	nummod
l.ed.2d	NN	nmod
247	CD	nummod
(	-LRB-	punct
1984	CD	appos
)	-RRB-	punct
(	-LRB-	punct
internal	JJ	amod
quotation	NNS	nsubj
omit	VBN	ROOT
)	-RRB-	punct
.	.	punct

 	_SP	

-PRON-	PRP	nsubj
reject	VBP	ROOT
Apotex	NNP	poss
's	POS	case
assertion	NN	dobj
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
err	VBD	acl
by	IN	prep
give	VBG	pcomp
weight	NN	dobj
to	IN	dative
the	DT	det
commercial	JJ	amod
success	NN	pobj
of	IN	prep
Norvasc	NNP	compound
(r)	SYM	pobj
.	.	punct

the	DT	det
district	NN	compound
court	NN	nsubj
rely	VBD	ROOT
on	IN	prep
the	DT	det
production	NN	pobj
of	IN	prep
billion	NNS	pobj
of	IN	prep
amlodipine	JJ	compound
besylate	NN	compound
tablet	NNS	pobj
by	IN	prep
Pfizer	NNP	pobj
as	IN	prep
evidence	NN	pobj
of	IN	prep
non	JJ	subtok
-	JJ	subtok
stickiness	JJ	amod
rather	RB	advmod
than	IN	cc
commercial	JJ	amod
success	NN	pobj
.	.	punct

Apotex	NNP	poss
's	POS	case
argument	NNS	nsubj
with	IN	prep
regard	NN	pobj
to	IN	prep
an	DT	det
alleged	JJ	amod
absence	NN	pobj
of	IN	prep
a	DT	det
"	``	punct
nexus	NN	pobj
"	''	punct
between	IN	prep
the	DT	det
claim	VBN	amod
feature	NNS	pobj
and	CC	cc
the	DT	det
sale	NNS	conj
of	IN	prep
Norvasc	NNP	compound
(r)	SYM	pobj
be	VBP	ROOT
therefore	RB	advmod
irrelevant	JJ	acomp
.	.	punct

 	_SP	

